2787530	355	Trauth BC	Monoclonal antibody-mediated tumor regression by induction of apoptosis.	Science	1989	249
8521815	355	Kischkel FC	Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.	The EMBO journal	1995	339
8946836	355	Strand S	Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?	Nature medicine	1996	129
9708736	355	Hakem R	Differential requirement for caspase 9 in apoptotic pathways in vivo.	Cell	1998	196
9988752	355	Sun XM	Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis.	The Journal of biological chemistry	1999	102
10601363	355	Kennedy NJ	Caspase activation is required for T cell proliferation.	The Journal of experimental medicine	1999	103
10779432	355	Fagnoni FF	Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging.	Blood	2000	91
15367603	355	Sanchez A	Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels.	Journal of virology	2004	85
15607806	355	Smyth MJ	Activation of NK cell cytotoxicity.	Molecular immunology	2005	84
18512812	355	Jacobi AM	Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95.	Arthritis and rheumatism	2008	61
19155494	355	Strauss L	Human circulating CD4+CD25highFoxp3+ regulatory T cells kill autologous CD8+ but not CD4+ responder cells by Fas-mediated apoptosis.	Journal of immunology	2009	50
23222456	355	Lugli E	Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells.	Nature protocols	2013	44
7528780	356	Alderson MR	Fas ligand mediates activation-induced cell death in human T lymphocytes.	The Journal of experimental medicine	1995	167
9064324	356	O'Connell J	The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.	The Journal of experimental medicine	1996	132
9180075	356	Stenger S	Differential effects of cytolytic T cell subsets on intracellular infection.	Science	1997	114
10202932	356	Baize S	Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients.	Nature medicine	1999	160
15655551	356	Taylor DD	Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects.	British journal of cancer	2005	87
15709166	356	Kim JW	Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.	Clinical cancer research 	2005	92
16424182	356	Taylor DD	Pregnancy-associated exosomes and their modulation of T cell signaling.	Journal of immunology	2006	85
19239902	356	Strasser A	The many roles of FAS receptor signaling in the immune system.	Immunity	2009	225
22904309	356	Lugini L	Immune surveillance properties of human NK cell-derived exosomes.	Journal of immunology	2012	47
24184557	356	Stenqvist AC	Exosomes secreted by human placenta carry functional Fas ligand and TRAIL molecules and convey apoptosis in activated immune cells, suggesting exosome-mediated immune privilege of the fetus.	Journal of immunology	2013	30
7890387	820	Larrick JW	Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein.	Infection and immunity	1995	117
9689116	820	Bals R	The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface.	Proceedings of the National Academy of Sciences of the United States of America	1998	155
10417311	820	Oren Z	Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.	The Biochemical journal	1999	128
11015447	820	De Yang	LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.	The Journal of experimental medicine	2000	241
11049988	820	Agerberth B	The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations.	Blood	2000	146
12244186	820	Scott MG	The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses.	Journal of immunology	2002	122
12603850	820	Heilborn JD	The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium.	The Journal of investigative dermatology	2003	104
15067080	820	Elssner A	A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release.	Journal of immunology	2004	97
15561843	820	Sieprawska-Lupa M	Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.	Antimicrobial agents and chemotherapy	2004	111
15569695	820	Bowdish DM	Impact of LL-37 on anti-infective immunity.	Journal of leukocyte biology	2005	89
16053249	820	Zanetti M	The role of cathelicidins in the innate host defenses of mammals.	Current issues in molecular biology	2005	78
16293630	820	Rosenfeld Y	Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action.	The Journal of biological chemistry	2006	63
16493063	820	Nagaoka I	An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7.	Journal of immunology	2006	61
16716248	820	DÃ¼rr UH	LL-37, the only human member of the cathelicidin family of antimicrobial peptides.	Biochimica et biophysica acta	2006	158
16909917	820	Bowdish DM	Immunomodulatory properties of defensins and cathelicidins.	Current topics in microbiology and immunology	2006	64
17873860	820	Lande R	Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.	Nature	2007	360
18439024	820	Porcelli F	NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles.	Biochemistry	2008	55
18852235	820	Seib KL	Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.	Infection and immunity	2009	49
19703986	820	Ganguly D	Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8.	The Journal of experimental medicine	2009	116
19710683	820	Cogen AL	Selective antimicrobial action is provided by phenol-soluble modulins derived from Staphylococcus epidermidis, a normal resident of the skin.	The Journal of investigative dermatology	2010	80
19748465	820	Yuk JM	Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin.	Cell host and microbe	2009	167
19808939	820	Doss M	Human defensins and LL-37 in mucosal immunity.	Journal of leukocyte biology	2010	59
22031815	820	Barlow PG	Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.	PloS one	2011	51
22589721	820	Campbell GR	Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy.	PLoS pathogens	2012	74
23267025	820	Kahlenberg JM	Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages.	Journal of immunology	2013	51
23722903	820	Knight JS	Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.	The Journal of clinical investigation	2013	70
24185823	820	Kahlenberg JM	Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease.	Journal of immunology	2013	28
7584140	909	Morita CT	Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells.	Immunity	1995	117
10888933	909	Wu SJ	Human skin Langerhans cells are targets of dengue virus infection.	Nature medicine	2000	176
15032598	909	Brigl M	CD1: antigen presentation and T cell function.	Annual review of immunology	2004	303
15186722	909	Zhang W	Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells.	Stem cells and development	2004	108
16887966	909	Nauta AJ	Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells.	Journal of immunology	2006	162
18789730	909	Klechevsky E	Functional specializations of human epidermal Langerhans cells and CD14+ dermal dendritic cells.	Immunity	2008	195
24362891	909	de Jong A	CD1a-autoreactive T cells recognize natural skin oils that function as headless antigens.	Nature immunology	2014	35
12796469	912	Dhodapkar MV	A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma.	The Journal of experimental medicine	2003	91
15665086	912	Wu D	Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells.	Proceedings of the National Academy of Sciences of the United States of America	2005	73
16007090	912	Koch M	The crystal structure of human CD1d with and without alpha-galactosylceramide.	Nature immunology	2005	122
16647712	912	Liu Y	A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.	Journal of immunological methods	2006	70
17485514	912	McCarthy C	The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.	The Journal of experimental medicine	2007	87
17581592	912	Borg NA	CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.	Nature	2007	191
17589542	912	Godfrey DI	Control points in NKT-cell development.	Nature reviews. Immunology	2007	98
18535199	912	Chang DH	Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer.	Blood	2008	55
19033672	912	De Santo C	Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans.	The Journal of clinical investigation	2008	101
19859526	912	Fox LM	Recognition of lyso-phospholipids by human natural killer T lymphocytes.	PLoS biology	2009	96
22406267	912	Bosma A	Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells.	Immunity	2012	32
22829134	912	Bai L	The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant VÎ´1 TCR.	European journal of immunology	2012	46
24795465	912	Gapin L	Check MAIT.	Journal of immunology	2014	20
1361652	920	-	1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.	MMWR. Recommendations and reports 	1992	637
2564898	920	Tersmette M	Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates.	Journal of virology	1989	210
2665081	920	Schnittman SM	The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4.	Science	1989	173
2823150	920	Doyle C	Interaction between CD4 and class II MHC molecules mediates cell adhesion.	Nature	1987	173
3107838	920	Stein BS	pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane.	Cell	1987	235
3257102	920	Willey RL	In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.	Journal of virology	1988	319
3299090	920	Richman DD	The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.	The New England journal of medicine	1987	195
6096719	920	Dalgleish AG	The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.	Nature	1984	854
7540117	920	Fisher GH	Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.	Cell	1995	207
7675046	920	Walter EA	Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.	The New England journal of medicine	1995	327
7738173	920	Roederer M	CD8 naive T cell counts decrease progressively in HIV-infected adults.	The Journal of clinical investigation	1995	130
8095306	920	Connor RI	Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.	Journal of virology	1993	135
8096068	920	Embretson J	Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.	Nature	1993	306
8187174	920	York IA	A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes.	Cell	1994	164
8294871	920	Posnett DN	Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy".	The Journal of experimental medicine	1994	147
8614801	920	Wolinsky SM	Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection.	Science	1996	176
9063413	920	Comans-Bitter WM	Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations.	The Journal of pediatrics	1997	111
9188531	920	Orenstein JM	Macrophages as a source of HIV during opportunistic infections.	Science	1997	152
9204894	920	Autran B	Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.	Science	1997	294
9360926	920	Wong JK	Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.	Science	1997	528
9360927	920	Finzi D	Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.	Science	1997	682
9371822	920	Chun TW	Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.	Proceedings of the National Academy of Sciences of the United States of America	1997	463
9420212	920	Matano T	Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.	Journal of virology	1998	185
9525993	920	Koelle DM	Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes.	The Journal of clinical investigation	1998	103
9702772	920	Rufer N	Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry.	Nature biotechnology	1998	106
9883844	920	Hellerstein M	Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.	Nature medicine	1999	140
10364556	920	Siegal FP	The nature of the principal type 1 interferon-producing cells in human blood.	Science	1999	466
10500077	920	Gerlach JT	Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C.	Gastroenterology	1999	163
10607709	920	Hazenberg MD	T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).	Blood	2000	129
10700238	920	Anderson RP	In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.	Nature medicine	2000	95
11076879	920	Spiller RC	Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.	Gut	2000	188
11309627	920	McCune JM	The dynamics of CD4+ T-cell depletion in HIV disease.	Nature	2001	151
11348697	920	Siegrist CA	Neonatal and early life vaccinology.	Vaccine	2001	132
11431351	920	Nakano O	Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.	Cancer research	2001	107
11483742	920	Janini M	Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells.	Journal of virology	2001	88
11500352	920	Retamales I	Amplification of inflammation in emphysema and its association with latent adenoviral infection.	American journal of respiratory and critical care medicine	2001	91
11672548	920	Eckstein DA	HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.	Immunity	2001	106
11696593	920	Mohri H	Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.	The Journal of experimental medicine	2001	105
11711588	920	Betts MR	Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.	Journal of virology	2001	251
11748275	920	Kovacs JA	Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.	The Journal of experimental medicine	2001	85
11752161	920	Zhu T	Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.	Journal of virology	2002	115
11861835	920	Edwards TG	Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.	Journal of virology	2002	92
11917238	920	Giorgi JV	Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection.	Journal of acquired immune deficiency syndromes	2002	96
12131186	920	Ling B	SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans.	AIDS	2002	89
12218162	920	Sousa AE	CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load.	Journal of immunology	2002	154
12393849	920	Schacker TW	Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.	The Journal of clinical investigation	2002	82
12411292	920	Gamadia LE	Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease.	Blood	2003	108
12524385	920	Douek DC	T cell dynamics in HIV-1 infection.	Annual review of immunology	2003	185
12552096	920	Chun TW	Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.	Proceedings of the National Academy of Sciences of the United States of America	2003	76
12648460	920	Silvestri G	Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.	Immunity	2003	257
12721933	920	Hunt PW	T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.	The Journal of infectious diseases	2003	296
12743287	920	Casimiro DR	Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.	Journal of virology	2003	140
12805437	920	Hermankova M	Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.	Journal of virology	2003	81
12960820	920	Hazenberg MD	Persistent immune activation in HIV-1 infection is associated with progression to AIDS.	AIDS	2003	255
14557216	920	Kaufmann GR	CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.	Archives of internal medicine	2003	85
14557656	920	Guadalupe M	Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.	Journal of virology	2003	336
14610491	920	Shearer WT	Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.	The Journal of allergy and clinical immunology	2003	152
14614606	920	Kamisawa T	A new clinicopathological entity of IgG4-related autoimmune disease.	Journal of gastroenterology	2003	132
14715541	920	Lugada ES	Population-based hematologic and immunologic reference values for a healthy Ugandan population.	Clinical and diagnostic laboratory immunology	2004	95
14722271	920	Brenchley JM	T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis.	Journal of virology	2004	161
14966528	920	Papagno L	Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection.	PLoS biology	2004	124
15034567	920	Reece WH	A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.	Nature medicine	2004	86
15117761	920	Deeks SG	Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.	Blood	2004	289
15163705	920	Han Y	Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.	Journal of virology	2004	127
15210746	920	Matano T	Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial.	The Journal of experimental medicine	2004	89
15247437	920	Hazuda DJ	Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.	Science	2004	73
15280419	920	Kinter AL	CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.	The Journal of experimental medicine	2004	159
15362047	920	Lauer GM	High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.	Gastroenterology	2004	96
15376257	920	Ulrichs T	Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung.	The Journal of pathology	2004	82
15545358	920	Messaoudi I	Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense.	The Journal of experimental medicine	2004	72
15616015	920	Lindley S	Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.	Diabetes	2005	181
15793563	920	Mattapallil JJ	Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.	Nature	2005	557
15827153	920	Nobile C	Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes.	Journal of virology	2005	65
15994817	920	Reynolds MR	CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little.	Journal of virology	2005	75
16081852	920	Sutherland JS	Activation of thymic regeneration in mice and humans following androgen blockade.	Journal of immunology	2005	103
16093359	920	Pudney J	Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.	Biology of reproduction	2005	105
16116467	920	Klenerman P	T cells and viral persistence: lessons from diverse infections.	Nature immunology	2005	132
16147978	920	Sylwester AW	Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects.	The Journal of experimental medicine	2005	363
16186818	920	Frentsch M	Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.	Nature medicine	2005	109
16227428	920	Thompson PM	Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline.	Proceedings of the National Academy of Sciences of the United States of America	2005	117
16276421	920	Chun TW	HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.	The Journal of clinical investigation	2005	117
16282341	920	Berger C	Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.	Blood	2006	87
16339561	920	Fletcher JM	Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion.	Journal of immunology	2005	66
16364740	920	Yamashita M	Retroviral infection of non-dividing cells: old and new perspectives.	Virology	2006	75
16421594	920	Hiraoka K	Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma.	British journal of cancer	2006	76
16482171	920	Brenchley JM	HIV disease: fallout from a mucosal catastrophe?	Nature immunology	2006	197
16540683	920	Fecci PE	Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.	Cancer research	2006	144
16631548	920	Battegay M	Immunological recovery and antiretroviral therapy in HIV-1 infection.	The Lancet. Infectious diseases	2006	61
16645169	920	Titanji K	Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.	Blood	2006	116
16704732	920	Palmer C	Cell-type specific gene expression profiles of leukocytes in human peripheral blood.	BMC genomics	2006	93
16735692	920	Mattapallil JJ	Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge.	The Journal of experimental medicine	2006	80
16753288	920	Picker LJ	Immunopathogenesis of acute AIDS virus infection.	Current opinion in immunology	2006	73
16763152	920	Letvin NL	Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys.	Science	2006	178
17024229	920	Mazmanian SK	The love-hate relationship between bacterial polysaccharides and the host immune system.	Nature reviews. Immunology	2006	68
17084877	920	Thomas ER	Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion.	Virology	2007	71
17205456	920	Moore RD	CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.	Clinical infectious diseases 	2007	108
17210718	920	Piersma SJ	High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer.	Cancer research	2007	70
17224919	920	Han Y	Experimental approaches to the study of HIV-1 latency.	Nature reviews. Microbiology	2007	91
17251286	920	Friedrich TC	Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication.	Journal of virology	2007	119
17255740	920	Lawn SD	Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa.	AIDS	2007	112
17258731	920	von Hahn T	Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo.	Gastroenterology	2007	144
17307815	920	Ip JY	Global analysis of alternative splicing during T-cell activation.	RNA	2007	62
17492591	920	Chun TW	Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.	The Journal of infectious diseases	2007	72
17565153	920	Biggar RJ	AIDS-related cancer and severity of immunosuppression in persons with AIDS.	Journal of the National Cancer Institute	2007	93
17570691	920	He B	Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.	Immunity	2007	180
17709519	920	Milush JM	Virally induced CD4+ T cell depletion is not sufficient to induce AIDS in a natural host.	Journal of immunology	2007	65
17717638	920	Talmadge JE	Inflammatory cell infiltration of tumors: Jekyll or Hyde.	Cancer metastasis reviews	2007	75
17728240	920	Chen P	Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.	Journal of virology	2007	172
17913974	920	Venet F	Regulatory T cell populations in sepsis and trauma.	Journal of leukocyte biology	2008	56
17916442	920	Boasso A	Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.	Clinical immunology	2008	78
17959677	920	Sankaran S	Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.	Journal of virology	2008	82
17986574	920	Koch S	Cytomegalovirus infection: a driving force in human T cell immunosenescence.	Annals of the New York Academy of Sciences	2007	62
18171295	920	Hunt PW	Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy.	The Journal of infectious diseases	2008	248
18172269	920	Welters MJ	Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.	Clinical cancer research 	2008	101
18198941	920	Denton PW	Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.	PLoS medicine	2008	154
18222733	920	Czesnikiewicz-Guzik M	T cell subset-specific susceptibility to aging.	Clinical immunology	2008	98
18240953	920	Moir S	Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease.	The Journal of infectious diseases	2008	62
18260759	920	Chun TW	Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy.	The Journal of infectious diseases	2008	177
18375792	920	Stasi R	Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab.	Blood	2008	58
18382686	920	Funderburg N	Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis.	PloS one	2008	60
18413766	920	Singh H	Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system.	Cancer research	2008	99
18427206	920	Toure S	Rapid scaling-up of antiretroviral therapy in 10,000 adults in CÃ´te d'Ivoire: 2-year outcomes and determinants.	AIDS	2008	101
18494555	920	Bisson GP	Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.	PLoS medicine	2008	68
18525257	920	Sagot-Lerolle N	Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir.	AIDS	2008	63
18525258	920	Archin NM	Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells.	AIDS	2008	84
18579608	920	Chase AJ	Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation.	Journal of virology	2008	59
18598193	920	Estes J	Collagen deposition limits immune reconstitution in the gut.	The Journal of infectious diseases	2008	63
18604266	920	Nielsen M	Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan.	PLoS computational biology	2008	83
18664624	920	Brenchley JM	Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections.	Blood	2008	245
18728188	920	Swijnenburg RJ	Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.	Proceedings of the National Academy of Sciences of the United States of America	2008	92
18776940	920	Manches O	HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.	The Journal of clinical investigation	2008	93
18802153	920	Dieu-Nosjean MC	Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.	Journal of clinical oncology 	2008	160
19056990	920	Mold JE	Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.	Science	2008	207
19079157	920	Brenchley JM	HIV infection and the gastrointestinal immune system.	Mucosal immunology	2008	132
19079215	920	Macal M	Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses.	Mucosal immunology	2008	81
19105657	920	MÃ¼nz C	Enhancing immunity through autophagy.	Annual review of immunology	2009	87
19114870	920	Lawn SD	Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa.	AIDS	2009	71
19123865	920	Robbins GK	Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.	Clinical infectious diseases 	2009	73
19123868	920	Gazzola L	The absence of CD4+ T cell count recovery despite receipt of virologically suppressive highly active antiretroviral therapy: clinical risk, immunological gaps, and therapeutic options.	Clinical infectious diseases 	2009	65
19171897	920	Brandes M	Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses.	Proceedings of the National Academy of Sciences of the United States of America	2009	54
19223334	920	Chi BH	Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia.	International journal of epidemiology	2009	48
19259065	920	Wang GP	Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells.	Molecular therapy 	2009	55
19265479	920	Jiang W	Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.	The Journal of infectious diseases	2009	236
19383966	920	Hasegawa A	The level of monocyte turnover predicts disease progression in the macaque model of AIDS.	Blood	2009	61
19535437	920	Brennan TP	Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy.	Journal of virology	2009	62
19564353	920	Geiger R	Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells.	The Journal of experimental medicine	2009	49
19570871	920	Dinoso JB	A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.	Journal of virology	2009	66
19617846	920	Bedimo RJ	Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.	Journal of acquired immune deficiency syndromes	2009	57
19640996	920	Piantadosi A	Breadth of neutralizing antibody response to human immunodeficiency virus type 1 is affected by factors early in infection but does not influence disease progression.	Journal of virology	2009	80
19647202	920	Carson KR	Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.	The Lancet. Oncology	2009	110
19648510	920	Chaturvedi AK	Risk of human papillomavirus-associated cancers among persons with AIDS.	Journal of the National Cancer Institute	2009	128
19713549	920	Barski A	Chromatin poises miRNA- and protein-coding genes for expression.	Genome research	2009	76
19728788	920	French MA	Serum immune activation markers are persistently increased in patients with HIV infection after 6 years of antiretroviral therapy despite suppression of viral replication and reconstitution of CD4+ T cells.	The Journal of infectious diseases	2009	67
19745753	920	Geng EH	Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach.	Journal of acquired immune deficiency syndromes	2010	120
19770514	920	Sauce D	Evidence of premature immune aging in patients thymectomized during early childhood.	The Journal of clinical investigation	2009	65
19837074	920	Lin J	Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance.	Journal of immunological methods	2010	120
20004464	920	DART Trial Team.	Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.	Lancet	2010	126
20086230	920	Vendrame F	Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells.	Diabetes	2010	62
20113183	920	Cohen RA	Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.	Journal of neurovirology	2010	72
20139992	920	Flatz L	Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.	Nature medicine	2010	43
20201977	920	Yi JS	T-cell exhaustion: characteristics, causes and conversion.	Immunology	2010	90
20208541	920	Carter CC	HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs.	Nature medicine	2010	112
20335261	920	Julg B	Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.	Journal of virology	2010	49
20352098	920	Dheda K	Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples.	PloS one	2010	47
20399961	920	Mougiakakos D	Regulatory T cells in cancer.	Advances in cancer research	2010	88
20414655	920	Ostrand-Rosenberg S	Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity.	Cancer immunology, immunotherapy 	2010	146
20428171	920	Baranzini SE	Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.	Nature	2010	122
20550452	920	Julg B	Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.	Clinical infectious diseases 	2010	49
20827162	920	Yukl SA	Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.	AIDS	2010	104
20833654	920	Murphy A	Mapping of numerous disease-associated expression polymorphisms in primary peripheral blood CD4+ lymphocytes.	Human molecular genetics	2010	57
20844049	920	Murray SM	Reduction of immune activation with chloroquine therapy during chronic HIV infection.	Journal of virology	2010	48
20889546	920	Gordon SN	Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.	Journal of immunology	2010	48
20924117	920	Kennedy EM	Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages.	The Journal of biological chemistry	2010	42
21034222	920	Moir S	Pathogenic mechanisms of HIV disease.	Annual review of pathology	2011	83
21048528	920	Issa F	Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model.	Transplantation	2010	55
21098232	920	Draper SJ	Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines.	Journal of immunology	2010	49
21105780	920	Soghoian DZ	Cytolytic CD4(+) T cells in viral immunity.	Expert review of vaccines	2010	48
21148519	920	Peggs KS	Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation.	Clinical infectious diseases 	2011	43
21211639	920	Akdis CA	Mechanisms of allergen-specific immunotherapy.	The Journal of allergy and clinical immunology	2011	60
21220772	920	Kaplan RC	T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.	The Journal of infectious diseases	2011	106
21249232	920	Mikell I	Characteristics of the earliest cross-neutralizing antibody response to HIV-1.	PLoS pathogens	2011	135
21325137	920	Ganesan A	High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.	The Journal of infectious diseases	2011	48
21367910	920	Anderson JA	Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells.	Journal of virology	2011	38
21378536	920	Chege D	Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy.	AIDS	2011	44
21398051	920	Finkelstein SE	Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.	International journal of radiation oncology, biology, physics	2012	35
21403397	920	Chen H	CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21.	The Journal of clinical investigation	2011	69
21412126	920	Appay V	Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients.	AIDS	2011	41
21471231	920	Ciccone EJ	CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors.	Journal of virology	2011	35
21471244	920	Xing S	Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation.	Journal of virology	2011	79
21494598	920	Merlini E	Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy.	PloS one	2011	42
21499132	920	Fadul CE	Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapy.	Journal of immunotherapy	2011	50
21502083	920	Hunt PW	Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy.	The Journal of infectious diseases	2011	98
21543722	920	Letvin NL	Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.	Science translational medicine	2011	109
21559280	920	Boyles TH	Factors influencing retention in care after starting antiretroviral therapy in a rural South African programme.	PloS one	2011	38
21625591	920	Gallegos AM	A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo.	PLoS pathogens	2011	54
21628667	920	Chun TW	Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy.	The Journal of infectious diseases	2011	58
21690402	920	Josefsson L	Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule.	Proceedings of the National Academy of Sciences of the United States of America	2011	75
21690475	920	Slingluff CL Jr	Randomized multicenter trial of the effects of melanoma-associated helper peptides and cyclophosphamide on the immunogenicity of a multipeptide melanoma vaccine.	Journal of clinical oncology 	2011	37
21725250	920	Byrd DA	Neurocognitive impact of substance use in HIV infection.	Journal of acquired immune deficiency syndromes	2011	46
21782230	920	Dixon AE	Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation.	The Journal of allergy and clinical immunology	2011	66
21811403	920	Rosen S	Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.	PLoS medicine	2011	306
21846636	920	Hoft DF	Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children.	The Journal of infectious diseases	2011	57
21857654	920	Sullivan NJ	CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates.	Nature medicine	2011	61
21881481	920	Hunt PW	Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.	AIDS	2011	87
21908576	920	Iyer JG	Merkel cell polyomavirus-specific CD8âº and CD4âº T-cell responses identified in Merkel cell carcinomas and blood.	Clinical cancer research 	2011	36
21917895	920	Lederman MM	Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells.	The Journal of infectious diseases	2011	93
21963677	920	Kreijtz JH	Immune responses to influenza virus infection.	Virus research	2011	63
22067665	920	Wandeler G	Outcomes of antiretroviral treatment programs in rural Southern Africa.	Journal of acquired immune deficiency syndromes	2012	35
22101430	920	Waggoner SN	Natural killer cells act as rheostats modulating antiviral T cells.	Nature	2011	142
22160724	920	Aubert RD	Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.	Proceedings of the National Academy of Sciences of the United States of America	2011	60
22170955	920	Tang Q	CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.	Journal of molecular cell biology	2012	54
22174559	920	Marshall NB	Cytotoxic CD4 T cells in antiviral immunity.	Journal of biomedicine and biotechnology	2011	52
22213804	920	Schulze Zur Wiesch J	Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.	The Journal of experimental medicine	2012	51
22219223	920	Mahnke YD	Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome.	Blood	2012	36
22240256	920	Witwer KW	Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients.	Retrovirology	2012	49
22275401	920	O'Hara GA	Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.	The Journal of infectious diseases	2012	70
22275402	920	Durand CM	HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy.	The Journal of infectious diseases	2012	40
22282593	920	Couser WG	Basic and translational concepts of immune-mediated glomerular diseases.	Journal of the American Society of Nephrology 	2012	35
22286307	920	Wilkinson TM	Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.	Nature medicine	2012	235
22291913	920	Lassen KG	A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.	PloS one	2012	42
22327072	920	Kwok WW	Frequency of epitope-specific naive CD4(+) T cells correlates with immunodominance in the human memory repertoire.	Journal of immunology	2012	36
22354001	920	Pegram HJ	Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.	Blood	2012	114
22406268	920	Shan L	Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.	Immunity	2012	263
22549246	920	Craft JE	Follicular helper T cells in immunity and systemic autoimmunity.	Nature reviews. Rheumatology	2012	70
22553251	920	Scholler J	Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells.	Science translational medicine	2012	143
22673491	920	Damjanovic D	Immunopathology in influenza virus infection: uncoupling the friend from foe.	Clinical immunology	2012	37
22837004	920	Archin NM	Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.	Nature	2012	340
22949321	920	Huh JR	Small molecule inhibitors of RORÎ³t: targeting Th17 cells and other applications.	European journal of immunology	2012	33
22990012	920	Brenchley JM	Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections.	Blood	2012	56
22999944	920	Eisele E	Redefining the viral reservoirs that prevent HIV-1 eradication.	Immunity	2012	116
23148285	920	Nayak JL	CD4+ T-cell expansion predicts neutralizing antibody responses to monovalent, inactivated 2009 pandemic influenza A(H1N1) virus subtype H1N1 vaccine.	The Journal of infectious diseases	2013	27
23175374	920	Pegu P	Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial.	Journal of virology	2013	49
23283367	920	GarcÃ­a F	A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication.	Science translational medicine	2013	46
23292280	920	Yang M	Regulatory B cells in autoimmune diseases.	Cellular and molecular immunology	2013	38
23323898	920	Le T	Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.	The New England journal of medicine	2013	117
23345163	920	Tel J	Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients.	Cancer research	2013	51
23395677	920	Su LF	Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults.	Immunity	2013	113
23408629	920	Dahabieh MS	A doubly fluorescent HIV-1 reporter shows that the majority of integrated HIV-1 is latent shortly after infection.	Journal of virology	2013	25
23429504	920	Geng EH	Failure to initiate antiretroviral therapy, loss to follow-up and mortality among HIV-infected patients during the pre-ART period in Uganda.	Journal of acquired immune deficiency syndromes	2013	37
23435170	920	van Heijst JW	Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation.	Nature medicine	2013	47
23459007	920	Eriksson S	Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies.	PLoS pathogens	2013	157
23719296	920	Younan PM	Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model.	Blood	2013	31
23732522	920	Pan X	Restrictions to HIV-1 replication in resting CD4+ T lymphocytes.	Cell research	2013	28
23737751	920	Laird GM	Rapid quantification of the latent reservoir for HIV-1 using a viral outgrowth assay.	PLoS pathogens	2013	58
23772614	920	Okoye AA	CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure.	Immunological reviews	2013	54
23772616	920	Paiardini M	HIV-associated chronic immune activation.	Immunological reviews	2013	47
23794702	920	Nagaraj S	Reciprocal relationship between myeloid-derived suppressor cells and T cells.	Journal of immunology	2013	38
23818847	920	Josefsson L	Single cell analysis of lymph node tissue from HIV-1 infected patients reveals that the majority of CD4+ T-cells contain one HIV-1 DNA molecule.	PLoS pathogens	2013	33
23852127	920	Jain V	Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.	The Journal of infectious diseases	2013	83
23886064	920	Lederman MM	Residual immune dysregulation syndrome in treated HIV infection.	Advances in immunology	2013	68
23921881	920	Mocroft A	The incidence of AIDS-defining illnesses at a current CD4 count â¥ 200 cells/Î¼L in the post-combination antiretroviral therapy era.	Clinical infectious diseases 	2013	26
23950730	920	Absher DM	Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations.	PLoS genetics	2013	70
24041796	920	Naranbhai V	Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy.	The Journal of infectious diseases	2014	21
24045046	920	Jane-Wit D	Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-ÎºB signaling in endothelial cells.	Circulation	2013	28
24064670	920	Turner DL	Lung niches for the generation and maintenance of tissue-resident memory T cells.	Mucosal immunology	2014	58
24097267	920	Buenrostro JD	Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position.	Nature methods	2013	375
24121761	920	Gray KM	Jurisdiction level differences in HIV diagnosis, retention in care, and viral suppression in the United States.	Journal of acquired immune deficiency syndromes	2014	21
24129370	920	Yehia BR	Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts.	Journal of acquired immune deficiency syndromes	2014	21
24180001	920	PÃ©rez-Santiago J	Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection.	AIDS	2013	28
24185941	920	Krishnan S	Evidence for innate immune system activation in HIV type 1-infected elite controllers.	The Journal of infectious diseases	2014	40
24204277	920	Wibmer CK	Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.	PLoS pathogens	2013	65
24225944	920	Kanakry CG	Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide.	Science translational medicine	2013	45
24226057	920	Luetkemeyer AF	Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs.	Journal of acquired immune deficiency syndromes	2014	21
24384692	920	Ananworanich J	Reduced markers of HIV persistence and restricted HIV-specific immune responses after early antiretroviral therapy in children.	AIDS	2014	23
24448112	920	Wang S	Micro-a-fluidics ELISA for rapid CD4 cell count at the point-of-care.	Scientific reports	2014	22
24501199	920	Wertheimer AM	Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans.	Journal of immunology	2014	40
24620025	920	Archin NM	HIV-1 expression within resting CD4+ T cells after multiple doses of vorinostat.	The Journal of infectious diseases	2014	75
24706775	920	Cillo AR	Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy.	Proceedings of the National Academy of Sciences of the United States of America	2014	73
24759213	920	Kumar A	HIV-1 latency in monocytes/macrophages.	Viruses	2014	37
24763540	920	Somers EC	Environmental exposures, epigenetic changes and the risk of lupus.	Lupus	2014	20
24786080	920	Raj T	Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes.	Science	2014	90
24814848	920	Grant I	Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.	Neurology	2014	52
24965451	920	Buzon MJ	Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.	Journal of virology	2014	52
25036865	920	Rosado MM	Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.	Stem cells and development	2015	15
25056899	920	Arenaccio C	Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism.	Journal of virology	2014	28
25101191	920	GÃ¡lvez J	Role of Th17 Cells in the Pathogenesis of Human IBD.	ISRN inflammation	2014	23
25187662	920	Derhovanessian E	Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly.	Journal of immunology	2014	23
25253353	920	Soriano-Sarabia N	Quantitation of replication-competent HIV-1 in populations of resting CD4+ T cells.	Journal of virology	2014	26
25254512	920	Mavigner M	Persistence of virus reservoirs in ART-treated SHIV-infected rhesus macaques after autologous hematopoietic stem cell transplant.	PLoS pathogens	2014	24
25277040	920	Lueg G	Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.	Neurobiology of aging	2015	20
25363779	920	Farh KK	Genetic and epigenetic fine mapping of causal autoimmune disease variants.	Nature	2015	216
25378643	920	Adusumilli PS	Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.	Science translational medicine	2014	62
25382623	920	Jaafoura S	Progressive contraction of the latent HIV reservoir around a core of less-differentiated CD4âº memory T Cells.	Nature communications	2014	27
25426834	920	Ledgerwood JE	Chimpanzee Adenovirus Vector Ebola Vaccine.	The New England journal of medicine	2017	37
25447326	920	Smith JA	Update on ankylosing spondylitis: current concepts in pathogenesis.	Current allergy and asthma reports	2015	16
25477212	920	Becattini S	T cell immunity. Functional heterogeneity of human memory CD4âº T cell clones primed by pathogens or vaccines.	Science	2015	44
25589335	920	Sung JA	Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoir.	The Journal of infectious diseases	2015	25
25593279	920	Hofmann U	Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction.	Circulation research	2015	20
25594465	920	Ueno H	Pathophysiology of T follicular helper cells in humans and mice.	Nature immunology	2015	60
25681373	920	Fouts TR	Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.	Proceedings of the National Academy of Sciences of the United States of America	2015	26
25775592	920	McElroy AK	Human Ebola virus infection results in substantial immune activation.	Proceedings of the National Academy of Sciences of the United States of America	2015	39
25888703	920	Goronzy JJ	Naive T cell maintenance and function in human aging.	Journal of immunology	2015	22
25908663	920	Hepworth MR	Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4âº T cells.	Science	2015	46
25967273	920	Wang Z	Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8âº T cells.	Nature communications	2015	19
26044074	920	Pera A	Immunosenescence: Implications for response to infection and vaccination in older people.	Maturitas	2015	25
26067822	920	Chavez L	HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells.	PLoS pathogens	2015	27
26130226	920	Lu W	CD4:CD8 ratio as a frontier marker for clinical outcome, immune dysfunction and viral reservoir size in virologically suppressed HIV-positive patients.	Journal of the International AIDS Society	2015	17
26169416	920	Spivak AM	Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.	Antimicrobial agents and chemotherapy	2015	20
26193635	920	Rigby MR	Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.	The Journal of clinical investigation	2015	20
26349551	920	Cao W	Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.	Clinical infectious diseases 	2016	13
26369987	920	Sommermeyer D	Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo.	Leukemia	2016	45
26405463	920	Kumar A	Epigenetic control of HIV-1 post integration latency: implications for therapy.	Clinical epigenetics	2015	17
26452565	920	Younas M	Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy.	HIV medicine	2016	16
26459351	920	Schulz AR	Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans.	Journal of immunology	2015	17
26657141	920	Thome JJ	Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues.	Nature medicine	2016	24
26724103	920	Hohlfeld R	The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.	The Lancet. Neurology	2016	13
26743582	920	Ondondo B	Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.	Molecular therapy 	2016	13
26842680	920	Muller L	Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.	Scientific reports	2016	14
26858442	920	Simonetti FR	Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2016	40
26885861	920	Procaccini C	The Proteomic Landscape of Human ExÂ Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements.	Immunity	2016	17
26934227	920	Ma C	NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis.	Nature	2016	23
26962942	920	Monaco CL	Altered Virome and Bacterial Microbiome in Human Immunodeficiency Virus-Associated Acquired Immunodeficiency Syndrome.	Cell host and microbe	2016	24
27019159	920	Bakulski KM	DNA methylation of cord blood cell types: Applications for mixed cell birth studies.	Epigenetics	2016	23
27199430	920	Lu CL	Enhanced clearance of HIV-1-infected cells by broadly neutralizing antibodies against HIV-1 in vivo.	Science	2016	37
27222480	920	Krejcik J	Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma.	Blood	2016	17
27738167	920	Byrareddy SN	Sustained virologic control in SIV+ macaques after antiretroviral and Î±4Î²7 antibody therapy.	Science	2016	20
28199305	920	MordmÃ¼ller B	Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.	Nature	2017	10
1352912	925	Riddell SR	Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones.	Science	1992	204
2431484	925	Walker CM	CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication.	Science	1986	248
6272109	925	Gottlieb MS	Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency.	The New England journal of medicine	1981	287
7808485	925	Cao Y	Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection.	The New England journal of medicine	1995	230
8892876	925	Wills MR	The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.	Journal of virology	1996	155
9510252	925	Albert ML	Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs.	Nature	1998	397
11014195	925	Allen TM	Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.	Nature	2000	264
11927944	925	Appay V	Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.	Nature medicine	2002	394
12076996	925	Lucchinetti CF	A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.	Brain 	2002	184
12165524	925	Khan N	Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals.	Journal of immunology	2002	167
12351674	925	Zhang L	Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.	Science	2002	83
12368910	925	Migueles SA	HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.	Nature immunology	2002	331
12415307	925	Reddehase MJ	Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance.	Nature reviews. Immunology	2002	85
12444144	925	Belnoue E	On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria.	Journal of immunology	2002	109
12574372	925	Karrer U	Memory inflation: continuous accumulation of antiviral CD8+ T cells over time.	Journal of immunology	2003	125
12808447	925	Mongkolsapaya J	Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.	Nature medicine	2003	218
15140968	925	Webster GJ	Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy.	Journal of virology	2004	82
15194783	925	Allen TM	Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.	Journal of virology	2004	140
15254203	925	Shrestha B	Role of CD8+ T cells in control of West Nile virus infection.	Journal of virology	2004	166
15280502	925	Feeney ME	Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child.	Journal of virology	2004	113
15585874	925	Khan N	Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection.	Journal of immunology	2004	87
15731261	925	Almanzar G	Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons.	Journal of virology	2005	103
15837811	925	Chen JL	Structural and kinetic basis for heightened immunogenicity of T cell vaccines.	The Journal of experimental medicine	2005	75
15882351	925	Effros RB	The role of CD8+ T-cell replicative senescence in human aging.	Immunological reviews	2005	98
15962289	925	Cox AL	Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.	Hepatology	2005	88
16227247	925	Allen TM	Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution.	Journal of virology	2005	164
16301748	925	de Bree GJ	Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung.	The Journal of experimental medicine	2005	69
16456027	925	Hadrup SR	Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly.	Journal of immunology	2006	115
16473124	925	Hoelscher MA	Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.	Lancet	2006	67
16496339	925	Neumann-Haefelin C	Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.	Hepatology	2006	67
16632554	925	Gold R	Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.	Brain 	2006	183
17101314	925	Konikoff MR	A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis.	Gastroenterology	2006	101
17143259	925	Johnson JE	The histopathology of fatal untreated human respiratory syncytial virus infection.	Modern pathology 	2007	115
17325200	925	Zhu J	Virus-specific CD8+ T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation.	The Journal of experimental medicine	2007	136
17369837	925	Mingozzi F	CD8(+) T-cell responses to adeno-associated virus capsid in humans.	Nature medicine	2007	197
17540778	925	Laugel B	Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.	The Journal of biological chemistry	2007	82
17712344	925	McFarland HF	Multiple sclerosis: a complicated picture of autoimmunity.	Nature immunology	2007	230
17767161	925	Belz GT	Minimal activation of memory CD8+ T cell by tissue-derived dendritic cells favors the stimulation of naive CD8+ T cells.	Nature immunology	2007	60
17979844	925	Palucka AK	Taming cancer by inducing immunity via dendritic cells.	Immunological reviews	2007	64
18060041	925	Berger C	Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates.	The Journal of clinical investigation	2008	262
18199637	925	Rehr M	Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy.	Journal of virology	2008	54
18319398	925	Chapel H	Common variable immunodeficiency disorders: division into distinct clinical phenotypes.	Blood	2008	123
18462013	925	Streeck H	Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells.	PLoS medicine	2008	110
18468462	925	Miller JD	Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines.	Immunity	2008	203
18535580	925	Appay V	CD8+ T cell efficacy in vaccination and disease.	Nature medicine	2008	117
18783315	925	Mark KE	Rapidly cleared episodes of herpes simplex virus reactivation in immunocompetent adults.	The Journal of infectious diseases	2008	81
19109229	925	Ferre AL	Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.	Blood	2009	93
19304471	925	Rosenberg SA	Adoptive cell therapy for the treatment of patients with metastatic melanoma.	Current opinion in immunology	2009	184
19381260	925	Chen CY	A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.	PLoS pathogens	2009	84
19487423	925	Goonetilleke N	The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.	The Journal of experimental medicine	2009	287
19494307	925	SÃ¡ez-CiriÃ³n A	Heterogeneity in HIV suppression by CD8 T cells from HIV controllers: association with Gag-specific CD8 T cell responses.	Journal of immunology	2009	82
19540809	925	Weng NP	CD28(-) T cells: their role in the age-associated decline of immune function.	Trends in immunology	2009	127
19879163	925	Turtle CJ	A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy.	Immunity	2009	56
20061007	925	Whiteside TL	Immune responses to malignancies.	The Journal of allergy and clinical immunology	2010	45
20071660	925	Warren EH	Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.	Blood	2010	56
20200354	925	Alanio C	Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies.	Blood	2010	48
20530795	925	Goodyear O	Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia.	Blood	2010	64
20536568	925	Welsh RM	Heterologous immunity between viruses.	Immunological reviews	2010	84
20811043	925	Robins HS	Overlap and effective size of the human CD8+ T cell receptor repertoire.	Science translational medicine	2010	103
21133926	925	Schmitt A	Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation.	Transfusion	2011	49
21148512	925	Berthoud TK	Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.	Clinical infectious diseases 	2011	91
21198668	925	Makedonas G	Living in a house of cards: re-evaluating CD8+ T-cell immune correlates against HIV.	Immunological reviews	2011	40
21383244	925	Venturi V	A mechanism for TCR sharing between T cell subsets and individuals revealed by pyrosequencing.	Journal of immunology	2011	54
21398582	925	Yamamoto T	Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.	Blood	2011	65
21422430	925	Paulson KG	Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.	Journal of clinical oncology 	2011	63
21557723	925	Mingozzi F	Immune responses to AAV in clinical trials.	Current gene therapy	2011	53
21869816	925	Sun JC	NK cell development, homeostasis and function: parallels with CD8âº T cells.	Nature reviews. Immunology	2011	137
21967977	925	Tacken PJ	Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity.	Blood	2011	41
22090105	925	Kloverpris HN	HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.	Journal of virology	2012	35
22123951	925	Vatakis DN	Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	36
22213807	925	Coppieters KT	Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients.	The Journal of experimental medicine	2012	124
22225723	925	Jacobs JF	Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?	The Lancet. Oncology	2012	41
22265676	925	Newell EW	Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes.	Immunity	2012	160
22302009	925	Phadwal K	A novel method for autophagy detection in primary cells: impaired levels of macroautophagy in immunosenescent T cells.	Autophagy	2012	31
22308228	925	Dock JN	Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.	Aging and disease	2011	40
22355106	925	Varadarajan N	Rapid, efficient functional characterization and recovery of HIV-specific human CD8+ T cells using microengraving.	Proceedings of the National Academy of Sciences of the United States of America	2012	38
22355349	925	Weiss WR	Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.	PloS one	2012	31
22420471	925	Liu S	CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer.	Breast cancer research 	2012	73
22554418	925	Nikolich-Å½ugich J	Age-related changes in CD8 T cell homeostasis and immunity to infection.	Seminars in immunology	2012	31
23061726	925	Chou JP	T cell replicative senescence in human aging.	Current pharmaceutical design	2013	42
23090074	925	Klebanoff CA	Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?	Journal of immunotherapy	2012	60
23290140	925	Nishimura T	Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation.	Cell stem cell	2013	64
23325831	925	Martino AT	Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells.	Blood	2013	43
23516357	925	Laidlaw BJ	Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity.	PLoS pathogens	2013	37
23516360	925	SÃ¡ez-CiriÃ³n A	Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study.	PLoS pathogens	2013	232
23536996	925	Jiang J	Cytokine-induced killer cells promote antitumor immunity.	Journal of translational medicine	2013	30
23651186	925	Vesely MD	Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy.	Annals of the New York Academy of Sciences	2013	39
23657257	925	Zhu J	Immune surveillance by CD8Î±Î±+ skin-resident T cells in human herpes virus infection.	Nature	2013	66
23681698	925	Howland SW	Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.	EMBO molecular medicine	2013	37
23704576	925	Hansen SG	Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.	Science	2013	129
23874205	925	Novais FO	Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis.	PLoS pathogens	2013	39
24062739	925	FÃ¼lÃ¶p T	Human T cell aging and the impact of persistent viral infections.	Frontiers in immunology	2013	42
24166483	925	Borthwick N	Vaccine-elicited human T cells recognizing conserved protein regions inhibit HIV-1.	Molecular therapy 	2014	65
24284865	925	Ewer KJ	Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation.	Nature communications	2013	86
24490585	925	Hanke T	Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines.	Expert opinion on biological therapy	2014	25
24691640	925	Anitei MG	Prognostic and predictive values of the immunoscore in patients with rectal cancer.	Clinical cancer research 	2014	36
24905492	925	Martin B	Restoration of HCV-specific CD8+ T cell function by interferon-free therapy.	Journal of hepatology	2014	25
24956473	925	Carethers JM	Influence of race on microsatellite instability and CD8+ T cell infiltration in colon cancer.	PloS one	2014	24
25165115	925	Pereyra F	HIV control is mediated in part by CD8+ T-cell targeting of specific epitopes.	Journal of virology	2014	20
25320311	925	Weiskopf D	The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.	Journal of virology	2015	24
25584002	925	Le DT	Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.	Journal of clinical oncology 	2015	84
25642773	925	Quinn KM	Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling.	The Journal of clinical investigation	2015	19
25680376	925	Donnem T	Stromal CD8+ T-cell DensityâA Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer.	Clinical cancer research 	2015	29
25855494	925	Fuertes Marraco SA	Long-lasting stem cell-like memory CD8+ T cells with a naÃ¯ve-like profile upon yellow fever vaccination.	Science translational medicine	2015	27
25904595	925	Butterfield LH	Cancer vaccines.	BMJ	2015	24
26178914	925	Balermpas P	CD8+ tumour-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: A multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG).	International journal of cancer	2016	20
26241053	925	Teng MW	From mice to humans: developments in cancer immunoediting.	The Journal of clinical investigation	2015	18
26362266	925	Ndhlovu ZM	Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point.	Immunity	2015	26
27158907	925	Ishizuka AS	Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.	Nature medicine	2016	24
27270402	925	Pulko V	Human memory T cells with a naive phenotype accumulate with aging and respond to persistent viruses.	Nature immunology	2016	14
28104840	925	Davoli T	Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy.	Science	2017	8
15334472	930	Looney RJ	B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab.	Arthritis and rheumatism	2004	112
16672701	930	van Zelm MC	An antibody-deficiency syndrome due to mutations in the CD19 gene.	The New England journal of medicine	2006	97
19509221	930	Baeuerle PA	Bispecific T-cell engaging antibodies for cancer therapy.	Cancer research	2009	103
19561539	930	Kochenderfer JN	Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.	Journal of immunotherapy	2009	60
19905893	930	Manuri PV	piggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.	Human gene therapy	2010	47
20237408	930	van Zelm MC	CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.	The Journal of clinical investigation	2010	69
20668228	930	Kochenderfer JN	Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19.	Blood	2010	256
21849486	930	Brentjens RJ	Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.	Blood	2011	283
22107246	930	Kebriaei P	Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies.	Human gene therapy	2012	35
22535661	930	Torikai H	A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.	Blood	2012	74
22589486	930	Lee DW	The future is now: chimeric antigen receptors as new targeted therapies for childhood cancer.	Clinical cancer research 	2012	40
23377665	930	Maiti SN	Sleeping beauty system to redirect T-cell specificity for human applications.	Journal of immunotherapy	2013	29
23515080	930	Brentjens RJ	CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia.	Science translational medicine	2013	375
23527958	930	Grupp SA	Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.	The New England journal of medicine	2013	559
23546520	930	Kochenderfer JN	Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors.	Nature reviews. Clinical oncology	2013	87
23550147	930	Sadelain M	The basic principles of chimeric antigen receptor design.	Cancer discovery	2013	156
23623807	930	Frankel SR	Targeting T cells to tumor cells using bispecific antibodies.	Current opinion in chemical biology	2013	36
23678006	930	Teachey DT	Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.	Blood	2013	70
23934177	930	Themeli M	Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy.	Nature biotechnology	2013	53
24030379	930	Cruz CR	Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.	Blood	2013	97
24055823	930	Kochenderfer JN	Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation.	Blood	2013	109
24329794	930	Jensen MC	Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.	Immunological reviews	2014	37
24664166	930	Frohman EM	JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab.	JAMA neurology	2014	21
24667955	930	Ramos CA	CD19-CAR trials.	Cancer journal	2014	27
24869942	930	Bertaina A	HLA-haploidentical stem cell transplantation after removal of Î±Î²+ T and B cells in children with nonmalignant disorders.	Blood	2014	36
25154820	930	Kochenderfer JN	Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.	Journal of clinical oncology 	2015	176
25319501	930	Lee DW	T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.	Lancet	2015	266
25510272	930	Gill S	Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies.	Immunological reviews	2015	63
25621840	930	Jensen MC	Designing chimeric antigen receptors to effectively and safely target tumors.	Current opinion in immunology	2015	26
26129802	930	van der Stegen SJ	The pharmacology of second-generation chimeric antigen receptors.	Nature reviews. Drug discovery	2015	31
26325036	930	Sadelain M	CAR therapy: the CD19 paradigm.	The Journal of clinical investigation	2015	34
26333935	930	Porter DL	Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.	Science translational medicine	2015	113
26352815	930	Garfall AL	Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma.	The New England journal of medicine	2015	57
26811520	930	Brudno JN	Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.	Journal of clinical oncology 	2016	38
26819347	930	Dai H	Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy.	Journal of the National Cancer Institute	2016	27
27000958	930	Jackson HJ	Driving CAR T-cells forward.	Nature reviews. Clinical oncology	2016	26
27111235	930	Turtle CJ	CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.	The Journal of clinical investigation	2016	63
27207800	930	Park JH	CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.	Blood	2016	20
27482888	930	Kebriaei P	Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.	The Journal of clinical investigation	2016	15
28129122	930	Locke FL	Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma.	Molecular therapy 	2017	10
16914538	1043	Lopez M	A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells.	Journal of the American Society of Nephrology 	2006	81
19740383	1043	Hu Y	Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.	Immunology	2009	49
23122650	1043	Coles AJ	Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.	Lancet	2012	110
23122652	1043	Cohen JA	Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial.	Lancet	2012	121
23599943	1043	Kieseier BC	Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.	JAMA neurology	2013	30
24577808	1043	Gotlib J	World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.	American journal of hematology	2014	21
25344374	1043	Hartung HP	Alemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis.	Multiple sclerosis	2015	19
26183927	1043	Poirot L	Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies.	Cancer research	2015	50
9704769	1088	Sacks GP	Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.	American journal of obstetrics and gynecology	1998	133
19201693	1088	Rodriguez PC	Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.	Cancer research	2009	180
19720929	1088	Jensen HK	Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.	Journal of clinical oncology 	2009	86
20644162	1088	Lechner MG	Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells.	Journal of immunology	2010	144
21112656	1088	Li YW	Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.	Journal of hepatology	2011	46
21953023	1088	Jensen TO	Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.	Cancer	2012	42
21953630	1088	Ilie M	Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.	Cancer	2012	32
23385730	1088	Ino Y	Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer.	British journal of cancer	2013	83
25385008	1088	Lin SJ	Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas.	Gut	2015	18
25624468	1088	Seifert M	Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions.	Proceedings of the National Academy of Sciences of the United States of America	2015	18
26360137	1088	Dieker J	Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.	Arthritis and rheumatology	2016	17
26924089	1088	Zhou SL	Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.	Gastroenterology	2016	12
16750987	1215	Bradding P	The role of the mast cell in the pathophysiology of asthma.	The Journal of allergy and clinical immunology	2006	103
8941660	1230	McKee CM	Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44.	The Journal of clinical investigation	1996	143
9334378	1230	Schols D	Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4.	The Journal of experimental medicine	1997	132
9449707	1230	Puren AJ	Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells.	The Journal of clinical investigation	1998	105
9500790	1230	Sallusto F	Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.	The Journal of experimental medicine	1998	291
10079101	1230	SÃ¸rensen TL	Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.	The Journal of clinical investigation	1999	139
10570316	1230	Shields PL	Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver.	Journal of immunology	1999	103
18492752	1230	Huber J	CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity.	The Journal of clinical endocrinology and metabolism	2008	75
19603542	1230	Seki E	CCR1 and CCR5 promote hepatic fibrosis in mice.	The Journal of clinical investigation	2009	119
20548789	1230	Zimmermann HW	Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.	PloS one	2010	70
9302298	1232	Sallusto F	Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells.	Science	1997	165
9311827	1232	BjÃ¶rndal A	Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.	Journal of virology	1997	213
9323208	1232	Boshoff C	Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines.	Science	1997	110
9419219	1232	Bonecchi R	Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.	The Journal of experimental medicine	1998	363
10359806	1232	Balashov KE	CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.	Proceedings of the National Academy of Sciences of the United States of America	1999	113
11581376	1232	Gorry PR	Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.	Journal of virology	2001	122
12149192	1232	McQuibban GA	Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo.	Blood	2002	127
15194768	1232	Peters PJ	Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.	Journal of virology	2004	99
15526056	1232	Grumelli S	An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema.	PLoS medicine	2004	129
17157662	1232	Stein ML	Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.	The Journal of allergy and clinical immunology	2006	75
19525930	1232	Takeda A	CCR3 is a target for age-related macular degeneration diagnosis and therapy.	Nature	2009	79
12576317	1233	Geginat J	Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines.	Blood	2003	117
15381728	1233	Rivino L	Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells.	The Journal of experimental medicine	2004	82
18698005	1233	Chizzolini C	Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion.	Blood	2008	70
19377047	1233	Di Stasi A	T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.	Blood	2009	98
19578368	1233	Trifari S	Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells.	Nature immunology	2009	228
19578369	1233	Duhen T	Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells.	Nature immunology	2009	234
20164417	1233	Oo YH	Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.	Journal of immunology	2010	43
20334681	1233	Shah K	Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus.	Arthritis research and therapy	2010	69
20484084	1233	Campbell JJ	Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors.	Blood	2010	44
20537408	1233	Jacobs JF	Prognostic significance and mechanism of Treg infiltration in human brain tumors.	Journal of neuroimmunology	2010	49
20583102	1233	Leipe J	Role of Th17 cells in human autoimmune arthritis.	Arthritis and rheumatism	2010	90
21197451	1233	Hammerich L	Role of IL-17 and Th17 cells in liver diseases.	Clinical and developmental immunology	2011	58
21908423	1233	Pere H	A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens.	Blood	2011	44
22312108	1233	Ishida T	Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study.	Journal of clinical oncology 	2012	62
24127572	1233	Sugiyama D	Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans.	Proceedings of the National Academy of Sciences of the United States of America	2013	69
25087232	1233	Yoshie O	CCR4 and its ligands: from bench to bedside.	International immunology	2015	22
9050881	1234	Bleul CC	The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.	Proceedings of the National Academy of Sciences of the United States of America	1997	302
9525605	1234	Platt EJ	Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.	Journal of virology	1998	505
10068581	1234	Giorgi JV	Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.	The Journal of infectious diseases	1999	379
10393974	1234	Kaul M	Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis.	Proceedings of the National Academy of Sciences of the United States of America	1999	135
11359797	1234	Campbell JJ	Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire.	Journal of immunology	2001	98
11588058	1234	Donaghy H	Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load.	Blood	2001	111
11748273	1234	Geginat J	Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells.	The Journal of experimental medicine	2001	128
11809184	1234	Fellay J	Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.	Lancet	2002	82
12368468	1234	MÃ¼nk C	A dominant block to HIV-1 replication at reverse transcription in simian cells.	Proceedings of the National Academy of Sciences of the United States of America	2002	130
12518064	1234	Qin XF	Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.	Proceedings of the National Academy of Sciences of the United States of America	2003	223
15078900	1234	Hu Q	Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue.	The Journal of experimental medicine	2004	85
15365096	1234	Brenchley JM	CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.	The Journal of experimental medicine	2004	650
15637236	1234	Gonzalez E	The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.	Science	2005	400
16685256	1234	Kanmogne GD	HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis.	Journal of cerebral blood flow and metabolism 	2007	80
16844419	1234	An DS	Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors.	Molecular therapy 	2006	65
16873279	1234	Guadalupe M	Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.	Journal of virology	2006	96
17013391	1234	Ariel A	Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression.	Nature immunology	2006	98
17015824	1234	Dunfee RL	The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia.	Proceedings of the National Academy of Sciences of the United States of America	2006	89
17132723	1234	Zhang L	HIV-1 infection and pathogenesis in a novel humanized mouse model.	Blood	2007	71
17147468	1234	Mehandru S	Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection.	PLoS medicine	2006	104
17296858	1234	Wu H	T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity.	Circulation	2007	192
17480119	1234	Sougrat R	Electron tomography of the contact between T cells and SIV/HIV-1: implications for viral entry.	PLoS pathogens	2007	73
17670939	1234	An DS	Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates.	Proceedings of the National Academy of Sciences of the United States of America	2007	69
17875002	1234	Zeremski M	The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.	Journal of viral hepatitis	2007	60
17928341	1234	Potter SJ	Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.	Journal of virology	2007	64
18427164	1234	Aranami T	Th17 Cells and autoimmune encephalomyelitis (EAE/MS).	Allergology international 	2008	55
18587387	1234	Perez EE	Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.	Nature biotechnology	2008	342
18632580	1234	Contento RL	CXCR4-CCR5: a couple modulating T cell functions.	Proceedings of the National Academy of Sciences of the United States of America	2008	53
19012957	1234	McElrath MJ	HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.	Lancet	2008	334
19201830	1234	Kondo T	Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.	Journal of immunology	2009	46
19213682	1234	HÃ¼tter G	Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.	The New England journal of medicine	2009	430
19414777	1234	Cassol E	M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms.	Journal of immunology	2009	49
19487424	1234	Salazar-Gonzalez JF	Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.	The Journal of experimental medicine	2009	343
19648930	1234	Zhu J	Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.	Nature medicine	2009	137
19997090	1234	Kim SS	RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice.	Molecular therapy 	2010	67
20018916	1234	Shimizu S	A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.	Blood	2010	73
20144043	1234	El Hed A	Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection.	The Journal of infectious diseases	2010	65
20147895	1234	Saba E	HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model.	Mucosal immunology	2010	57
20369317	1234	Maghazachi AA	Role of chemokines in the biology of natural killer cells.	Current topics in microbiology and immunology	2010	42
20410263	1234	Tu W	Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.	Journal of virology	2010	68
20601939	1234	Holt N	Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo.	Nature biotechnology	2010	236
20943670	1234	Rogacev KS	CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease.	European heart journal	2011	58
21047964	1234	Schulze Zur Wiesch J	Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.	Journal of virology	2011	56
21148083	1234	Allers K	Evidence for the cure of HIV infection by CCR5Î32/Î32 stem cell transplantation.	Blood	2011	204
21533216	1234	Wilen CB	Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.	PLoS pathogens	2011	64
22002519	1234	Sun X	Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression.	Breast cancer research and treatment	2012	35
22006178	1234	Rossol M	The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population.	Arthritis and rheumatism	2012	67
22048765	1234	McKinnon LR	Characterization of a human cervical CD4+ T cell subset coexpressing multiple markers of HIV susceptibility.	Journal of immunology	2011	59
22190722	1234	Ochsenbauer C	Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages.	Journal of virology	2012	129
22273578	1234	Yuan J	Zinc-finger nuclease editing of human cxcr4 promotes HIV-1 CD4(+) T cell resistance and enrichment.	Molecular therapy 	2012	36
22398281	1234	Walker JE	Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.	Journal of virology	2012	30
22784116	1234	Reshef R	Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.	The New England journal of medicine	2012	58
23903844	1234	Alvarez Y	Preferential HIV infection of CCR6+ Th17 cells is associated with higher levels of virus receptor expression and lack of CCR5 ligands.	Journal of virology	2013	35
24129241	1234	Bedognetti D	CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.	British journal of cancer	2013	25
24141062	1234	Weitzenfeld P	The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer.	Cancer letters	2014	28
24162716	1234	Didigu CA	Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection.	Blood	2014	36
24218476	1234	Bachelerie F	International Union of Basic and Clinical Pharmacology. corrected. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.	Pharmacological reviews	2014	112
24597865	1234	Tebas P	Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.	The New England journal of medicine	2014	257
24813472	1234	Wilson EM	Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.	The Journal of infectious diseases	2014	25
25384214	1234	Eruslanov EB	Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.	The Journal of clinical investigation	2014	49
25854553	1234	Li C	Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR/Cas9.	The Journal of general virology	2015	21
25964300	1234	Mock U	mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.	Nucleic acids research	2015	19
26109379	1234	Mikucki ME	Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.	Nature communications	2015	26
26424571	1234	Sather BD	Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template.	Science translational medicine	2015	36
27070705	1234	Halama N	Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.	Cancer cell	2016	13
28225754	1234	Eyquem J	Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection.	Nature	2017	9
10521347	1235	Yang D	Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.	Science	1999	338
16283305	1235	Baj-Krzyworzeka M	Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes.	Cancer immunology, immunotherapy 	2006	106
18097022	1235	Singh SP	Human T cells that are able to produce IL-17 express the chemokine receptor CCR6.	Journal of immunology	2008	97
18490742	1235	PÃ¨ne J	Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes.	Journal of immunology	2008	116
20109749	1235	Cosmi L	Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4.	The Journal of allergy and clinical immunology	2010	67
20483750	1235	RÃ¶hrl J	Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2.	Journal of immunology	2010	62
20511548	1235	Ghannam S	Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.	Journal of immunology	2010	120
20679229	1235	Nistala K	Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment.	Proceedings of the National Academy of Sciences of the United States of America	2010	103
20954258	1235	van Hamburg JP	Th17 cells, but not Th1 cells, from patients with early rheumatoid arthritis are potent inducers of matrix metalloproteinases and proinflammatory cytokines upon synovial fibroblast interaction, including autocrine interleukin-17A production.	Arthritis and rheumatism	2011	67
21381000	1235	Cosmi L	Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis.	Arthritis and rheumatism	2011	48
21813772	1235	Laggner U	Identification of a novel proinflammatory human skin-homing VÎ³9VÎ´2 T cell subset with a potential role in psoriasis.	Journal of immunology	2011	60
21935436	1235	Chen KJ	Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.	PloS one	2011	40
22796894	1235	Oo YH	CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver.	Journal of hepatology	2012	32
23358848	1235	Lindestam Arlehamn CS	Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset.	PLoS pathogens	2013	55
23959575	1235	Hammerich L	Chemokine receptor CCR6-dependent accumulation of Î³Î´ T cells in injured liver restricts hepatic inflammation and fibrosis.	Hepatology	2014	28
24069401	1235	Le Coz C	Circulating TFH subset distribution is strongly affected in lupus patients with an active disease.	PloS one	2013	30
24855210	1235	Munneke JM	Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.	Blood	2014	31
25972006	1235	Cao Y	Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis.	Science translational medicine	2015	26
10537110	1236	Sallusto F	Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.	Nature	1999	1345
11592079	1236	Krug A	Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12.	European journal of immunology	2001	142
11602640	1236	Bouchon A	A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells.	The Journal of experimental medicine	2001	105
11745357	1236	Jarrossay D	Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells.	European journal of immunology	2001	160
12149218	1236	Scandella E	Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.	Blood	2002	114
12414515	1236	Muller DN	Immunosuppressive treatment protects against angiotensin II-induced renal damage.	The American journal of pathology	2002	83
12782673	1236	Wulff H	The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.	The Journal of clinical investigation	2003	137
12829791	1236	KivisÃ¤kk P	Human cerebrospinal fluid central memory CD4+ T cells: evidence for trafficking through choroid plexus and meninges via P-selectin.	Proceedings of the National Academy of Sciences of the United States of America	2003	90
12975468	1236	Day CL	Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.	The Journal of clinical investigation	2003	101
14676302	1236	Younes SA	HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.	The Journal of experimental medicine	2003	160
14978162	1236	Kerjaschki D	Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates.	Journal of the American Society of Nephrology 	2004	110
15057302	1236	Accapezzato D	Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection.	The Journal of clinical investigation	2004	81
15067072	1236	Pichyangkul S	Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.	Journal of immunology	2004	83
15090447	1236	Hoffmann P	Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells.	Blood	2004	110
15342370	1236	Mailliard RB	alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity.	Cancer research	2004	139
15345595	1236	Powell DJ Jr	Transition of late-stage effector T cells to CD27+ CD28+ tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy.	Blood	2005	92
15534368	1236	Qu C	Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes.	The Journal of experimental medicine	2004	77
15707400	1236	Pearl JP	Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion.	American journal of transplantation 	2005	111
15958543	1236	Wei S	Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma.	Cancer research	2005	88
16034093	1236	Caron G	Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.	Journal of immunology	2005	119
16203865	1236	Mailliard RB	IL-18-induced CD83+CCR7+ NK helper cells.	The Journal of experimental medicine	2005	69
16547270	1236	Ebert LM	Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillance.	Journal of immunology	2006	66
16917003	1236	Hoffmann P	Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.	Blood	2006	98
17182569	1236	Strauss L	Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin.	Journal of immunology	2007	105
17371966	1236	Romero P	Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.	Journal of immunology	2007	96
17671115	1236	Strauss L	A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.	Clinical cancer research 	2007	106
18390722	1236	Seubert A	The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells.	Journal of immunology	2008	64
18452966	1236	Durbin AP	Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.	Virology	2008	55
18820174	1236	Chattopadhyay PK	The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.	Journal of leukocyte biology	2009	76
18852441	1236	Mehling M	FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis.	Neurology	2008	57
19570762	1236	Iliev ID	Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells.	Gut	2009	98
19733489	1236	Bogunovic M	Origin of the lamina propria dendritic cell network.	Immunity	2009	260
19933869	1236	Akondy RS	The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.	Journal of immunology	2009	100
20889923	1236	Moretta L	Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.	Blood	2011	49
21051556	1236	Beauvillain C	CCR7 is involved in the migration of neutrophils to lymph nodes.	Blood	2011	45
21298111	1236	Deiuliis J	Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers.	PloS one	2011	62
21709158	1236	Heusinkveld M	M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.	Journal of immunology	2011	80
21926977	1236	Gattinoni L	A human memory T cell subset with stem cell-like properties.	Nature medicine	2011	318
22290798	1236	Durafourt BA	Comparison of polarization properties of human adult microglia and blood-derived macrophages.	Glia	2012	86
22740309	1236	Melief J	Phenotyping primary human microglia: tight regulation of LPS responsiveness.	Glia	2012	32
23196209	1236	Derhovanessian E	Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor humoral response to influenza vaccination.	Vaccine	2013	30
23334413	1236	Diehl GE	Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells.	Nature	2013	98
23710834	1236	Mercalli A	Rapamycin unbalances the polarization of human macrophages to M1.	Immunology	2013	32
24056771	1236	Sridhar S	Cellular immune correlates of protection against symptomatic pandemic influenza.	Nature medicine	2013	137
24232855	1236	Johnson LA	Control of dendritic cell trafficking in lymphatics by chemokines.	Angiogenesis	2014	22
24282306	1236	Jones JL	Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.	Proceedings of the National Academy of Sciences of the United States of America	2013	27
24504370	1236	Mei Z	Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.	British journal of cancer	2014	39
24838938	1236	Hodi FS	Bevacizumab plus ipilimumab in patients with metastatic melanoma.	Cancer immunology research	2014	66
25470347	1236	Peferoen LA	Activation status of human microglia is dependent on lesion formation stage and remyelination in multiple sclerosis.	Journal of neuropathology and experimental neurology	2015	20
25581113	1236	Choi JY	Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity.	Arthritis and rheumatology	2015	24
25715355	1236	Canavan JB	Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.	Gut	2016	14
25787765	1236	Watanabe R	Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells.	Science translational medicine	2015	43
2108212	1378	Schlesinger LS	Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.	Journal of immunology	1990	162
24419525	1378	Baron F	Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.	Bone marrow transplantation	2014	22
6087328	1380	Fingeroth JD	Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.	Proceedings of the National Academy of Sciences of the United States of America	1984	205
11504927	1380	Moir S	HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.	Proceedings of the National Academy of Sciences of the United States of America	2001	92
11817590	1380	Baumann I	Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus.	Arthritis and rheumatism	2002	104
11861266	1380	Warnatz K	Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.	Blood	2002	106
12592401	1380	Tugizov SM	Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells.	Nature medicine	2003	77
17898316	1380	Wehr C	The EUROclass trial: defining subgroups in common variable immunodeficiency.	Blood	2008	125
18625747	1380	Moir S	Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals.	The Journal of experimental medicine	2008	235
19666505	1380	Rakhmanov M	Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	57
20231422	1380	Isnardi I	Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones.	Blood	2010	75
21421840	1380	Charles ED	Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.	Blood	2011	40
21703392	1380	Coppola D	Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling.	The American journal of pathology	2011	37
21860027	1380	Fridkis-Hareli M	Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases.	Blood	2011	36
10700656	1401	Lanquillon S	Cytokine production and treatment response in major depressive disorder.	Neuropsychopharmacology 	2000	125
11238260	1401	Zwaka TP	C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis.	Circulation	2001	97
11532280	1401	Volanakis JE	Human C-reactive protein: expression, structure, and function.	Molecular immunology	2001	101
12234944	1401	Venugopal SK	Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells.	Circulation	2002	99
12615790	1401	Yokoe T	Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.	Circulation	2003	134
12654604	1401	Vasan RS	Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.	Circulation	2003	103
12905467	1401	Cambridge G	Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.	Arthritis and rheumatism	2003	78
15280421	1401	Ehrenstein MR	Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy.	The Journal of experimental medicine	2004	276
16505242	1401	Devaraj S	Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes.	Diabetes	2006	84
17043079	1401	Fitzpatrick AL	Leukocyte telomere length and cardiovascular disease in the cardiovascular health study.	American journal of epidemiology	2007	200
17329698	1401	Tonetti MS	Treatment of periodontitis and endothelial function.	The New England journal of medicine	2007	166
17536046	1401	Tan ZS	Inflammatory markers and the risk of Alzheimer disease: the Framingham Study.	Neurology	2007	116
17540785	1401	Celli BR	Exacerbations of chronic obstructive pulmonary disease.	The European respiratory journal	2007	60
19011614	1401	Lu J	Structural recognition and functional activation of FcgammaR by innate pentraxins.	Nature	2008	67
19075102	1401	Liu PY	Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.	Circulation	2009	53
19240794	1401	van Leeuwen WM	Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.	PloS one	2009	82
19318937	1401	McMillan DC	Systemic inflammation, nutritional status and survival in patients with cancer.	Current opinion in clinical nutrition and metabolic care	2009	123
19324974	1401	Shyamsundar M	Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers.	American journal of respiratory and critical care medicine	2009	56
19387353	1401	Triant VA	Association of C-reactive protein and HIV infection with acute myocardial infarction.	Journal of acquired immune deficiency syndromes	2009	99
19433690	1401	Rohleder N	Biologic cost of caring for a cancer patient: dysregulation of pro- and anti-inflammatory signaling pathways.	Journal of clinical oncology 	2009	50
19449008	1401	Packard RR	Innate and adaptive immunity in atherosclerosis.	Seminars in immunopathology	2009	45
19520972	1401	Eisenhardt SU	Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques.	Circulation research	2009	46
20181810	1401	Bakker GC	An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach.	The American journal of clinical nutrition	2010	42
20194272	1401	Skinner AC	Multiple markers of inflammation and weight status: cross-sectional analyses throughout childhood.	Pediatrics	2010	50
20643463	1401	Ohno Y	Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma.	The Journal of urology	2010	47
21106722	1401	Sarnaik AA	Extended dose ipilimumab with a peptide vaccine: immune correlates associated with clinical benefit in patients with resected high-risk stage IIIc/IV melanoma.	Clinical cancer research 	2011	37
21252259	1401	Sandler NG	Plasma levels of soluble CD14 independently predict mortality in HIV infection.	The Journal of infectious diseases	2011	346
21253011	1401	Boulware DR	Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.	PLoS medicine	2010	85
21324198	1401	Koch A	Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients.	Critical care	2011	50
22055018	1401	Wikgren M	Short telomeres in depression and the general population are associated with a hypocortisolemic state.	Biological psychiatry	2012	41
22307011	1401	Pinato DJ	Inflammation-based prognostic indices in malignant pleural mesothelioma.	Journal of thoracic oncology 	2012	36
22345378	1401	Wood LG	The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma.	Chest	2012	46
22446338	1401	Gondo T	Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.	Urology	2012	39
22476808	1401	Wang DS	Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.	Medical oncology	2012	41
22549948	1401	Imayama I	Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial.	Cancer research	2012	49
22820791	1401	Subramanian S	Arterial inflammation in patients with HIV.	JAMA	2012	122
23820256	1401	Ishizuka M	Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer.	British journal of cancer	2013	29
23842110	1401	Groeger D	Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut.	Gut microbes	2013	28
23844064	1401	Gary T	Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.	PloS one	2013	26
24154724	1401	Rook GA	Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health.	Proceedings of the National Academy of Sciences of the United States of America	2013	38
24205846	1401	Coelho R	Childhood maltreatment and inflammatory markers: a systematic review.	Acta psychiatrica Scandinavica	2014	28
24425829	1401	Deelen J	Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers.	International journal of epidemiology	2014	28
24488982	1401	Kim EJ	Metabolic activity of the spleen and bone marrow in patients with acute myocardial infarction evaluated by 18f-fluorodeoxyglucose positron emission tomograpic imaging.	Circulation. Cardiovascular imaging	2014	21
24553386	1401	Davila ML	Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.	Science translational medicine	2014	297
24559495	1401	Dogan MV	The effect of smoking on DNA methylation of peripheral blood mononuclear cells from African American women.	BMC genomics	2014	53
24864079	1401	Ridker PM	Anti-inflammatory therapies for cardiovascular disease.	European heart journal	2014	40
24903083	1401	Garnacho-Montero J	Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis.	Critical care	2014	29
25082648	1401	Christian LM	Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index.	Cytokine	2014	27
25390655	1401	Willeit P	Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis.	PloS one	2014	25
25577441	1401	Emami H	Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humans.	JACC. Cardiovascular imaging	2015	31
25734736	1401	Chey WD	Irritable bowel syndrome: a clinical review.	JAMA	2015	69
25965853	1401	Dopico XC	Widespread seasonal gene expression reveals annual differences in human immunity and physiology.	Nature communications	2015	40
26063409	1401	Zhang WW	Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients.	Tumour biology 	2015	19
26169974	1401	Fernandes BS	C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.	Molecular psychiatry	2016	17
26351344	1401	Hurwitz HI	Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed.	Journal of clinical oncology 	2015	26
26390126	1401	Xu XL	A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.	PloS one	2015	20
26467665	1401	Tang LQ	Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma.	Journal of the National Cancer Institute	2016	16
26530445	1401	Ishizuka M	Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.	Annals of surgical oncology	2016	13
7997261	1432	Lee JC	A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.	Nature	1994	535
9069290	1432	Han J	Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation.	Nature	1997	165
9452444	1432	Vanden Berghe W	p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.	The Journal of biological chemistry	1998	120
10623843	1432	Hartmann G	Mechanism and function of a newly identified CpG DNA motif in human primary B cells.	Journal of immunology	2000	93
12509443	1432	Frevel MA	p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts.	Molecular and cellular biology	2003	91
12682440	1432	Abraham E	Neutrophils and acute lung injury.	Critical care medicine	2003	214
12853196	1432	Maiuri L	Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease.	Lancet	2003	97
14699082	1432	Doyle SE	Toll-like receptors induce a phagocytic gene program through p38.	The Journal of experimental medicine	2004	95
15855434	1432	Zink MC	Neuroprotective and anti-human immunodeficiency virus activity of minocycline.	JAMA	2005	65
16385087	1432	Isoda K	Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.	Arteriosclerosis, thrombosis, and vascular biology	2006	72
16402404	1432	Sadeghi K	Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns.	European journal of immunology	2006	100
17170118	1432	Sun L	Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA.	The Journal of biological chemistry	2007	69
17481747	1432	Cuenda A	p38 MAP-kinases pathway regulation, function and role in human diseases.	Biochimica et biophysica acta	2007	249
17656116	1432	Peng G	Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway.	Immunity	2007	95
18206122	1432	Matsuzawa A	Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling.	Biochimica et biophysica acta	2008	117
18492738	1432	Bhavsar P	Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma.	Thorax	2008	63
19124752	1432	Hui KP	Induction of proinflammatory cytokines in primary human macrophages by influenza A virus (H5N1) is selectively regulated by IFN regulatory factor 3 and p38 MAPK.	Journal of immunology	2009	56
19843704	1432	Wong CK	Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation.	American journal of respiratory cell and molecular biology	2010	41
20110572	1432	Schwartz EA	Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2010	42
21205892	1432	Adachi K	T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	36
22213806	1432	Li D	Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10-producing suppressive CD4+ T cells.	The Journal of experimental medicine	2012	64
22969168	1432	Lim AK	Inflammation in diabetic nephropathy.	Mediators of inflammation	2012	62
24024497	1432	Goleva E	The effects of airway microbiome on corticosteroid responsiveness in asthma.	American journal of respiratory and critical care medicine	2013	46
24521784	1432	Ifrim DC	Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors.	Clinical and vaccine immunology 	2014	25
24759787	1432	Aye IL	Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways.	Biology of reproduction	2014	35
25083993	1432	Henson SM	p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8âº T cells.	The Journal of clinical investigation	2014	34
25151490	1432	Lanna A	The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells.	Nature immunology	2014	37
26320263	1432	Carestia A	Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets.	Journal of leukocyte biology	2016	13
3258626	1435	Gendelman HE	Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.	The Journal of experimental medicine	1988	307
8600162	1435	Haynesworth SE	Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha.	Journal of cellular physiology	1996	118
8760823	1435	Caux C	CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha.	The Journal of experimental medicine	1996	125
9618145	1435	Majumdar MK	Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells.	Journal of cellular physiology	1998	120
9845545	1435	Menetrier-Caux C	Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.	Blood	1998	102
14755726	1435	Henkel JS	Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.	Annals of neurology	2004	105
17082649	1435	Martinez FO	Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.	Journal of immunology	2006	524
17374712	1435	Harman-Boehm I	Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity.	The Journal of clinical endocrinology and metabolism	2007	106
18332234	1435	Shao DD	Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation.	Journal of leukocyte biology	2008	85
18553315	1435	Komohara Y	Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.	The Journal of pathology	2008	120
19299742	1435	Leidi M	M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.	Journal of immunology	2009	73
19432671	1435	Kawamura K	Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors.	Pathology international	2009	55
19934330	1435	Patsialou A	Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.	Cancer research	2009	94
20335529	1435	Gleissner CA	CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages.	Journal of immunology	2010	47
20580464	1435	Sierra-Filardi E	Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release.	Immunobiology	2010	50
20957152	1435	Wauquier N	Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.	PLoS neglected tropical diseases	2010	96
21890660	1435	Svensson J	Macrophages at the fetal-maternal interface express markers of alternative activation and are induced by M-CSF and IL-10.	Journal of immunology	2011	47
21911939	1435	Vogt G	In vitro differentiation of human macrophages with enhanced antimycobacterial activity.	The Journal of clinical investigation	2011	38
22161841	1435	Laoui D	Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions.	The International journal of developmental biology	2011	57
22186992	1435	Hume DA	Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling.	Blood	2012	106
22547697	1435	Lacey DC	Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models.	Journal of immunology	2012	85
22880072	1435	Rey-Giraud F	In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions.	PloS one	2012	43
24521472	1435	Mia S	An optimized protocol for human M2 macrophages using M-CSF and IL-4/IL-10/TGF-Î² yields a dominant immunosuppressive phenotype.	Scandinavian journal of immunology	2014	23
24898549	1435	Ries CH	Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.	Cancer cell	2014	126
25429076	1435	Pignatelli J	Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration.	Science signaling	2014	23
25446896	1435	Ruffell B	Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells.	Cancer cell	2014	76
26538619	1435	Stafford JH	Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.	Neuro-oncology	2016	15
1940799	1437	de Waal Malefyt R	Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.	The Journal of experimental medicine	1991	645
3488815	1437	Shaw G	A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.	Cell	1986	914
3923623	1437	Wong GG	Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins.	Science	1985	191
7629501	1437	Sallusto F	Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.	The Journal of experimental medicine	1995	427
8006603	1437	Romani N	Proliferating dendritic cell progenitors in human blood.	The Journal of experimental medicine	1994	266
8145033	1437	Sallusto F	Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.	The Journal of experimental medicine	1994	905
8274730	1437	Tilg H	Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.	Blood	1994	127
8841451	1437	Bender A	Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood.	Journal of immunological methods	1996	112
9500607	1437	Nestle FO	Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells.	Nature medicine	1998	310
9712065	1437	Luft T	Type I IFNs enhance the terminal differentiation of dendritic cells.	Journal of immunology	1998	123
10679127	1437	Ziolkowska M	High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism.	Journal of immunology	2000	141
10811870	1437	Santini SM	Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.	The Journal of experimental medicine	2000	112
10866317	1437	Mach N	Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.	Cancer research	2000	115
11160266	1437	Goriely S	Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes.	Journal of immunology	2001	88
11238037	1437	Sugiyama S	Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes.	The American journal of pathology	2001	100
11544464	1437	Molet S	IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.	The Journal of allergy and clinical immunology	2001	206
12473579	1437	Giaccone G	A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.	Clinical cancer research 	2002	124
12829592	1437	Hayashi F	Toll-like receptors stimulate human neutrophil function.	Blood	2003	187
12952922	1437	Doran KS	Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis.	The Journal of clinical investigation	2003	76
14688315	1437	Finney HM	Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.	Journal of immunology	2004	96
15289501	1437	Thomas AM	Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients.	The Journal of experimental medicine	2004	104
15661881	1437	Gorden KB	Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.	Journal of immunology	2005	147
15692068	1437	Jiang XX	Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells.	Blood	2005	260
15871677	1437	Hughes MS	Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.	Human gene therapy	2005	77
15917384	1437	Korzenik JR	Sargramostim for active Crohn's disease.	The New England journal of medicine	2005	67
16204061	1437	Queen MM	Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression.	Cancer research	2005	73
16951685	1437	Rossi AG	Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis.	Nature medicine	2006	138
17220794	1437	Ramasamy R	Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle.	Transplantation	2007	89
17492620	1437	Dubsky P	IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.	European journal of immunology	2007	57
17577033	1437	Filipazzi P	Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine.	Journal of clinical oncology 	2007	230
18287062	1437	Hodi FS	Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.	Proceedings of the National Academy of Sciences of the United States of America	2008	171
18292469	1437	O'Reilly MA	Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus.	American journal of respiratory and critical care medicine	2008	53
18550585	1437	Smithgall MD	IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.	International immunology	2008	130
19147575	1437	Fong L	Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.	Cancer research	2009	83
19157572	1437	Li X	Elevated immune response in the brain of autistic patients.	Journal of neuroimmunology	2009	132
19201905	1437	Motohashi S	A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.	Journal of immunology	2009	54
19308771	1437	Berg M	Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.	Cytotherapy	2009	72
19609242	1437	Weide B	Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.	Journal of immunotherapy	2009	45
19636017	1437	McNeel DG	Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer.	Journal of clinical oncology 	2009	74
19666104	1437	Enstrom AM	Differential monocyte responses to TLR ligands in children with autism spectrum disorders.	Brain, behavior, and immunity	2010	73
19805669	1437	Emens LA	Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation.	Journal of clinical oncology 	2009	69
19903780	1437	Slingluff CL Jr	Effect of granulocyte/macrophage colony-stimulating factor on circulating CD8+ and CD4+ T-cell responses to a multipeptide melanoma vaccine: outcome of a multicenter randomized trial.	Clinical cancer research 	2009	62
19915919	1437	Kaufman HL	Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma.	Annals of surgical oncology	2010	118
19966223	1437	Chen Q	Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice.	Proceedings of the National Academy of Sciences of the United States of America	2009	75
20017188	1437	Scriba TJ	Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells.	European journal of immunology	2010	67
20083662	1437	Torres-Aguilar H	Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells.	Journal of immunology	2010	55
20179677	1437	Morgan RA	Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2.	Molecular therapy 	2010	397
20386463	1437	Correale P	Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.	Journal of immunotherapy	2010	60
20406969	1437	Ko JS	Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained.	Cancer research	2010	81
20484030	1437	Cerullo V	Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients.	Cancer research	2010	69
20817712	1437	Tadokera R	Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome.	The European respiratory journal	2011	47
20833247	1437	Ashwood P	Altered T cell responses in children with autism.	Brain, behavior, and immunity	2011	60
21030562	1437	Rosenblatt J	Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma.	Blood	2011	44
21217520	1437	Lutz E	A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.	Annals of surgery	2011	94
21630267	1437	Pesonen S	Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors.	International journal of cancer	2012	32
21734236	1437	Solito S	A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.	Blood	2011	77
21989902	1437	Mittendorf EA	Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.	Cancer	2012	34
22271649	1437	Sharkey DJ	Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus.	Journal of immunology	2012	60
23075808	1437	Gleason MK	Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.	Molecular cancer therapeutics	2012	38
23493351	1437	Kanerva A	Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus.	Clinical cancer research 	2013	42
23924790	1437	Le DT	Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.	Journal of immunotherapy	2013	92
24217582	1437	Burmester GR	Emerging cell and cytokine targets in rheumatoid arthritis.	Nature reviews. Rheumatology	2014	32
24458546	1437	Helm O	Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.	International journal of cancer	2014	25
24520093	1437	Rapoport AP	Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.	Clinical cancer research 	2014	27
24643864	1437	Saijo T	Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.	mBio	2014	30
24667615	1437	Walko TD 3rd	Cerebrospinal fluid mitochondrial DNA: a novel DAMP in pediatric traumatic brain injury.	Shock	2014	20
24816404	1437	Wu P	Î³Î´T17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer.	Immunity	2014	60
24823638	1437	Su S	A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis.	Cancer cell	2014	85
24942756	1437	Lutz ER	Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation.	Cancer immunology research	2014	63
24954781	1437	Middleton G	Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.	The Lancet. Oncology	2014	45
25732812	1437	Koenders MI	Novel therapeutic targets in rheumatoid arthritis.	Trends in pharmacological sciences	2015	17
26104913	1437	Arnold KB	Increased levels of inflammatory cytokines in the female reproductive tract are associated with altered expression of proteases, mucosal barrier proteins, and an influx of HIV-susceptible target cells.	Mucosal immunology	2016	23
26491076	1437	Li R	Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy.	Science translational medicine	2015	28
26633290	1437	Wicks IP	Targeting GM-CSF in inflammatory diseases.	Nature reviews. Rheumatology	2016	16
26783184	1437	Scheibe K	IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo.	Gut	2017	7
27374224	1437	Singhal S	Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer.	Cancer cell	2016	13
12387964	1440	PÃ¼tsep K	Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.	Lancet	2002	95
12974876	1440	Treutiger CJ	High mobility group 1 B-box mediates activation of human endothelium.	Journal of internal medicine	2003	82
15743872	1440	Ishizu T	Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.	Brain 	2005	70
16046292	1440	Cancello R	Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss.	Diabetes	2005	222
18182579	1440	Metcalf D	Hematopoietic cytokines.	Blood	2008	104
18832668	1440	von Vietinghoff S	Homeostatic regulation of blood neutrophil counts.	Journal of immunology	2008	64
20007560	1440	Hsieh MM	Allogeneic hematopoietic stem-cell transplantation for sickle cell disease.	The New England journal of medicine	2009	79
21256188	1440	Morel S	Adjuvant System AS03 containing Î±-tocopherol modulates innate immune response and leads to improved adaptive immunity.	Vaccine	2011	64
21480223	1440	Eruslanov E	Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer.	International journal of cancer	2012	32
21636707	1440	Raychaudhuri B	Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma.	Neuro-oncology	2011	85
21907922	1440	Granot Z	Tumor entrained neutrophils inhibit seeding in the premetastatic lung.	Cancer cell	2011	105
22828446	1440	Mougiakakos D	Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.	Leukemia	2013	27
23165479	1440	Di Bartolomeo P	Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.	Blood	2013	33
25131807	1440	Bendall LJ	G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent.	Cytokine and growth factor reviews	2014	32
7534620	1493	Linsley PS	Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.	Immunity	1994	143
10225967	1493	Abrams JR	CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.	The Journal of clinical investigation	1999	98
11067871	1493	Jonuleit H	Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.	The Journal of experimental medicine	2000	253
11390435	1493	Jonuleit H	Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.	The Journal of experimental medicine	2001	227
11390436	1493	Levings MK	Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.	The Journal of experimental medicine	2001	180
11390437	1493	Dieckmann D	Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.	The Journal of experimental medicine	2001	209
11390478	1493	Yamagiwa S	A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood.	Journal of immunology	2001	116
11560999	1493	Iellem A	Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells.	The Journal of experimental medicine	2001	193
11895781	1493	Steinbrink K	CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity.	Blood	2002	81
11970966	1493	Woo EY	Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation.	Journal of immunology	2002	140
12193750	1493	Liyanage UK	Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma.	Journal of immunology	2002	314
12370347	1493	Zheng SG	Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.	Journal of immunology	2002	110
12576425	1493	Wolf AM	Increase of regulatory T cells in the peripheral blood of cancer patients.	Clinical cancer research 	2003	159
12826605	1493	Phan GQ	Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.	Proceedings of the National Academy of Sciences of the United States of America	2003	320
14604957	1493	Marshall NA	Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma.	Blood	2004	90
14997000	1493	Sasaki Y	Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases.	Molecular human reproduction	2004	104
15034022	1493	Munn DH	Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.	Journal of immunology	2004	109
15128835	1493	de Kleer IM	CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis.	Journal of immunology	2004	78
15611238	1493	Sugiyama H	Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation.	Journal of immunology	2005	76
15749840	1493	Andersson J	The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.	Journal of immunology	2005	139
15820948	1493	Maccario R	Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.	Haematologica	2005	123
15914560	1493	Beyer M	Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.	Blood	2005	103
15932517	1493	Gregg R	The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age.	Clinical and experimental immunology	2005	84
16167085	1493	Bisikirska B	TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.	The Journal of clinical investigation	2005	90
16204013	1493	Ribas A	Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.	Journal of clinical oncology 	2005	101
16301685	1493	Maker AV	Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.	Journal of immunology	2005	75
16328385	1493	Kono K	CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.	Cancer immunology, immunotherapy 	2006	63
16493086	1493	Babu S	Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence.	Journal of immunology	2006	85
16505437	1493	Cesana GC	Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma.	Journal of clinical oncology 	2006	66
16723631	1493	El Andaloussi A	An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.	Neuro-oncology	2006	75
17293384	1493	Czerniecki BJ	Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.	Cancer research	2007	79
17363537	1493	Small EJ	A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer.	Clinical cancer research 	2007	102
17606437	1493	Prevosto C	Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction.	Haematologica	2007	83
17673617	1493	Weber J	Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events.	The oncologist	2007	65
17906628	1493	Kaufmann DE	Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction.	Nature immunology	2007	185
18512248	1493	HÃ¶lttÃ¤ V	IL-23/IL-17 immunity as a hallmark of Crohn's disease.	Inflammatory bowel diseases	2008	52
18519750	1493	Sfanos KS	Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing.	Clinical cancer research 	2008	119
18523152	1493	Kavanagh B	CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion.	Blood	2008	59
18818309	1493	Liakou CI	CTLA-4 blockade increases IFNgamma-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients.	Proceedings of the National Academy of Sciences of the United States of America	2008	103
19009291	1493	Galustian C	The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells.	Cancer immunology, immunotherapy 	2009	78
19036923	1493	Flores-Borja F	Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis.	Proceedings of the National Academy of Sciences of the United States of America	2008	60
19074257	1493	Yuan J	CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit.	Proceedings of the National Academy of Sciences of the United States of America	2008	111
19130927	1493	Shreffler WG	Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein.	The Journal of allergy and clinical immunology	2009	45
19198837	1493	Weber J	Ipilimumab: controversies in its development, utility and autoimmune adverse events.	Cancer immunology, immunotherapy 	2009	59
19202079	1493	Chen H	Anti-CTLA-4 therapy results in higher CD4+ICOShi T cell frequency and IFN-gamma levels in both nonmalignant and malignant prostate tissues.	Proceedings of the National Academy of Sciences of the United States of America	2009	48
19247441	1493	Nakamoto N	Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.	PLoS pathogens	2009	113
19338264	1493	Oble DA	Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma.	Cancer immunity	2009	53
19494038	1493	Schmidl C	Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity.	Genome research	2009	78
19789309	1493	Ribas A	Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma.	Clinical cancer research 	2009	53
19808874	1493	Ansell SM	Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma.	Clinical cancer research 	2009	59
19843932	1493	Jeffery LE	1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.	Journal of immunology	2009	96
20038811	1493	DerrÃ© L	BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.	The Journal of clinical investigation	2010	67
20220088	1493	Allen CE	Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.	Journal of immunology	2010	43
20437560	1493	Correale J	Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis.	Annals of neurology	2010	41
20460488	1493	Carthon BC	Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial.	Clinical cancer research 	2010	91
20479064	1493	Vonderheide RH	Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells.	Clinical cancer research 	2010	46
20596022	1493	Petukhova L	Genome-wide association study in alopecia areata implicates both innate and adaptive immunity.	Nature	2010	94
20660788	1493	Antonelli LR	Elevated frequencies of highly activated CD4+ T cells in HIV+ patients developing immune reconstitution inflammatory syndrome.	Blood	2010	55
21074063	1493	Callahan MK	Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy.	Seminars in oncology	2010	59
21074065	1493	Di Giacomo AM	The emerging toxicity profiles of anti-CTLA-4 antibodies across clinical indications.	Seminars in oncology	2010	52
21074069	1493	Hoos A	Development of ipilimumab: contribution to a new paradigm for cancer immunotherapy.	Seminars in oncology	2010	60
21360567	1493	Schurich A	Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection.	Hepatology	2011	55
21474713	1493	Qureshi OS	Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4.	Science	2011	248
21723783	1493	Wing K	Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation.	Trends in immunology	2011	50
21933959	1493	Yuan J	Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab.	Proceedings of the National Academy of Sciences of the United States of America	2011	90
22071969	1493	Dias JD	Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4.	Gene therapy	2012	34
22146893	1493	Ji RR	An immune-active tumor microenvironment favors clinical response to ipilimumab.	Cancer immunology, immunotherapy 	2012	127
22155204	1493	Kessel A	Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.	Autoimmunity reviews	2012	41
22193102	1493	Mellman I	Cancer immunotherapy comes of age.	Nature	2011	489
22326924	1493	Madan RA	Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.	The Lancet. Oncology	2012	92
22397654	1493	Postow MA	Immunologic correlates of the abscopal effect in a patient with melanoma.	The New England journal of medicine	2012	313
22585562	1493	Schuler PJ	Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.	European journal of immunology	2012	33
22878899	1493	Santegoets SJ	T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment.	Cancer immunology, immunotherapy 	2013	29
23028051	1493	Corrales L	Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression.	Journal of immunology	2012	36
23160205	1493	Pardoll DM	Immunology beats cancer: a blueprint for successful translation.	Nature immunology	2012	36
23356291	1493	Whiteside TL	Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes).	Biochemical Society transactions	2013	55
23452415	1493	Ascierto PA	The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment.	Journal of translational medicine	2013	33
23460531	1493	Melero I	Clinical development of immunostimulatory monoclonal antibodies and opportunities for combination.	Clinical cancer research 	2013	46
23460532	1493	Ascierto PA	Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types.	Clinical cancer research 	2013	44
23460535	1493	Melero I	Agonist antibodies to TNFR molecules that costimulate T and NK cells.	Clinical cancer research 	2013	35
23580578	1493	Aerts JG	Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer.	Cancer research	2013	27
23667165	1493	Callahan MK	At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy.	Journal of leukocyte biology	2013	75
23690483	1493	Besser MJ	Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies.	Clinical cancer research 	2013	42
23922369	1493	Gautam S	CD8 T cell exhaustion in human visceral leishmaniasis.	The Journal of infectious diseases	2014	29
23960017	1493	Han Y	Human CD14+ CTLA-4+ regulatory dendritic cells suppress T-cell response by cytotoxic T-lymphocyte antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase production in hepatocellular carcinoma.	Hepatology	2014	26
24045166	1493	Kmiecik J	Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level.	Journal of neuroimmunology	2013	32
24161671	1493	Kyi C	Checkpoint blocking antibodies in cancer immunotherapy.	FEBS letters	2014	52
24169351	1493	Jie HB	Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.	British journal of cancer	2013	46
24388175	1493	Rong Z	An effective approach to prevent immune rejection of human ESC-derived allografts.	Cell stem cell	2014	25
24445516	1493	Gangadhar TC	Mitigating the toxic effects of anticancer immunotherapy.	Nature reviews. Clinical oncology	2014	32
24485523	1493	Perez-Gracia JL	Orchestrating immune check-point blockade for cancer immunotherapy in combinations.	Current opinion in immunology	2014	27
24514956	1493	Jochems C	A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.	Cancer immunology, immunotherapy 	2014	23
24563870	1493	Golden EB	An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.	Cancer immunology research	2013	85
24583799	1493	Robert L	CTLA4 blockade broadens the peripheral T-cell receptor repertoire.	Clinical cancer research 	2014	44
24610577	1493	Ryder M	Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution.	Endocrine-related cancer	2014	30
24777852	1493	Ng Tang D	Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapy.	Cancer immunology research	2013	33
24795351	1493	Anderson AC	Tim-3: an emerging target in the cancer immunotherapy landscape.	Cancer immunology research	2014	30
24825462	1493	Kalathil SG	T-regulatory cells and programmed death 1+ T cells contribute to effector T-cell dysfunction in patients with chronic obstructive pulmonary disease.	American journal of respiratory and critical care medicine	2014	20
24860567	1493	Corthay A	Does the immune system naturally protect against cancer?	Frontiers in immunology	2014	29
25211661	1493	Naidoo J	Immune modulation for cancer therapy.	British journal of cancer	2014	33
25213377	1493	Kuehn HS	Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4.	Science	2014	83
25232180	1493	Kvistborg P	Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response.	Science translational medicine	2014	57
25323844	1493	Philips GK	Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies.	International immunology	2015	46
25415283	1493	Soares KC	PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.	Journal of immunotherapy	2015	49
25428504	1493	Herbst RS	Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.	Nature	2014	530
25526312	1493	Wing JB	Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4.	Immunity	2014	42
25583297	1493	Zamarin D	Immune checkpoint modulation: rational design of combination strategies.	Pharmacology and therapeutics	2015	24
25589619	1493	Liu L	The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4.	Clinical cancer research 	2015	31
25621841	1493	Shin DS	The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?	Current opinion in immunology	2015	63
25634360	1493	Rosenzwajg M	Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.	Journal of autoimmunity	2015	24
25672397	1493	Beavis PA	Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell Responses.	Cancer immunology research	2015	16
25733707	1493	Anagnostou VK	Cancer immunotherapy: a future paradigm shift in the treatment of non-small cell lung cancer.	Clinical cancer research 	2015	32
25795410	1493	Weber JS	Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.	The Lancet. Oncology	2015	227
25824720	1493	Carosella ED	A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.	European urology	2015	24
25832655	1493	Jie HB	CTLA-4âº Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.	Cancer research	2015	33
25918390	1493	Romano E	Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients.	Proceedings of the National Academy of Sciences of the United States of America	2015	38
26206937	1493	Lo B	AUTOIMMUNE DISEASE. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy.	Science	2015	32
26323609	1493	Nduom EK	PD-L1 expression and prognostic impact in glioblastoma.	Neuro-oncology	2016	30
26325034	1493	Buchbinder E	Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade.	The Journal of clinical investigation	2015	20
26337719	1493	Bertrand A	Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis.	BMC medicine	2015	25
26558876	1493	Buchbinder EI	CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition.	American journal of clinical oncology	2016	32
26765102	1493	Michot JM	Immune-related adverse events with immune checkpoint blockade: a comprehensive review.	European journal of cancer	2016	41
26940869	1493	McGranahan N	Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.	Science	2016	126
26972336	1493	Webb JR	PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.	Gynecologic oncology	2016	17
27084739	1493	Zarour HM	Reversing T-cell Dysfunction and Exhaustion in Cancer.	Clinical cancer research 	2016	15
27141885	1493	Boutros C	Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination.	Nature reviews. Clinical oncology	2016	15
27192565	1493	Anderson AC	Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.	Immunity	2016	32
27216414	1493	Hughes PE	Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer.	Trends in immunology	2016	14
27256570	1493	Vilgelm AE	Combinatorial approach to cancer immunotherapy: strength in numbers.	Journal of leukocyte biology	2016	11
27332730	1493	Pitt JM	Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors.	Immunity	2016	18
27410923	1493	Davids MS	Ipilimumab for Patients with Relapse after Allogeneic Transplantation.	The New England journal of medicine	2016	23
27828943	1493	De Henau O	Overcoming resistance to checkpoint blockade therapy by targeting PI3KÎ³ in myeloid cells.	Nature	2016	12
27951441	1493	O'Donnell JS	Resistance to PD1/PDL1 checkpoint inhibition.	Cancer treatment reviews	2017	6
28102259	1493	Chen DS	Elements of cancer immunity and the cancer-immune set point.	Nature	2017	15
9782118	1524	Fong AM	Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow.	The Journal of experimental medicine	1998	136
11818437	1524	Robertson MJ	Role of chemokines in the biology of natural killer cells.	Journal of leukocyte biology	2002	100
15653504	1524	Niess JH	CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.	Science	2005	389
16877434	1524	Checchin D	Potential role of microglia in retinal blood vessel formation.	Investigative ophthalmology and visual science	2006	63
20554025	1524	Prinz M	Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS.	Journal of neuroimmunology	2010	43
20565954	1524	Seidler S	Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults.	BMC immunology	2010	61
20921622	1524	Hertoghs KM	Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation.	The Journal of clinical investigation	2010	45
24296810	1524	Westhorpe CL	Associations between surface markers on blood monocytes and carotid atherosclerosis in HIV-positive individuals.	Immunology and cell biology	2014	21
26045138	1524	Knoop KA	Antibiotics promote inflammation through the translocation of native commensal colonic bacteria.	Gut	2016	16
26195744	1524	Weiskopf D	Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity.	Proceedings of the National Academy of Sciences of the United States of America	2015	25
27606804	1524	Pachnio A	Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium.	PLoS pathogens	2016	10
10102815	1991	Wakasugi K	Two distinct cytokines released from a human aminoacyl-tRNA synthetase.	Science	1999	123
12778173	1991	Person RE	Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.	Nature genetics	2003	83
17947611	1991	Simpson JL	Clarithromycin targets neutrophilic airway inflammation in refractory asthma.	American journal of respiratory and critical care medicine	2008	57
23328639	1991	Hoenderdos K	The neutrophil in chronic obstructive pulmonary disease.	American journal of respiratory cell and molecular biology	2013	43
24740504	1991	Yoo DG	Release of cystic fibrosis airway inflammatory markers from Pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation.	Journal of immunology	2014	20
24865846	1991	Fortelny N	Network analyses reveal pervasive functional regulation between proteases in the human protease web.	PLoS biology	2014	24
24928093	1991	Sur Chowdhury C	Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility.	Arthritis research and therapy	2014	26
26673780	1991	Rochael NC	Classical ROS-dependent and early/rapid ROS-independent release of Neutrophil Extracellular Traps triggered by Leishmania parasites.	Scientific reports	2015	17
26712312	1991	Martinod K	Neutrophil elastase-deficient mice form neutrophil extracellular traps in an experimental model of deep vein thrombosis.	Journal of thrombosis and haemostasis 	2016	10
12060624	2064	Schindl M	Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.	Clinical cancer research 	2002	96
12147373	2064	Andre F	Malignant effusions and immunogenic tumour-derived exosomes.	Lancet	2002	187
15256471	2064	Yu JS	Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma.	Cancer research	2004	132
15355889	2064	Gennari R	Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2.	Clinical cancer research 	2004	100
15455388	2064	Lengyel E	C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.	International journal of cancer	2005	85
15534099	2064	Camp RL	X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.	Clinical cancer research 	2004	274
15561805	2064	Cianfrocca M	Prognostic and predictive factors in early-stage breast cancer.	The oncologist	2004	94
16258083	2064	Tan-Chiu E	Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31.	Journal of clinical oncology 	2005	121
16404427	2064	Arnould L	Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?	British journal of cancer	2006	109
16611412	2064	Ghebeh H	The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.	Neoplasia	2006	129
17347129	2064	Chapman C	Autoantibodies in breast cancer: their use as an aid to early diagnosis.	Annals of oncology 	2007	62
17395729	2064	BÃ¼hring HJ	Novel markers for the prospective isolation of human MSC.	Annals of the New York Academy of Sciences	2007	96
17683518	2064	Teschendorff AE	An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.	Genome biology	2007	168
18037158	2064	TomsovÃ¡ M	Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.	Gynecologic oncology	2008	60
19272155	2064	Rody A	T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.	Breast cancer research 	2009	90
19664291	2064	Fehm T	Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.	Breast cancer research 	2009	59
19720923	2064	Disis ML	Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer.	Journal of clinical oncology 	2009	78
19858088	2064	Aitken SJ	Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases.	Annals of oncology 	2010	40
20231686	2064	Staaf J	Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.	Journal of clinical oncology 	2010	54
21437909	2064	Ladoire S	In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival.	The Journal of pathology	2011	47
21505063	2064	Sieuwerts AM	mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.	Clinical cancer research 	2011	59
21562709	2064	Ono M	Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer.	Breast cancer research and treatment	2012	53
21717105	2064	Liu F	CD8âº cytotoxic T cell and FOXP3âº regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes.	Breast cancer research and treatment	2011	42
21795664	2064	Yaghjyan L	Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics.	Journal of the National Cancer Institute	2011	41
21908711	2064	Kristensen VN	Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling.	Proceedings of the National Academy of Sciences of the United States of America	2012	62
22049225	2064	Mahmoud SM	Tumour-infiltrating macrophages and clinical outcome in breast cancer.	Journal of clinical pathology	2012	43
22264265	2064	Kasimir-Bauer S	Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells.	Breast cancer research 	2012	66
22738135	2064	Marleau AM	Exosome removal as a therapeutic adjuvant in cancer.	Journal of translational medicine	2012	55
23034170	2064	Ma C	Tumor-infiltrating Î³Î´ T lymphocytes predict clinical outcome in human breast cancer.	Journal of immunology	2012	37
23341518	2064	Loi S	Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98.	Journal of clinical oncology 	2013	199
23738752	2064	Chen WC	Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor.	Histopathology	2013	31
23756627	2064	Muenst S	The presence of programmed death 1 (PD-1)-positive tumor-infiltrating lymphocytes is associated with poor prognosis in human breast cancer.	Breast cancer research and treatment	2013	49
24239210	2064	Buzdar AU	Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial.	The Lancet. Oncology	2013	27
24448237	2064	Almendro V	Genetic and phenotypic diversity in breast tumor metastases.	Cancer research	2014	39
24480556	2064	Bianchini G	The immune system and response to HER2-targeted treatment in breast cancer.	The Lancet. Oncology	2014	29
24532163	2064	Dirican A	Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?	International journal of clinical oncology	2015	20
24608200	2064	Loi S	Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial.	Annals of oncology 	2014	129
24665085	2064	SÃ¶rensen J	First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule.	Journal of nuclear medicine 	2014	36
24915873	2064	Ali HR	Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.	Annals of oncology 	2014	49
25025958	2064	Singh JC	HER2-positive advanced breast cancer: optimizing patient outcomes and opportunities for drug development.	British journal of cancer	2014	22
25373520	2064	SchÃ¶nfeld K	Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptor.	Molecular therapy 	2015	30
25587647	2064	Rimawi MF	Targeting HER2 for the treatment of breast cancer.	Annual review of medicine	2015	26
25800760	2064	Ahmed N	Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma.	Journal of clinical oncology 	2015	70
25959051	2064	Acerbi I	Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration.	Integrative biology 	2015	45
25995301	2064	Dieci MV	Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials.	Annals of oncology 	2015	21
26093818	2064	Mazel M	Frequent expression of PD-L1 on circulating breast cancer cells.	Molecular oncology	2015	23
26181252	2064	Salgado R	Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.	JAMA oncology	2015	37
26444637	2064	Kroemer G	Natural and therapy-induced immunosurveillance in breast cancer.	Nature medicine	2015	31
26469139	2064	Perez EA	Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer.	JAMA oncology	2016	12
26559813	2064	Suck G	NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy.	Cancer immunology, immunotherapy 	2016	15
26598540	2064	Pruneri G	Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer.	Annals of oncology 	2016	12
26598746	2064	Levine MN	Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.	Journal of clinical oncology 	2016	12
26667975	2064	Savas P	Clinical relevance of host immunity in breast cancer: from TILs to the clinic.	Nature reviews. Clinical oncology	2016	32
1719545	2187	Burton DR	A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.	Proceedings of the National Academy of Sciences of the United States of America	1991	194
11377686	2187	Valent P	Diagnostic criteria and classification of mastocytosis: a consensus proposal.	Leukemia research	2001	110
15226186	2187	Ross ME	Gene expression profiling of pediatric acute myelogenous leukemia.	Blood	2004	122
22474370	2187	Smith P	Mouse model recapitulating human FcÎ³ receptor structural and functional diversity.	Proceedings of the National Academy of Sciences of the United States of America	2012	54
26759369	2187	Rodgers DT	Switch-mediated activation and retargeting of CAR-T cells for B-cell malignancies.	Proceedings of the National Academy of Sciences of the United States of America	2016	18
19506243	2205	Pushparaj PN	The cytokine interleukin-33 mediates anaphylactic shock.	Proceedings of the National Academy of Sciences of the United States of America	2009	75
19828304	2205	Kawakami T	Mast cells in atopic dermatitis.	Current opinion in immunology	2009	49
20410486	2205	Gill MA	Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells.	Journal of immunology	2010	67
2552313	2208	Young L	Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.	The New England journal of medicine	1989	199
8006591	2208	Pascual V	Analysis of somatic mutation in five B cell subsets of human tonsil.	The Journal of experimental medicine	1994	156
8097323	2208	Punnonen J	Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.	Proceedings of the National Academy of Sciences of the United States of America	1993	153
11934717	2209	Dyugovskaya L	Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients.	American journal of respiratory and critical care medicine	2002	105
15703291	2209	Dhodapkar KM	Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells.	Proceedings of the National Academy of Sciences of the United States of America	2005	72
17318616	2209	Jacobsen M	Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis.	Journal of molecular medicine	2007	73
18041019	2209	Kou Z	Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells.	Journal of medical virology	2008	60
18201370	2209	SkrzeczyÅska-Moncznik J	Peripheral blood CD14high CD16+ monocytes are main producers of IL-10.	Scandinavian journal of immunology	2008	67
18628480	2209	Wu L	lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.	Clinical cancer research 	2008	94
22766097	2209	Durrani SR	Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children.	The Journal of allergy and clinical immunology	2012	46
24948369	2209	Chang TW	The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.	The Journal of allergy and clinical immunology	2015	21
25522163	2209	Kim HS	Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-Î²1 alleviate atopic dermatitis by reducing mast cell degranulation.	Stem cells	2015	18
26563133	2209	Brunstein CG	Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.	Blood	2016	25
2478233	2214	Passlick B	Identification and characterization of a novel monocyte subpopulation in human peripheral blood.	Blood	1989	186
3086432	2214	Lanier LL	The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.	Journal of immunology	1986	163
9078201	2214	Pulliam L	Unique monocyte subset in patients with AIDS dementia.	Lancet	1997	110
11062267	2214	Mahnke K	The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments.	The Journal of cell biology	2000	113
11698225	2214	Cooper MA	The biology of human natural killer-cell subsets.	Trends in immunology	2001	486
11704885	2214	Fischer-Smith T	CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection.	Journal of neurovirology	2001	109
12393628	2214	MacDonald KP	Characterization of human blood dendritic cell subsets.	Blood	2002	178
14645713	2214	Mavilio D	Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.	Proceedings of the National Academy of Sciences of the United States of America	2003	96
15269840	2214	Schlitt A	CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels.	Thrombosis and haemostasis	2004	76
16203869	2214	Bryceson YT	Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.	The Journal of experimental medicine	2005	137
17100877	2214	Bryceson YT	Activation, coactivation, and costimulation of resting human natural killer cells.	Immunological reviews	2006	129
17135573	2214	Ziegler-Heitbrock L	The CD14+ CD16+ blood monocytes: their role in infection and inflammation.	Journal of leukocyte biology	2007	255
17277081	2214	Nigrovic PA	Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1.	Proceedings of the National Academy of Sciences of the United States of America	2007	58
17404276	2214	Romagnani C	CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.	Journal of immunology	2007	119
18203207	2214	Carrega P	Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.	Cancer	2008	68
19278419	2214	Poli A	CD56bright natural killer (NK) cells: an important NK cell subset.	Immunology	2009	96
19573729	2214	Tsujioka H	Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction.	Journal of the American College of Cardiology	2009	69
19628705	2214	Bryceson YT	Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.	Blood	2009	58
19965656	2214	Fauriat C	Regulation of human NK-cell cytokine and chemokine production by target cell recognition.	Blood	2010	141
20513525	2214	Kolbeck R	MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.	The Journal of allergy and clinical immunology	2010	43
20711229	2214	Zhang J	Natural killer cell-triggered vascular transformation: maternal care before birth?	Cellular and molecular immunology	2011	51
21187373	2214	De Maria A	Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation.	Proceedings of the National Academy of Sciences of the United States of America	2011	78
21242295	2214	Bigley V	The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency.	The Journal of experimental medicine	2011	80
21741920	2214	Ahlenstiel G	Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C.	Gastroenterology	2011	56
21825173	2214	Lopez-VergÃ¨s S	Expansion of a unique CD57âºNKG2Chi natural killer cell subset during acute human cytomegalovirus infection.	Proceedings of the National Academy of Sciences of the United States of America	2011	166
22096237	2214	Della Chiesa M	Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?	Blood	2012	60
22246032	2214	Kwissa M	Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates.	Blood	2012	32
22313961	2214	Hearps AC	HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy.	AIDS	2012	49
22430559	2214	Wong KL	The three human monocyte subsets: implications for health and disease.	Immunologic research	2012	84
22669579	2214	Xu H	IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques.	Mucosal immunology	2012	42
22815256	2214	Matsubara T	TIE2-expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis.	Hepatology	2013	28
22911542	2214	Liaskou E	Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics.	Hepatology	2013	35
22927533	2214	Asgharzadeh S	Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma.	Journal of clinical oncology 	2012	47
23100308	2214	Richter J	Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma.	Blood	2013	43
23212525	2214	Tel J	Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.	Blood	2013	41
23334791	2214	Bernink JH	Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.	Nature immunology	2013	113
23365694	2214	Martin GE	Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women.	PloS one	2013	37
23441128	2214	Bruno A	The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.	Neoplasia	2013	28
23509156	2214	Reiners KS	Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity.	Blood	2013	41
23690482	2214	Wiernik A	Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition.	Clinical cancer research 	2013	44
23966310	2214	van der Laan AM	Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir.	European heart journal	2014	32
24253250	2214	Funderburg NT	Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy.	Clinical infectious diseases 	2014	41
24358127	2214	Veremeyko T	IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation.	PloS one	2013	26
24370480	2214	Baker JV	Immunologic predictors of coronary artery calcium progression in a contemporary HIV cohort.	AIDS	2014	32
24652987	2214	Gleason MK	CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets.	Blood	2014	35
24862332	2214	Tavazzi E	Brain inflammation is a common feature of HIV-infected patients without HIV encephalitis or productive brain infection.	Current HIV research	2014	28
24981333	2214	Kwissa M	Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation.	Cell host and microbe	2014	30
27117418	2214	Liu LL	Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans.	Cell reports	2016	17
7516411	2315	Kawakami Y	Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.	The Journal of experimental medicine	1994	147
8170938	2315	Kawakami Y	Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.	Proceedings of the National Academy of Sciences of the United States of America	1994	184
15696196	2315	Speiser DE	Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.	The Journal of clinical investigation	2005	124
16140584	2315	Zhao Y	High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation.	Molecular therapy 	2006	73
17315189	2315	Mahnke K	Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro.	International journal of cancer	2007	65
17898045	2315	Wong RM	Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs.	International immunology	2007	58
18496571	2315	Yang S	Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognition.	Gene therapy	2008	61
20719934	2315	Hong JJ	Successful treatment of melanoma brain metastases with adoptive cell therapy.	Clinical cancer research 	2010	44
21555851	2315	Baitsch L	Exhaustion of tumor-specific CD8âº T cells in metastases from melanoma patients.	The Journal of clinical investigation	2011	145
22529253	2315	Weide B	Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis.	Journal of clinical oncology 	2012	32
24634374	2315	Chodon T	Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.	Clinical cancer research 	2014	25
1980124	2357	Diamond MS	ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18).	The Journal of cell biology	1990	168
8257416	2357	Arcaro A	Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses.	The Biochemical journal	1993	211
9017350	2357	Delamaire M	Impaired leucocyte functions in diabetic patients.	Diabetic medicine 	1997	111
18006643	2357	Lehmann DM	Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation.	Molecular pharmacology	2008	85
10935639	2625	Van Esch H	GATA3 haplo-insufficiency causes human HDR syndrome.	Nature	2000	96
12642820	2625	LarchÃ© M	The role of T lymphocytes in the pathogenesis of asthma.	The Journal of allergy and clinical immunology	2003	109
12874827	2625	Mahon BD	The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells.	Journal of cellular biochemistry	2003	90
19541359	2625	Cao PP	Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese.	The Journal of allergy and clinical immunology	2009	56
19805038	2625	Jenner RG	The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes.	Proceedings of the National Academy of Sciences of the United States of America	2009	69
21339327	2625	De Monte L	Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer.	The Journal of experimental medicine	2011	120
22088562	2625	Guerau-de-Arellano M	Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity.	Brain 	2011	39
23063330	2625	MjÃ¶sberg J	The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells.	Immunity	2012	122
23143995	2625	Henkel JS	Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival.	EMBO molecular medicine	2013	45
23273958	2625	Wood RA	The natural history of milk allergy in an observational cohort.	The Journal of allergy and clinical immunology	2013	26
24406104	2625	Ribeiro A	Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.	Stem cell research and therapy	2013	36
24778151	2625	Hazenberg MD	Human innate lymphoid cells.	Blood	2014	54
24924975	2625	Miljkovic D	Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis.	Allergy	2014	25
25042748	2625	Irvin C	Increased frequency of dual-positive TH2/TH17 cells in bronchoalveolar lavage fluid characterizes a population of patients with severe asthma.	The Journal of allergy and clinical immunology	2014	31
25555213	2625	Caballero MT	TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization.	The Journal of clinical investigation	2015	16
25803478	2625	van Meijgaarden KE	Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.	PLoS pathogens	2015	18
25981191	2625	Krug N	Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.	The New England journal of medicine	2015	28
9636198	2736	Ricote M	Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein.	Proceedings of the National Academy of Sciences of the United States of America	1998	116
11160388	2736	Combs CK	beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.	The Journal of neuroscience 	2001	132
11698284	2736	Kulkosky J	Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.	Blood	2001	119
12508154	2736	Lewis KN	Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-GuÃ©rin attenuation.	The Journal of infectious diseases	2003	163
12522003	2736	Ludwiczek S	Cytokine-mediated regulation of iron transport in human monocytic cells.	Blood	2003	75
17222336	2736	Sharif O	Transcriptional profiling of the LPS induced NF-kappaB response in macrophages.	BMC immunology	2007	62
17599095	2736	Fernandes-Alnemri T	The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activation.	Cell death and differentiation	2007	231
17675463	2736	Liu PT	Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin.	Journal of immunology	2007	184
18070897	2736	FontÃ¡n P	Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection.	Infection and immunity	2008	56
18073346	2736	Theurl I	Autocrine formation of hepcidin induces iron retention in human monocytes.	Blood	2008	64
19281927	2736	Patel S	Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes.	Journal of the American College of Cardiology	2009	51
19427777	2736	Mullen A	Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages.	The Journal of nutritional biochemistry	2010	40
19607894	2736	Foldbjerg R	PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes.	Toxicology letters	2009	70
20622002	2736	Tili E	Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD.	Carcinogenesis	2010	57
20841504	2736	Spencer M	Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation.	American journal of physiology. Endocrinology and metabolism	2010	78
20881210	2736	Krejbich-Trotot P	Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses.	FASEB journal 	2011	37
21102562	2736	Akao Y	Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages.	Molecular therapy 	2011	42
21731490	2736	Daniel J	Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages.	PLoS pathogens	2011	100
21862628	2736	Beare PA	Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages.	mBio	2011	74
21978918	2736	Qin Z	The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature.	Atherosclerosis	2012	55
22258631	2736	Diehl P	Microparticles: major transport vehicles for distinct microRNAs in circulation.	Cardiovascular research	2012	86
22472194	2736	Murphy FA	The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells.	Particle and fibre toxicology	2012	41
22508334	2736	Gao D	1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes.	International journal of obesity	2013	27
22903635	2736	Freytes DO	Macrophages modulate the viability and growth of human mesenchymal stem cells.	Journal of cellular biochemistry	2013	28
24092747	2736	Camont L	Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.	Arteriosclerosis, thrombosis, and vascular biology	2013	32
24256422	2736	Yan Y	Differential roles of the protein corona in the cellular uptake of nanoporous polymer particles by monocyte and macrophage cell lines.	ACS nano	2013	26
24367916	2736	Zhang B	Mesenchymal stem cells secrete immunologically active exosomes.	Stem cells and development	2014	59
25130606	2736	Chanput W	THP-1 cell line: an in vitro cell model for immune modulation approach.	International immunopharmacology	2014	28
25422265	2736	Larson CL	Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication.	Infection and immunity	2015	21
26527689	2736	Saha B	MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages.	The Journal of biological chemistry	2016	16
9064356	2833	Loetscher M	Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.	The Journal of experimental medicine	1996	231
10426316	2833	Cella M	Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.	Nature medicine	1999	297
11017101	2833	Cella M	Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization.	Nature immunology	2000	146
15507523	2833	Odendahl M	Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response.	Blood	2005	94
15764644	2833	Spurrell JC	Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection.	American journal of physiology. Lung cellular and molecular physiology	2005	79
15879427	2833	Brightling CE	The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle.	American journal of respiratory and critical care medicine	2005	71
21170961	2833	Bose A	Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination.	International journal of cancer	2011	46
23486778	2833	Bentebibel SE	Induction of ICOS+CXCR3+CXCR5+ TH cells correlates with antibody responses to influenza vaccination.	Science translational medicine	2013	111
23716586	2833	Youn JC	Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension.	Hypertension	2013	31
16380507	2908	Ito K	Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression.	The Journal of experimental medicine	2006	141
18536531	2908	Oberlander TF	Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses.	Epigenetics	2008	301
19624809	2908	Wong HR	Identification of pediatric septic shock subclasses based on genome-wide expression profiling.	BMC medicine	2009	59
20854893	2908	Bower JE	Fatigue and gene expression in human leukocytes: increased NF-ÎºB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue.	Brain, behavior, and immunity	2011	50
21980503	2908	Charmandari E	Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man.	PloS one	2011	38
22088795	2908	Antoni MH	Cognitive-behavioral stress management reverses anxiety-related leukocyte transcriptional dynamics.	Biological psychiatry	2012	51
22295073	2908	Tyrka AR	Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults.	PloS one	2012	106
24594779	2908	LabontÃ© B	Epigenetic modulation of glucocorticoid receptors in posttraumatic stress disorder.	Translational psychiatry	2014	20
24661442	2908	Yehuda R	Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder.	Biological psychiatry	2015	41
24832930	2908	Yehuda R	Influences of maternal and paternal PTSD on epigenetic regulation of the glucocorticoid receptor gene in Holocaust survivor offspring.	The American journal of psychiatry	2014	36
9348298	3002	Hamann D	Phenotypic and functional separation of memory and effector human CD8+ T cells.	The Journal of experimental medicine	1997	299
9721846	3002	Naito Y	CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.	Cancer research	1998	248
10499920	3002	Casciola-Rosen L	Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity.	The Journal of experimental medicine	1999	95
15485635	3002	Grossman WJ	Human T regulatory cells can use the perforin pathway to cause autologous target cell death.	Immunity	2004	198
15746048	3002	Alvaro T	Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.	Clinical cancer research 	2005	86
16081850	3002	Gottlieb AB	TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.	Journal of immunology	2005	65
16670345	3002	McElhaney JE	T cell responses are better correlates of vaccine protection in the elderly.	Journal of immunology	2006	154
17360672	3002	Verjans GM	Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia.	Proceedings of the National Academy of Sciences of the United States of America	2007	88
17535975	3002	Stary G	Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.	The Journal of experimental medicine	2007	86
17828272	3002	Kebir H	Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.	Nature medicine	2007	327
18216355	3002	Kawai T	HLA-mismatched renal transplantation without maintenance immunosuppression.	The New England journal of medicine	2008	263
18413832	3002	Ladoire S	Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells.	Clinical cancer research 	2008	62
18762240	3002	Enstrom AM	Altered gene expression and function of peripheral blood natural killer cells in children with autism.	Brain, behavior, and immunity	2009	65
19680671	3002	TÃ¼zÃ¼n E	Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma.	Acta neuropathologica	2009	58
20385003	3002	Deschoolmeester V	Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.	BMC immunology	2010	57
21825174	3002	Ruffell B	Leukocyte composition of human breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2012	78
21846824	3002	Halama N	Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy.	Cancer research	2011	71
22105371	3002	BÃ©ziat V	CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.	European journal of immunology	2012	79
22156613	3002	Wilmott JS	Selective BRAF inhibitors induce marked T-cell infiltration into human metastatic melanoma.	Clinical cancer research 	2012	131
22966165	3002	Tel J	Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities.	Blood	2012	32
23321919	3002	Santos Cda S	CD8(+) granzyme B(+)-mediated tissue injury vs. CD4(+)IFNÎ³(+)-mediated parasite killing in human cutaneous leishmaniasis.	The Journal of investigative dermatology	2013	41
23384943	3002	Lindner S	Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells.	Cancer research	2013	33
24431112	3002	Schlapbach C	Human TH9 cells are skin-tropic and have autocrine and paracrine proinflammatory capacity.	Science translational medicine	2014	31
25347474	3002	Lin R	Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.	The Journal of clinical investigation	2014	22
25644114	3002	Chesneau M	Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties.	Journal of the American Society of Nephrology 	2015	21
25967142	3002	Hossain DM	TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients.	Clinical cancer research 	2015	19
26669617	3002	Garnelo M	Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.	Gut	2017	9
667938	3105	Barnstable CJ	Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.	Cell	1978	408
10371507	3105	Lee PP	Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients.	Nature medicine	1999	201
11148222	3105	Goulder PJ	Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection.	The Journal of experimental medicine	2001	87
15592417	3105	Kiepiela P	Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.	Nature	2004	328
15936272	3105	Prugnolle F	Pathogen-driven selection and worldwide HLA class I diversity.	Current biology 	2005	101
16237114	3105	Rosenberg SA	Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.	Journal of immunology	2005	128
17620360	3105	Hislop AD	A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates.	The Journal of experimental medicine	2007	64
18953350	3105	Friese MA	Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis.	Nature medicine	2008	50
18997777	3105	Varela-Rohena A	Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor.	Nature medicine	2008	101
19151783	3105	Willemze R	KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia.	Leukemia	2009	53
20631300	3105	Van Tendeloo VF	Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination.	Proceedings of the National Academy of Sciences of the United States of America	2010	85
21873457	3105	Chazara O	Maternal KIR and fetal HLA-C: a fine balance.	Journal of leukocyte biology	2011	40
22418738	3105	Dutoit V	Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy.	Brain 	2012	34
22776426	3105	Kono K	Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.	Journal of translational medicine	2012	35
23741009	3105	Torikai H	Toward eliminating HLA class I expression to generate universal cells from allogeneic donors.	Blood	2013	37
23770775	3105	Linette GP	Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.	Blood	2013	168
23926201	3105	Cameron BJ	Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.	Science translational medicine	2013	103
25054717	3105	Gragert L	HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.	The New England journal of medicine	2014	87
25754738	3105	Apps R	Relative expression levels of the HLA class-I proteins in normal and HIV-infected cells.	Journal of immunology	2015	18
25837513	3105	Carreno BM	Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.	Science	2015	95
11460164	3106	Goulder PJ	Evolution and transmission of stable CTL escape mutations in HIV infection.	Nature	2001	205
12768008	3106	Migueles SA	The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.	Journal of virology	2003	77
15067030	3106	Draenert R	Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.	The Journal of experimental medicine	2004	140
16369537	3106	Frahm N	Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes.	Nature immunology	2006	101
16682496	3106	Bailey JR	Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations.	The Journal of experimental medicine	2006	123
17496894	3106	Martin MP	Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.	Nature genetics	2007	273
17892322	3106	Lewinsohn DA	Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.	PLoS pathogens	2007	57
18353945	3106	Emu B	HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control.	Journal of virology	2008	117
18596105	3106	Matthews PC	Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.	Journal of virology	2008	91
18971283	3106	Miura T	HLA-associated alterations in replication capacity of chimeric NL4-3 viruses carrying gag-protease from elite controllers of human immunodeficiency virus type 1.	Journal of virology	2009	67
19242411	3106	Kawashima Y	Adaptation of HIV-1 to human leukocyte antigen class I.	Nature	2009	187
19307327	3106	Crawford H	Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.	The Journal of experimental medicine	2009	100
20064448	3106	Macdonald WA	T cell allorecognition via molecular mimicry.	Immunity	2009	82
20523897	3106	Hersperger AR	Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.	PLoS pathogens	2010	134
20616031	3106	Gras S	Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.	Proceedings of the National Academy of Sciences of the United States of America	2010	54
21248258	3106	Bowness P	Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.	Journal of immunology	2011	50
21868630	3106	Abi-Rached L	The shaping of modern human immune systems by multiregional admixture with archaic humans.	Science	2011	86
22102287	3106	Wooldridge L	A single autoimmune T cell receptor recognizes more than a million different peptides.	The Journal of biological chemistry	2012	87
22322005	3106	Wei CY	Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.	The Journal of allergy and clinical immunology	2012	37
22683743	3106	Chen H	TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.	Nature immunology	2012	83
23023123	3106	Mudd PA	Vaccine-induced CD8+ T cells control AIDS virus replication.	Nature	2012	76
10403641	3107	Cohen GB	The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.	Immunity	1999	283
10611338	3107	Davis DM	The human natural killer cell immune synapse.	Proceedings of the National Academy of Sciences of the United States of America	1999	97
15356110	3107	Barber DF	LFA-1 contributes an early signal for NK cell cytotoxicity.	Journal of immunology	2004	77
15731175	3107	Hsu KC	Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.	Blood	2005	116
19543285	3107	Hadrup SR	Parallel detection of antigen-specific T-cell responses by multidimensional encoding of MHC multimers.	Nature methods	2009	63
19553639	3107	RomagnÃ© F	Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.	Blood	2009	88
19846760	3107	International MHC and Autoimmunity Genetics Network.	Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases.	Proceedings of the National Academy of Sciences of the United States of America	2009	80
21262263	3107	Trowsdale J	The MHC, disease and selection.	Immunology letters	2011	50
22772445	3107	Hilton HG	Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.	Journal of immunology	2012	33
22931314	3107	Venstrom JM	HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.	The New England journal of medicine	2012	103
23559252	3107	Apps R	Influence of HLA-C expression level on HIV control.	Science	2013	85
23613577	3107	LÃ³pez-Sagaseta J	The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
24577131	3107	Kieckbusch J	MHC-dependent inhibition of uterine NK cells impedes fetal growth and decidual vascular remodelling.	Nature communications	2014	27
26516200	3107	Tran E	Immunogenicity of somatic mutations in human gastrointestinal cancers.	Science	2015	61
27959684	3107	Tran E	T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.	The New England journal of medicine	2016	31
12620891	3146	Park JS	Activation of gene expression in human neutrophils by high mobility group box 1 protein.	American journal of physiology. Cell physiology	2003	102
15502843	3146	Wang H	Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis.	Nature medicine	2004	249
15944249	3146	Dumitriu IE	Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products.	Journal of immunology	2005	127
16267105	3146	Park JS	High mobility group box 1 protein interacts with multiple Toll-like receptors.	American journal of physiology. Cell physiology	2006	236
16966386	3146	Yang D	High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin.	Journal of leukocyte biology	2007	116
17114460	3146	Youn JH	Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion.	Journal of immunology	2006	97
17704786	3146	Apetoh L	Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.	Nature medicine	2007	613
17979839	3146	Apetoh L	The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy.	Immunological reviews	2007	133
18354232	3146	Youn JH	High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes.	Journal of immunology	2008	70
18431461	3146	Klune JR	HMGB1: endogenous danger signaling.	Molecular medicine	2008	192
18519658	3146	Apetoh L	Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies.	Cancer research	2008	58
19064698	3146	Urbonaviciute V	Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.	The Journal of experimental medicine	2008	154
19197071	3146	Lolmede K	Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways.	Journal of leukocyte biology	2009	59
19564572	3146	Hreggvidsdottir HS	The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.	Journal of leukocyte biology	2009	92
20530955	3146	de Jong HK	The systemic pro-inflammatory response in sepsis.	Journal of innate immunity	2010	44
21389264	3146	Garcia-Romo GS	Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus.	Science translational medicine	2011	238
21473909	3146	Vezzani A	IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures.	Brain, behavior, and immunity	2011	53
21602432	3146	Fucikova J	Human tumor cells killed by anthracyclines induce a tumor-specific immune response.	Cancer research	2011	62
22700877	3146	Suzuki Y	Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma.	Cancer research	2012	44
24070090	3146	Maugeri N	Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis.	Antioxidants and redox signaling	2014	20
24464016	3146	Jia L	Extracellular HMGB1 promotes differentiation of nurse-like cells in chronic lymphocytic leukemia.	Blood	2014	27
24572365	3146	Bald T	Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma.	Nature	2014	82
25941621	3146	Kepp O	Consensus guidelines for the detection of immunogenic cell death.	Oncoimmunology	2014	89
1361507	3383	Ades EW	HMEC-1: establishment of an immortalized human microvascular endothelial cell line.	The Journal of investigative dermatology	1992	283
1675157	3383	Diamond MS	Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation.	Cell	1991	157
2566624	3383	Smith CW	Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.	The Journal of clinical investigation	1989	203
7542286	3383	De Caterina R	Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.	The Journal of clinical investigation	1995	226
8476577	3383	Bevilacqua MP	Endothelial-leukocyte adhesion molecules.	Annual review of immunology	1993	186
9453485	3383	D'Haens GR	Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum.	Gastroenterology	1998	110
10433933	3383	Silamut K	A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain.	The American journal of pathology	1999	125
10545519	3383	Peled A	The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow.	The Journal of clinical investigation	1999	113
11108718	3383	Kim I	Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells.	The Journal of biological chemistry	2001	142
12589164	3383	Tse WT	Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.	Transplantation	2003	278
15021878	3383	Schenkel AR	Locomotion of monocytes on endothelium is a critical step during extravasation.	Nature immunology	2004	103
15811956	3383	Yang L	ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow.	Blood	2005	150
16429128	3383	MillÃ¡n J	Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains.	Nature cell biology	2006	104
16973825	3383	Csiszar A	Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition.	American journal of physiology. Heart and circulatory physiology	2006	88
17112620	3383	Giulietti A	Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory.	Diabetes research and clinical practice	2007	58
19587009	3383	Podgrabinska S	Inflamed lymphatic endothelium suppresses dendritic cell maturation and function via Mac-1/ICAM-1-dependent mechanism.	Journal of immunology	2009	54
19909745	3383	Mlecnik B	Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer.	Gastroenterology	2010	71
20610626	3383	Huh SJ	Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development.	Cancer research	2010	63
21164106	3383	Rautou PE	Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration.	Circulation research	2011	40
21399646	3383	Flach TL	Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity.	Nature medicine	2011	83
21448265	3383	Meijer K	Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages.	PloS one	2011	52
21478334	3383	Lohr J	Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-Î².	Clinical cancer research 	2011	48
22535415	3383	Kan AA	Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response.	Cellular and molecular life sciences 	2012	42
22865266	3383	Sheikh NA	Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer.	Cancer immunology, immunotherapy 	2013	60
23864627	3383	Nanbo A	Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.	Journal of virology	2013	35
24471509	3383	Kennedy JL	Comparison of viral load in individuals with and without asthma during infections with rhinovirus.	American journal of respiratory and critical care medicine	2014	22
1907934	3439	Taylor MW	Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.	FASEB journal 	1991	203
6411853	3439	Nathan CF	Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.	The Journal of experimental medicine	1983	396
11199920	3439	Bengtsson AA	Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.	Lupus	2000	102
11313392	3439	Levings MK	IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.	Journal of immunology	2001	132
11390447	3439	Giacomini E	Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response.	Journal of immunology	2001	114
11449369	3439	Krug A	Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.	European journal of immunology	2001	168
11711679	3439	Blanco P	Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus.	Science	2001	304
11971031	3439	Chehimi J	Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals.	Journal of immunology	2002	102
12604793	3439	Baechler EC	Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.	Proceedings of the National Academy of Sciences of the United States of America	2003	515
12960254	3439	Izaguirre A	Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells.	Journal of leukocyte biology	2003	112
14530357	3439	LorÃ© K	Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.	Journal of immunology	2003	81
14639532	3439	Bosio CM	Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.	The Journal of infectious diseases	2003	83
14984025	3439	Crow MK	Microarray analysis of interferon-regulated genes in SLE.	Autoimmunity	2003	83
14991609	3439	Coccia EM	Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells.	European journal of immunology	2004	122
15070685	3439	Poeck H	Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help.	Blood	2004	83
15188363	3439	LÃ¶vgren T	Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.	Arthritis and rheumatism	2004	120
15383579	3439	He B	CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.	Journal of immunology	2004	90
15593221	3439	Kirou KA	Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.	Arthritis and rheumatism	2004	96
15634892	3439	Gerosa F	The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.	Journal of immunology	2005	106
15699120	3439	SirÃ©n J	IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.	Journal of immunology	2005	73
15854645	3439	Sioud M	Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization.	Journal of molecular biology	2005	73
15998792	3439	Nestle FO	Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production.	The Journal of experimental medicine	2005	173
16034103	3439	Hart OM	TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production.	Journal of immunology	2005	72
16188985	3439	Best SM	Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.	Journal of virology	2005	102
16284360	3439	Guerrero-Plata A	Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus.	American journal of respiratory cell and molecular biology	2006	76
16293610	3439	Ito T	Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells.	Blood	2006	68
16418394	3439	Peng G	Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.	The Journal of experimental medicine	2006	119
16632604	3439	Herbeuval JP	Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.	Proceedings of the National Academy of Sciences of the United States of America	2006	86
16840343	3439	Chen K	Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.	Journal of virology	2006	64
17327884	3439	Capuron L	Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy.	Neuropsychopharmacology 	2007	65
17353365	3439	Dunn C	Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage.	The Journal of experimental medicine	2007	102
17488182	3439	Critchley-Thorne RJ	Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.	PLoS medicine	2007	56
17678633	3439	Felger JC	Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression.	Biological psychiatry	2007	58
18424722	3439	Errington F	Reovirus activates human dendritic cells to promote innate antitumor immunity.	Journal of immunology	2008	58
18490415	3439	RÃ¶nnblom L	The innate immune system in SLE: type I interferons and dendritic cells.	Lupus	2008	74
18521089	3439	Raison CL	Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior.	Molecular psychiatry	2010	69
18801471	3439	Raison CL	Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression.	Biological psychiatry	2009	96
19339987	3439	Kariuki SN	Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.	Genes and immunity	2009	46
19424421	3439	Brown KN	Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection.	PLoS pathogens	2009	65
19451644	3439	Critchley-Thorne RJ	Impaired interferon signaling is a common immune defect in human cancer.	Proceedings of the National Academy of Sciences of the United States of America	2009	64
19597505	3439	Meier A	Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.	Nature medicine	2009	138
19648060	3439	Belderbos ME	Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life.	Clinical immunology	2009	56
19910029	3439	Ogbogu PU	Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.	The Journal of allergy and clinical immunology	2009	60
19917677	3439	Kollmann TR	Neonatal innate TLR-mediated responses are distinct from those of adults.	Journal of immunology	2009	136
19918244	3439	Raison CL	CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.	Molecular psychiatry	2010	125
19959873	3439	Jacquelin B	Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.	The Journal of clinical investigation	2009	184
20046205	3439	Hall JC	Type I interferons: crucial participants in disease amplification in autoimmunity.	Nature reviews. Rheumatology	2010	57
20145197	3439	Fitzgerald-Bocarsly P	Plasmacytoid dendritic cells in HIV infection: striking a delicate balance.	Journal of leukocyte biology	2010	59
20404274	3439	Her Z	Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response.	Journal of immunology	2010	52
20519386	3439	Gardner J	Chikungunya virus arthritis in adult wild-type mice.	Journal of virology	2010	94
20610724	3439	Goujon C	Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.	Journal of virology	2010	62
20660196	3439	Rodriguez-Madoz JR	Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex.	Journal of virology	2010	46
20844193	3439	Santer DM	C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes.	Journal of immunology	2010	42
21604071	3439	Mundy-Bosse BL	Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4âº T cells from patients with GI malignancy.	Cancer immunology, immunotherapy 	2011	46
22617827	3439	Knight JS	Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis.	Current opinion in rheumatology	2012	38
22981791	3439	Baraldo S	Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma.	The Journal of allergy and clinical immunology	2012	33
23046671	3439	Micco L	Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B.	Journal of hepatology	2013	35
25754160	3439	Serti E	Successful Interferon-Free Therapy of Chronic Hepatitis C Virus Infection Normalizes Natural Killer Cell Function.	Gastroenterology	2015	19
27432357	3439	Grenn RC	Endothelial progenitor dysfunction associates with a type I interferon signature in primary antiphospholipid syndrome.	Annals of the rheumatic diseases	2017	6
11298337	3456	Taams LS	Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.	European journal of immunology	2001	92
12480361	3456	Cheung CY	Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?	Lancet	2002	247
17011763	3456	Pascual V	Systemic lupus erythematosus: all roads lead to type I interferons.	Current opinion in immunology	2006	93
17617600	3456	Kato A	TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells.	Journal of immunology	2007	129
17897326	3456	Venken K	Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.	Immunology	2008	78
19364933	3456	Bielekova B	Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.	Archives of neurology	2009	60
19475668	3456	Durelli L	T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.	Annals of neurology	2009	73
19596239	3456	Ramirez-Carrozzi VR	A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling.	Cell	2009	196
20011590	3456	Lee SM	Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages.	PloS one	2009	48
20163990	3456	Wynn D	Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.	The Lancet. Neurology	2010	67
20592255	3456	Mehling M	Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.	Neurology	2010	45
21321205	3456	Cervantes JL	Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta.	Proceedings of the National Academy of Sciences of the United States of America	2011	46
21540856	3456	Dominguez-Villar M	Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease.	Nature medicine	2011	84
22879820	3456	Marsh GA	Cedar virus: a novel Henipavirus isolated from Australian bats.	PLoS pathogens	2012	50
23045237	3456	Krumbholz M	B cells and antibodies in multiple sclerosis pathogenesis and therapy.	Nature reviews. Neurology	2012	57
23345332	3456	Horan KA	Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors.	Journal of immunology	2013	54
23449998	3456	Teles RM	Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses.	Science	2013	89
23685241	3456	Wu S	miR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6.	The Journal of infection	2013	25
24403588	3456	GarcÃ­a-Arriaza J	A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.	Journal of virology	2014	24
25596473	3456	Gharibi T	Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.	Cellular immunology	2015	16
1590992	3458	Sher A	Regulation of immunity to parasites by T cells and T cell-derived cytokines.	Annual review of immunology	1992	153
1672545	3458	Chan SH	Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.	The Journal of experimental medicine	1991	182
1681588	3458	Salgame P	Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones.	Science	1991	187
3926894	3458	Shalaby MR	Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.	Journal of immunology	1985	172
7475549	3458	Diepolder HM	Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection.	Lancet	1995	151
8102388	3458	D'Andrea A	Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.	The Journal of experimental medicine	1993	292
8445253	3458	Jung T	Detection of intracellular cytokines by flow cytometry.	Journal of immunological methods	1993	149
8536356	3458	Duchmann R	Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)	Clinical and experimental immunology	1995	157
8666949	3458	Valitutti S	Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.	The Journal of experimental medicine	1996	124
8757634	3458	Fuss IJ	Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.	Journal of immunology	1996	241
8993017	3458	D'Elios MM	T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease.	Journal of immunology	1997	135
9120388	3458	Rogge L	Selective expression of an interleukin-12 receptor component by human T helper 1 cells.	The Journal of experimental medicine	1997	107
9176497	3458	DÃ¶cke WD	Monocyte deactivation in septic patients: restoration by IFN-gamma treatment.	Nature medicine	1997	203
9294140	3458	Lalvani A	Rapid effector function in CD8+ memory T cells.	The Journal of experimental medicine	1997	171
9366401	3458	Steinbrink K	Induction of tolerance by IL-10-treated dendritic cells.	Journal of immunology	1997	220
9428763	3458	Wilson SB	Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.	Nature	1998	126
9464798	3458	Jonuleit H	Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions.	European journal of immunology	1997	226
9603732	3458	Altare F	Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.	Science	1998	172
9617578	3458	Maes M	The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety.	Cytokine	1998	106
9923875	3458	Prescott SL	Development of allergen-specific T-cell memory in atopic and normal children.	Lancet	1999	100
10201989	3458	Fehniger TA	Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.	Journal of immunology	1999	129
10428293	3458	FrostegÃ¥rd J	Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines.	Atherosclerosis	1999	141
10438971	3458	Heeger PS	Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.	Journal of immunology	1999	111
10725715	3458	Hwu P	Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.	Journal of immunology	2000	131
10779751	3458	Vieira PL	Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction.	Journal of immunology	2000	91
10790425	3458	Lechner F	Analysis of successful immune responses in persons infected with hepatitis C virus.	The Journal of experimental medicine	2000	356
10792007	3458	Boussiotis VA	IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.	The Journal of clinical investigation	2000	117
10880527	3458	Appay V	HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function.	The Journal of experimental medicine	2000	201
10905243	3458	Gereda JE	Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma.	Lancet	2000	90
10955814	3458	Ueno T	Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.	Clinical cancer research 	2000	160
11100127	3458	Kwak B	Statins as a newly recognized type of immunomodulator.	Nature medicine	2000	192
11160295	3458	Verthelyi D	Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs.	Journal of immunology	2001	88
11170064	3458	To KF	Pathology of fatal human infection associated with avian influenza A H5N1 virus.	Journal of medical virology	2001	104
11358808	3458	Schumacher K	Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas.	Cancer research	2001	102
11406550	3458	Woo EY	Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.	Cancer research	2001	243
11418482	3458	Davies FE	Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.	Blood	2001	145
11673535	3458	Pathan AA	Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment.	Journal of immunology	2001	103
11717429	3458	Bennett BL	SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.	Proceedings of the National Academy of Sciences of the United States of America	2001	591
11781358	3458	Kukreja A	Multiple immuno-regulatory defects in type-1 diabetes.	The Journal of clinical investigation	2002	156
11828007	3458	Gerosa F	Reciprocal activating interaction between natural killer cells and dendritic cells.	The Journal of experimental medicine	2002	218
11900986	3458	Ikeda H	The roles of IFN gamma in protection against tumor development and cancer immunoediting.	Cytokine and growth factor reviews	2002	152
12023394	3458	Saurwein-Teissl M	Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines.	Journal of immunology	2002	126
12147537	3458	Adrie C	Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome.	Circulation	2002	113
12218109	3458	Artavanis-Tsakonas K	Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes.	Journal of immunology	2002	84
12239255	3458	Braun-FahrlÃ¤nder C	Environmental exposure to endotoxin and its relation to asthma in school-age children.	The New England journal of medicine	2002	250
12438348	3458	Bacellar O	Up-regulation of Th1-type responses in mucosal leishmaniasis patients.	Infection and immunity	2002	100
12447360	3458	Messi M	Memory and flexibility of cytokine gene expression as separable properties of human T(H)1 and T(H)2 lymphocytes.	Nature immunology	2003	100
12529460	3458	Zhang L	Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.	The New England journal of medicine	2003	639
12731045	3458	Jutel M	IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy.	European journal of immunology	2003	108
12750172	3458	Dufour C	TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro.	Blood	2003	82
12810858	3458	Alimonti JB	Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.	The Journal of general virology	2003	96
12898444	3458	Wang SM	Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema.	The Journal of infectious diseases	2003	75
12942579	3458	Sasada T	CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression.	Cancer	2003	81
12951047	3458	Kaser S	Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.	Biochemical and biophysical research communications	2003	82
12957413	3458	Whelan JA	A method for the absolute quantification of cDNA using real-time PCR.	Journal of immunological methods	2003	112
12960359	3458	Morgan RA	High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens.	Journal of immunology	2003	77
14512316	3458	Nieda M	Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity.	Blood	2004	86
14555512	3458	Ichihara F	Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.	Clinical cancer research 	2003	97
14718545	3458	Zitt C	Potent inhibition of Ca2+ release-activated Ca2+ channels and T-lymphocyte activation by the pyrazole derivative BTP2.	The Journal of biological chemistry	2004	74
15240741	3458	Viguier M	Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.	Journal of immunology	2004	136
15383574	3458	Moseman EA	Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.	Journal of immunology	2004	139
15390107	3458	Guillemin GJ	Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.	Glia	2005	93
15479680	3458	Hart AL	Modulation of human dendritic cell phenotype and function by probiotic bacteria.	Gut	2004	93
15494483	3458	De Rosa SC	Vaccination in humans generates broad T cell cytokine responses.	Journal of immunology	2004	73
15502839	3458	McShane H	Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.	Nature medicine	2004	194
15537905	3458	Mannon PJ	Anti-interleukin-12 antibody for active Crohn's disease.	The New England journal of medicine	2004	154
15546386	3458	Kovanen PE	Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways.	Immunological reviews	2004	78
15589309	3458	Dorman SE	Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies.	Lancet	2004	89
15694227	3458	Schiepers OJ	Cytokines and major depression.	Progress in neuro-psychopharmacology and biological psychiatry	2005	155
15709009	3458	Lindesmith L	Cellular and humoral immunity following Snow Mountain virus challenge.	Journal of virology	2005	79
15710900	3458	Mohamadzadeh M	Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization.	Proceedings of the National Academy of Sciences of the United States of America	2005	87
15764907	3458	Ngoc PL	Cytokines, allergy, and asthma.	Current opinion in allergy and clinical immunology	2005	70
15864738	3458	Klyushnenkova E	T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.	Journal of biomedical science	2005	97
15939793	3458	Ruprecht CR	Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia.	The Journal of experimental medicine	2005	103
15979412	3458	PulÃ¨ MA	A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells.	Molecular therapy 	2005	122
15987480	3458	Raza K	Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin.	Arthritis research and therapy	2005	99
16029895	3458	dupont NC	Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants.	Journal of reproductive immunology	2005	71
16123384	3458	Krampera M	Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.	Stem cells	2006	252
16299275	3458	Faria DR	Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis.	Infection and immunity	2005	79
16301659	3458	Leid JG	The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing.	Journal of immunology	2005	91
16330536	3458	Verreck FA	Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation.	Journal of leukocyte biology	2006	91
16374252	3458	Fuss IJ	Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody.	Inflammatory bowel diseases	2006	68
16505141	3458	Trumpfheller C	Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.	The Journal of experimental medicine	2006	96
16542361	3458	Ribeiro-Rodrigues R	A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis.	Clinical and experimental immunology	2006	68
16543949	3458	Amedei A	The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.	The Journal of clinical investigation	2006	70
16547287	3458	Longhi MS	Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.	Journal of immunology	2006	64
16785573	3458	Xu D	Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B.	Journal of immunology	2006	101
16803570	3458	Feuchtinger T	Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.	British journal of haematology	2006	65
16931093	3458	Leyten EM	Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis.	Microbes and infection	2006	87
16971810	3458	Palucka AK	Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.	Journal of immunotherapy	2006	71
17185041	3458	Pillai V	Transient regulatory T-cells: a state attained by all activated human T-cells.	Clinical immunology	2007	89
17230481	3458	Correale J	Association between parasite infection and immune responses in multiple sclerosis.	Annals of neurology	2007	88
17255300	3458	Ochoa AC	Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma.	Clinical cancer research 	2007	133
17336692	3458	Dinarello CA	Interleukin-18 and the pathogenesis of inflammatory diseases.	Seminars in nephrology	2007	61
17339431	3458	Bogiatzi SI	Cutting Edge: Proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes.	Journal of immunology	2007	59
17379663	3458	Heidel JD	Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.	Proceedings of the National Academy of Sciences of the United States of America	2007	87
17386024	3458	Rasmusson I	Mesenchymal stem cells stimulate antibody secretion in human B cells.	Scandinavian journal of immunology	2007	56
17433516	3458	Kim YK	Cytokine imbalance in the pathophysiology of major depressive disorder.	Progress in neuro-psychopharmacology and biological psychiatry	2007	55
17438063	3458	Aspord C	Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development.	The Journal of experimental medicine	2007	79
17442979	3458	Germain SJ	Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles.	Journal of immunology	2007	68
17507983	3458	Barton ES	Herpesvirus latency confers symbiotic protection from bacterial infection.	Nature	2007	194
17553885	3458	Kannanganat S	Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells.	Journal of virology	2007	114
17641026	3458	Haniffa MA	Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells.	Journal of immunology	2007	88
17641064	3458	Admyre C	Exosomes with immune modulatory features are present in human breast milk.	Journal of immunology	2007	168
17655740	3458	Zeuthen LH	Epithelial cells prime the immune response to an array of gut-derived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta.	Immunology	2008	57
17671215	3458	Dieli F	Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer.	Cancer research	2007	115
17709496	3458	Jones S	The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells.	Journal of immunology	2007	63
17916356	3458	Dolganiuc A	Viral and host factors induce macrophage activation and loss of toll-like receptor tolerance in chronic HCV infection.	Gastroenterology	2007	65
17948267	3458	Beveridge NE	Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations.	European journal of immunology	2007	102
17995965	3458	Reddy N	Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo.	British journal of haematology	2008	62
18005941	3458	Potvin S	Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review.	Biological psychiatry	2008	171
18039949	3458	Zaba LC	Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.	The Journal of experimental medicine	2007	134
18077358	3458	Salio M	Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation.	Proceedings of the National Academy of Sciences of the United States of America	2007	78
18172268	3458	Kenter GG	Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity.	Clinical cancer research 	2008	76
18179856	3458	Trivedi P	Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.	Experimental hematology	2008	67
18183290	3458	Kubica M	A potential new pathway for Staphylococcus aureus dissemination: the silent survival of S. aureus phagocytosed by human monocyte-derived macrophages.	PloS one	2008	91
18209073	3458	Roti M	Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus.	Journal of immunology	2008	57
18209095	3458	Scriba TJ	Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response.	Journal of immunology	2008	135
18256187	3458	Trumpfheller C	The microbial mimic poly IC induces durable and protective CD4+ T cell immunity together with a dendritic cell targeted vaccine.	Proceedings of the National Academy of Sciences of the United States of America	2008	114
18275276	3458	Pereyra F	Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.	The Journal of infectious diseases	2008	244
18276911	3458	Doran AC	Role of smooth muscle cells in the initiation and early progression of atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2008	167
18292584	3458	Soares AP	Bacillus Calmette-GuÃ©rin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles.	Journal of immunology	2008	81
18359186	3458	Witek-Janusek L	Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.	Brain, behavior, and immunity	2008	75
18391061	3458	Luger D	Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category.	The Journal of experimental medicine	2008	221
18397264	3458	Hedegaard CJ	T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis.	Immunology	2008	57
18420999	3458	Kintscher U	T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance.	Arteriosclerosis, thrombosis, and vascular biology	2008	181
18448618	3458	Forrest BD	Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.	Clinical and vaccine immunology 	2008	62
18479258	3458	Atreya I	NF-kappaB in inflammatory bowel disease.	Journal of internal medicine	2008	101
18497880	3458	Kamada N	Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis.	The Journal of clinical investigation	2008	139
18554755	3458	Elias D	Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.	Vaccine	2008	59
18579762	3458	Chi W	Upregulated IL-23 and IL-17 in BehÃ§et patients with active uveitis.	Investigative ophthalmology and visual science	2008	73
18624725	3458	Wang M	The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro.	Immunology	2009	57
18632651	3458	Wheeler CJ	Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients.	Cancer research	2008	92
18678243	3458	Reale M	Peripheral cytokines profile in Parkinson's disease.	Brain, behavior, and immunity	2009	75
18684007	3458	Cranage M	Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.	PLoS medicine	2008	72
18684158	3458	Nograles KE	Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.	The British journal of dermatology	2008	139
18755923	3458	Meintjes G	Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome.	American journal of respiratory and critical care medicine	2008	54
18802076	3458	Kryczek I	Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.	Journal of immunology	2008	104
18840671	3458	Spencer LA	Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially.	Journal of leukocyte biology	2009	65
18927310	3458	Finke JH	Sunitinib reverses type-1 immune suppression and decreases T-regulatory cells in renal cell carcinoma patients.	Clinical cancer research 	2008	113
19017986	3458	Bertholet S	Identification of human T cell antigens for the development of vaccines against Mycobacterium tuberculosis.	Journal of immunology	2008	52
19055947	3458	Terabe M	The role of NKT cells in tumor immunity.	Advances in cancer research	2008	91
19074986	3458	Putnam AL	Expansion of human regulatory T-cells from patients with type 1 diabetes.	Diabetes	2009	102
19105661	3458	Martinez FO	Alternative activation of macrophages: an immunologic functional perspective.	Annual review of immunology	2009	630
19105884	3458	Pai M	T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India.	The international journal of tuberculosis and lung disease 	2009	45
19118066	3458	Trimble CL	A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.	Clinical cancer research 	2009	67
19139565	3458	Urry Z	Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function.	The Journal of clinical investigation	2009	48
19231921	3458	DelaRosa O	Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.	Tissue engineering. Part A	2009	59
19251324	3458	Brietzke E	Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder.	Journal of affective disorders	2009	46
19255340	3458	Eid RE	Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells.	Circulation	2009	111
19268625	3458	Billiau A	Interferon-gamma: a historical perspective.	Cytokine and growth factor reviews	2009	78
19276286	3458	Ko JS	Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients.	Clinical cancer research 	2009	227
19282851	3458	Streeck H	The role of IFN-gamma Elispot assay in HIV vaccine research.	Nature protocols	2009	48
19287090	3458	Levy Y	Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.	The Journal of clinical investigation	2009	114
19351841	3458	MÃ©nard C	Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients.	Cancer research	2009	52
19387262	3458	Dheda K	T-cell interferon-gamma release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings.	Current opinion in pulmonary medicine	2009	64
19401385	3458	Aydemir TB	Zinc transporter ZIP8 (SLC39A8) and zinc influence IFN-gamma expression in activated human T cells.	Journal of leukocyte biology	2009	53
19458616	3458	Hadjur S	Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus.	Nature	2009	211
19470694	3458	Kryczek I	Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.	Blood	2009	202
19487422	3458	Strowig T	Priming of protective T cell responses against virus-induced tumors in mice with human immune system components.	The Journal of experimental medicine	2009	92
19536809	3458	Xu Q	Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.	Stem cells	2009	54
19542050	3458	Gao B	Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.	Journal of leukocyte biology	2009	93
19564875	3458	O'Rourke RW	Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-gamma in inflammation in human adipose tissue.	International journal of obesity	2009	46
19569965	3458	Kester KE	Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.	The Journal of infectious diseases	2009	150
19577283	3458	Jones SM	Clinical efficacy and immune regulation with peanut oral immunotherapy.	The Journal of allergy and clinical immunology	2009	135
19585513	3458	Lynch L	Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.	European journal of immunology	2009	55
19608159	3458	Yoo KH	Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.	Cellular immunology	2009	80
19636353	3458	Malhotra I	Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.	PLoS medicine	2009	62
19675671	3458	Smolders J	Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis.	PloS one	2009	53
19740775	3458	Rovedatti L	Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease.	Gut	2009	67
19747917	3458	Ahlenstiel G	Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.	Gastroenterology	2010	91
19818653	3458	Feuerer M	How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets.	Immunity	2009	83
19822900	3458	Gutman JA	Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.	Blood	2010	44
19875682	3458	Mauad T	Lung pathology in fatal novel human influenza A (H1N1) infection.	American journal of respiratory and critical care medicine	2010	99
19890056	3458	JÃ¤ger A	Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes.	Journal of immunology	2009	186
19915051	3458	Santner-Nanan B	Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.	Journal of immunology	2009	87
19917691	3458	Fletcher JM	CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.	Journal of immunology	2009	118
19923445	3458	Zhang Q	Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis.	Journal of immunology	2009	111
19940845	3458	Hill DA	Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis.	Mucosal immunology	2010	121
19996179	3458	Fujita H	Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production.	Proceedings of the National Academy of Sciences of the United States of America	2009	57
20003352	3458	Bermejo-Martin JF	Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.	Critical care	2009	91
20015486	3458	Dowlati Y	A meta-analysis of cytokines in major depression.	Biological psychiatry	2010	516
20019339	3458	Chen X	Reduced Th17 response in patients with tuberculosis correlates with IL-6R expression on CD4+ T Cells.	American journal of respiratory and critical care medicine	2010	48
20039303	3458	Recalcati S	Differential regulation of iron homeostasis during human macrophage polarized activation.	European journal of immunology	2010	55
20050849	3458	Schafer PH	Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.	British journal of pharmacology	2010	44
20063313	3458	Wammes LJ	Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum.	European journal of immunology	2010	46
20103780	3458	Moosmann A	Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.	Blood	2010	47
20112361	3458	Kokkonen H	Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis.	Arthritis and rheumatism	2010	94
20146084	3458	Ardon H	Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.	Journal of neuro-oncology	2010	41
20164424	3458	Denny MF	A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.	Journal of immunology	2010	110
20194818	3458	Wright RJ	Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort.	American journal of respiratory and critical care medicine	2010	58
20200277	3458	Unsinger J	IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis.	Journal of immunology	2010	75
20207200	3458	Chen K	Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism.	Clinical immunology	2010	45
20222111	3458	Shamji MF	Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues.	Arthritis and rheumatism	2010	53
20226890	3458	van Dissel JT	Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naÃ¯ve human volunteers.	Vaccine	2010	61
20231693	3458	Wu X	Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses.	Journal of immunology	2010	50
20339534	3458	Waddell SJ	Dissecting interferon-induced transcriptional programs in human peripheral blood cells.	PloS one	2010	58
20368575	3458	Vermijlen D	Human cytomegalovirus elicits fetal gammadelta T cell responses in utero.	The Journal of experimental medicine	2010	50
20368733	3458	Shi Y	Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair.	Cell research	2010	112
20376398	3458	Han Q	Multidimensional analysis of the frequencies and rates of cytokine secretion from single cells by quantitative microengraving.	Lab on a chip	2010	63
20400682	3458	Maslak PG	Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia.	Blood	2010	43
20404924	3458	Verma S	Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis.	PloS one	2010	41
20437580	3458	Bar-Or A	Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?	Annals of neurology	2010	85
20491796	3458	Harris J	How tumour necrosis factor blockers interfere with tuberculosis immunity.	Clinical and experimental immunology	2010	52
20511558	3458	Boniface K	Human Th17 cells comprise heterogeneous subsets including IFN-gamma-producing cells with distinct properties from the Th1 lineage.	Journal of immunology	2010	53
20554959	3458	Oseroff C	Molecular determinants of T cell epitope recognition to the common Timothy grass allergen.	Journal of immunology	2010	60
20610802	3458	McCall MB	Interferon-Î³--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria.	Journal of leukocyte biology	2010	61
20725040	3458	Berry MP	An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.	Nature	2010	449
20824205	3458	Mehra S	Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas.	PloS one	2010	41
20881185	3458	Silverman JM	Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells.	Journal of immunology	2010	56
21102458	3458	Wilhelm K	Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R.	Nature medicine	2010	95
21106641	3458	Brandau S	Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.	Journal of leukocyte biology	2011	65
21169542	3458	Jagannathan-Bogdan M	Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes.	Journal of immunology	2011	70
21187448	3458	Rajasagi NK	Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.	Journal of immunology	2011	44
21187913	3458	Peppa D	Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.	PLoS pathogens	2010	64
21288814	3458	Skowronski DM	Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.	The Journal of infectious diseases	2011	41
21315435	3458	Dworski R	Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways.	The Journal of allergy and clinical immunology	2011	39
21368230	3458	McClymont SA	Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.	Journal of immunology	2011	98
21375540	3458	Cosmi L	Th17 cells: new players in asthma pathogenesis.	Allergy	2011	60
21377040	3458	Akdis M	Interleukins, from 1 to 37, and interferon-Î³: receptors, functions, and roles in diseases.	The Journal of allergy and clinical immunology	2011	98
21414808	3458	Saini D	Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.	The Journal of heart and lung transplantation 	2011	45
21624938	3458	Zoller EE	Hemophagocytosis causes a consumptive anemia of inflammation.	The Journal of experimental medicine	2011	37
21628665	3458	Wauquier N	The acute phase of Chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation.	The Journal of infectious diseases	2011	39
21669030	3458	Mandalakas AM	Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis.	The international journal of tuberculosis and lung disease 	2011	42
21706005	3458	Rossi RL	Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b.	Nature immunology	2011	86
21734244	3458	Rikihisa Y	Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.	Clinical microbiology reviews	2011	44
21775682	3458	Day CL	Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load.	Journal of immunology	2011	84
21934657	3458	FranÃ§ois M	Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.	Molecular therapy 	2012	87
21965332	3458	Varadarajan N	A high-throughput single-cell analysis of human CD8âº T cell functions reveals discordance for cytokine secretion and cytolysis.	The Journal of clinical investigation	2011	50
21998409	3458	Fabri M	Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages.	Science translational medicine	2011	135
22029655	3458	FranÃ§ois M	Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-Î³ licensing.	Cytotherapy	2012	47
22084432	3458	Cichocki F	Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling.	Journal of immunology	2011	44
22160692	3458	Han Q	Polyfunctional responses by human T cells result from sequential release of cytokines.	Proceedings of the National Academy of Sciences of the United States of America	2012	78
22239614	3458	Elliott DE	Helminth-host immunological interactions: prevention and control of immune-mediated diseases.	Annals of the New York Academy of Sciences	2012	50
22289511	3458	McElhaney JE	The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.	Vaccine	2012	48
22297636	3458	Harris JE	A mouse model of vitiligo with focused epidermal depigmentation requires IFN-Î³ for autoreactive CD8âº T-cell accumulation in the skin.	The Journal of investigative dermatology	2012	31
22323453	3458	Gleason MK	Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.	Blood	2012	58
22349514	3458	Schmieder A	Differentiation and gene expression profile of tumor-associated macrophages.	Seminars in cancer biology	2012	41
22370101	3458	Darmochwal-Kolarz D	The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia.	Journal of reproductive immunology	2012	31
22378844	3458	Trotta R	miR-155 regulates IFN-Î³ production in natural killer cells.	Blood	2012	61
22416258	3458	Jurado JO	IL-17 and IFN-Î³ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease.	Journal of leukocyte biology	2012	42
22466287	3458	Zielinski CE	Pathogen-induced human TH17 cells produce IFN-Î³ or IL-10 and are regulated by IL-1Î².	Nature	2012	190
22485125	3458	Zhang L	Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis.	PloS one	2012	36
22539471	3458	Singh OP	Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood.	Clinical and vaccine immunology 	2012	33
22569268	3458	Kamat A	Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.	Journal of acquired immune deficiency syndromes	2012	61
22592608	3458	Klinger M	Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab.	Blood	2012	74
22658928	3458	Thakur A	Immune markers and correlates of protection for vaccine induced immune responses.	Vaccine	2012	35
22761577	3458	Niedelman W	The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response.	PLoS pathogens	2012	48
22772450	3458	Smith KM	miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.	Journal of immunology	2012	45
22983442	3458	Romee R	Cytokine activation induces human memory-like NK cells.	Blood	2012	82
23169501	3458	Icheva V	Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation.	Journal of clinical oncology 	2013	47
23223131	3458	Hijnen D	CD8(+) T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-Î³, IL-13, IL-17, and IL-22.	The Journal of investigative dermatology	2013	29
23260195	3458	Sathaliyawala T	Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets.	Immunity	2013	127
23271808	3458	Fu B	Natural killer cells promote immune tolerance by regulating inflammatory TH17 cells at the human maternal-fetal interface.	Proceedings of the National Academy of Sciences of the United States of America	2013	36
23323860	3458	Padgett LE	The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis.	Annals of the New York Academy of Sciences	2013	54
23414212	3458	SellarÃ©s J	Molecular diagnosis of antibody-mediated rejection in human kidney transplants.	American journal of transplantation 	2013	30
23468501	3458	Jegaskanda S	Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques.	Journal of virology	2013	47
23493728	3458	Jarvis JN	The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis.	The Journal of infectious diseases	2013	29
23768870	3458	Munkholm K	Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis.	Journal of psychiatric research	2013	35
23867552	3458	Carreno BM	IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity.	The Journal of clinical investigation	2013	37
23915137	3458	Swindell WR	Dissecting the psoriasis transcriptome: inflammatory- and cytokine-driven gene expression in lesions from 163 patients.	BMC genomics	2013	34
23999600	3458	Garg A	HIV type 1 gp120-induced expansion of myeloid derived suppressor cells is dependent on interleukin 6 and suppresses immunity.	The Journal of infectious diseases	2014	22
24009159	3458	Cosmi L	T helper cells plasticity in inflammation.	Cytometry. Part A 	2014	28
24012417	3458	Qiao Y	Synergistic activation of inflammatory cytokine genes by interferon-Î³-induced chromatin remodeling and toll-like receptor signaling.	Immunity	2013	56
24173214	3458	Taylor HE	The innate immune factor apolipoprotein L1 restricts HIV-1 infection.	Journal of virology	2014	22
24434782	3458	Leong JW	Preactivation with IL-12, IL-15, and IL-18 induces CD25 and a functional high-affinity IL-2 receptor on human cytokine-induced memory-like natural killer cells.	Biology of blood and marrow transplantation 	2014	40
24442432	3458	Della Chiesa M	Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.	Journal of immunology	2014	31
24488563	3458	Stringaris K	Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia.	Haematologica	2014	25
24518246	3458	Voraphani N	An airway epithelial iNOS-DUOX2-thyroid peroxidase metabolome drives Th1/Th2 nitrative stress in human severe asthma.	Mucosal immunology	2014	20
24934179	3458	Masi A	Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis.	Molecular psychiatry	2015	34
24967632	3458	Jo J	Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver.	PLoS pathogens	2014	29
25184558	3458	Dutta NK	Latent tuberculosis infection: myths, models, and molecular mechanisms.	Microbiology and molecular biology reviews 	2014	23
25210141	3458	Jensen KJ	Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial.	The Journal of infectious diseases	2015	19
25211344	3458	Sedegah M	Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes.	PloS one	2014	25
25244096	3458	Kirabo A	DC isoketal-modified proteins activate T cells and promote hypertension.	The Journal of clinical investigation	2014	60
25329659	3458	Luetke-Eversloh M	Human cytomegalovirus drives epigenetic imprinting of the IFNG locus in NKG2Chi natural killer cells.	PLoS pathogens	2014	34
25416807	3458	Huss DJ	In vivo maintenance of human regulatory T cells during CD25 blockade.	Journal of immunology	2015	15
25461470	3458	Antonelli A	Autoimmune thyroid disorders.	Autoimmunity reviews	2015	35
25534940	3458	Cardoso TM	Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection.	Infection and immunity	2015	16
25611466	3458	Gideon HP	Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization.	PLoS pathogens	2015	42
25644696	3458	Jiang W	Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease.	Scientific reports	2015	23
25647269	3458	Talaat RM	Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.	Cytokine	2015	23
25703555	3458	Boisson-Dupuis S	Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.	Immunological reviews	2015	21
26084023	3458	Kolev M	Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses.	Immunity	2015	23
26405286	3458	Getahun H	Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.	The European respiratory journal	2015	21
27068708	3458	Fletcher HA	T-cell activation is an immune correlate of risk in BCG vaccinated infants.	Nature communications	2016	16
27111145	3458	Bal SM	IL-1Î², IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs.	Nature immunology	2016	14
1655948	3552	de Waal Malefyt R	Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.	The Journal of experimental medicine	1991	343
2065663	3552	Schreck R	Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1.	The EMBO journal	1991	506
2294996	3552	Schindler R	Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.	Blood	1990	149
2328723	3552	Rubartelli A	A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence.	The EMBO journal	1990	154
2886992	3552	Wahl SM	Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.	Proceedings of the National Academy of Sciences of the United States of America	1987	214
3877078	3552	Bevilacqua MP	Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.	The Journal of clinical investigation	1985	204
6083565	3552	Auron PE	Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.	Proceedings of the National Academy of Sciences of the United States of America	1984	183
7523569	3552	Caux C	Activation of human dendritic cells through CD40 cross-linking.	The Journal of experimental medicine	1994	221
8052854	3552	Kopp E	Inhibition of NF-kappa B by sodium salicylate and aspirin.	Science	1994	266
8496693	3552	Taub DD	Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells.	The Journal of experimental medicine	1993	178
9759850	3552	SchÃ¶nbeck U	Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.	Journal of immunology	1998	139
10767254	3552	Opal SM	Anti-inflammatory cytokines.	Chest	2000	187
11581570	3552	Alexander C	Bacterial lipopolysaccharides and innate immunity.	Journal of endotoxin research	2001	149
12270950	3552	Watkins LR	Beyond neurons: evidence that immune and glial cells contribute to pathological pain states.	Physiological reviews	2002	132
12522051	3552	de Jager W	Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells.	Clinical and diagnostic laboratory immunology	2003	105
15851489	3552	Pascual V	Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade.	The Journal of experimental medicine	2005	174
15885777	3552	Dunn AJ	Cytokines as mediators of depression: what can we learn from animal studies?	Neuroscience and biobehavioral reviews	2005	80
16402109	3552	Lucas SM	The role of inflammation in CNS injury and disease.	British journal of pharmacology	2006	233
17088043	3552	Dantzer R	Twenty years of research on cytokine-induced sickness behavior.	Brain, behavior, and immunity	2007	262
17593905	3552	Zeyda M	Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production.	International journal of obesity	2007	122
17724127	3552	Allantaz F	Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade.	The Journal of experimental medicine	2007	81
18258476	3552	Blanco P	Dendritic cells and cytokines in human inflammatory and autoimmune diseases.	Cytokine and growth factor reviews	2008	88
18302763	3552	Shaftel SS	The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective.	Journal of neuroinflammation	2008	103
18438814	3552	Gattorno M	The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis.	Arthritis and rheumatism	2008	66
19181644	3552	Lust JA	Induction of a chronic disease state in patients with smoldering or indolent multiple myeloma by targeting interleukin 1{beta}-induced interleukin 6 production and the myeloma proliferative component.	Mayo Clinic proceedings	2009	54
19224657	3552	Khairova RA	A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder.	The international journal of neuropsychopharmacology	2009	49
19362022	3552	Chung Y	Critical regulation of early Th17 cell differentiation by interleukin-1 signaling.	Immunity	2009	337
19785746	3552	de Jager W	Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.	BMC immunology	2009	70
20021321	3552	Drexhage RC	The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder.	Expert review of neurotherapeutics	2010	43
20081871	3552	Sims JE	The IL-1 family: regulators of immunity.	Nature reviews. Immunology	2010	231
22142165	3552	Rossol M	LPS-induced cytokine production in human monocytes and macrophages.	Critical reviews in immunology	2011	80
22945591	3552	Rock KL	Uric acid as a danger signal in gout and its comorbidities.	Nature reviews. Rheumatology	2013	38
23995233	3552	Freigang S	Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1Î± and sterile vascular inflammation in atherosclerosis.	Nature immunology	2013	46
26656658	3552	Schett G	Interleukin-1 function and role in rheumatic disease.	Nature reviews. Rheumatology	2016	20
27340270	3552	Prabhu SD	The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.	Circulation research	2016	31
1373520	3553	Cerretti DP	Molecular cloning of the interleukin-1 beta converting enzyme.	Science	1992	141
1574116	3553	Thornberry NA	A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.	Nature	1992	385
8403503	3553	Reinecker HC	Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.	Clinical and experimental immunology	1993	157
8520783	3553	Bonfield TL	Inflammatory cytokines in cystic fibrosis lungs.	American journal of respiratory and critical care medicine	1995	150
8787820	3553	Blum-Degen D	Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.	Neuroscience letters	1995	120
9233643	3553	Ferrari D	Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages.	Journal of immunology	1997	148
9466984	3553	Fadok VA	Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.	The Journal of clinical investigation	1998	656
9531313	3553	Jovanovic DV	IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.	Journal of immunology	1998	209
10358063	3553	Nath A	Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon.	The Journal of biological chemistry	1999	105
11489912	3553	Lindemann S	Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.	The Journal of cell biology	2001	97
11728343	3553	MacKenzie A	Rapid secretion of interleukin-1beta by microvesicle shedding.	Immunity	2001	201
12529419	3553	Osman I	Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term.	Molecular human reproduction	2003	120
12626527	3553	Mahanty S	Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.	Journal of immunology	2003	113
14662866	3553	Cowland JB	Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha.	Journal of immunology	2003	75
15192144	3553	Andrei C	Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes.	Proceedings of the National Academy of Sciences of the United States of America	2004	102
15198989	3553	Li J	Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.	Human molecular genetics	2004	72
15671098	3553	Bruun JM	Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT.	The Journal of clinical endocrinology and metabolism	2005	91
15855327	3553	Brusko TM	Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes.	Diabetes	2005	83
15910952	3553	van Heel DA	Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.	Lancet	2005	75
16006665	3553	Fiala M	Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients.	Journal of Alzheimer's disease 	2005	70
16038786	3553	Groh ME	Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells.	Experimental hematology	2005	87
16373510	3553	Gavrilin MA	Internalization and phagosome escape required for Francisella to induce human monocyte IL-1beta processing and release.	Proceedings of the National Academy of Sciences of the United States of America	2006	103
16387690	3553	Ahn KS	Transcription factor NF-kappaB: a sensor for smoke and stress signals.	Annals of the New York Academy of Sciences	2005	81
16785446	3553	Chae JJ	The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production.	Proceedings of the National Academy of Sciences of the United States of America	2006	88
17044947	3553	Cavaillon JM	Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis.	Critical care	2006	123
17383420	3553	Liebregts T	Immune activation in patients with irritable bowel syndrome.	Gastroenterology	2007	101
17429439	3553	Watanabe H	Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity.	The Journal of investigative dermatology	2007	76
17636564	3553	Nesbitt A	Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.	Inflammatory bowel diseases	2007	60
17853946	3553	Schenk M	TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.	The Journal of clinical investigation	2007	73
18042719	3553	Tiemessen MM	CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.	Proceedings of the National Academy of Sciences of the United States of America	2007	176
18262644	3553	Challier JC	Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta.	Placenta	2008	129
18385818	3553	Prasad AS	Zinc in human health: effect of zinc on immune cells.	Molecular medicine	2008	64
18523012	3553	Piccini A	ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way.	Proceedings of the National Academy of Sciences of the United States of America	2008	120
18768898	3553	Jarvinen L	Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator.	Journal of immunology	2008	53
18928408	3553	Chen G	NOD-like receptors: role in innate immunity and inflammatory disease.	Annual review of pathology	2009	144
19085934	3553	Slominski A	Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells.	International journal of cancer	2009	48
19104081	3553	Netea MG	Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages.	Blood	2009	195
19125209	3553	Anisman H	Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.	Journal of psychiatry and neuroscience 	2009	75
19166877	3553	Ren K	Role of interleukin-1beta during pain and inflammation.	Brain research reviews	2009	60
19171879	3553	Beriou G	IL-17-producing human peripheral regulatory T cells retain suppressive function.	Blood	2009	118
19234215	3553	Bryan NB	Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain.	Journal of immunology	2009	59
19487419	3553	Minegishi Y	Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome.	The Journal of experimental medicine	2009	71
19503839	3553	Liu PT	Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses.	PloS one	2009	85
19583551	3553	Hallab NJ	Biologic effects of implant debris.	Bulletin of the NYU hospital for joint diseases	2009	53
19710611	3553	Prasad AS	Zinc: role in immunity, oxidative stress and chronic inflammation.	Current opinion in clinical nutrition and metabolic care	2009	56
19842207	3553	Zhang JY	Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.	Hepatology	2010	89
19895991	3553	Zaba LC	Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes.	The Journal of allergy and clinical immunology	2009	63
20127816	3553	Chakraborty S	Inflammasome signaling at the heart of central nervous system pathology.	Journal of neuroscience research	2010	45
20148899	3553	Mishra BB	Mycobacterium tuberculosis protein ESAT-6 is a potent activator of the NLRP3/ASC inflammasome.	Cellular microbiology	2010	73
20398664	3553	Ng J	Clostridium difficile toxin-induced inflammation and intestinal injury are mediated by the inflammasome.	Gastroenterology	2010	54
20398920	3553	Hastie AT	Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes.	The Journal of allergy and clinical immunology	2010	88
20522023	3553	Barbarroja N	The obese healthy paradox: is inflammation the answer?	The Biochemical journal	2010	40
20620944	3553	Hughes T	Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue.	Immunity	2010	64
21232790	3553	Roberts KA	Placental structure and inflammation in pregnancies associated with obesity.	Placenta	2011	48
21700772	3553	Wang JG	Monocytic microparticles activate endothelial cells in an IL-1Î²-dependent manner.	Blood	2011	55
21752263	3553	Chang BY	The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells.	Arthritis research and therapy	2011	46
21784976	3553	Novikov A	Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1Î² production in human macrophages.	Journal of immunology	2011	60
21901289	3553	Dayan V	Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction.	Basic research in cardiology	2011	47
22195044	3553	Mitroulis I	Neutrophil extracellular trap formation is associated with IL-1Î² and autophagy-related signaling in gout.	PloS one	2011	58
22412385	3553	Eizirik DL	The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines.	PLoS genetics	2012	82
22521247	3553	Philbin VJ	Imidazoquinoline Toll-like receptor 8 agonists activate human newborn monocytes and dendritic cells through adenosine-refractory and caspase-1-dependent pathways.	The Journal of allergy and clinical immunology	2012	32
22699287	3553	Cavelti-Weder C	Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.	Diabetes care	2012	49
22723639	3553	Deretic V	Autophagy: an emerging immunological paradigm.	Journal of immunology	2012	51
22770526	3553	Yang EJ	Inflammasome formation and IL-1Î² release by human blood monocytes in response to silver nanoparticles.	Biomaterials	2012	34
23110185	3553	Keshari RS	Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition.	PloS one	2012	31
23306544	3553	Tiringer K	A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.	American journal of respiratory and critical care medicine	2013	26
23347265	3553	Gomez-Lopez N	Evidence for a role for the adaptive immune response in human term parturition.	American journal of reproductive immunology	2013	25
23360282	3553	Gola H	Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells.	BMC psychiatry	2013	33
23401508	3553	Scotti C	Engineering of a functional bone organ through endochondral ossification.	Proceedings of the National Academy of Sciences of the United States of America	2013	49
23483986	3553	Dowling DJ	The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.	PloS one	2013	25
23557933	3553	TomÃ©-Carneiro J	One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease.	Pharmacological research	2013	38
23630220	3553	Jaremka LM	Loneliness promotes inflammation during acute stress.	Psychological science	2013	28
23904163	3553	Farrera C	Macrophage clearance of neutrophil extracellular traps is a silent process.	Journal of immunology	2013	51
23935251	3553	More SV	Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease.	Mediators of inflammation	2013	38
24133185	3553	Allers K	Macrophages accumulate in the gut mucosa of untreated HIV-infected patients.	The Journal of infectious diseases	2014	22
24203055	3553	Uhlig HH	Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.	Gut	2013	39
24225954	3553	Bretz NP	Body fluid exosomes promote secretion of inflammatory cytokines in monocytic cells via Toll-like receptor signaling.	The Journal of biological chemistry	2013	37
24277153	3553	Guiducci C	RNA recognition by human TLR8 can lead to autoimmune inflammation.	The Journal of experimental medicine	2013	25
24356306	3553	Doitsh G	Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.	Nature	2014	194
24356959	3553	van der Burgh R	Defects in mitochondrial clearance predispose human monocytes to interleukin-1Î² hypersecretion.	The Journal of biological chemistry	2014	24
24497828	3553	Sereti I	Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration.	PLoS pathogens	2014	32
24520123	3553	Dalmas E	T cell-derived IL-22 amplifies IL-1Î²-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.	Diabetes	2014	30
24554772	3553	Samstad EO	Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release.	Journal of immunology	2014	37
24634448	3553	Braun HJ	The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy.	The American journal of sports medicine	2014	24
24736635	3553	Fernando MR	The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages.	PloS one	2014	28
24743880	3553	Portugal S	Exposure-dependent control of malaria-induced inflammation in children.	PLoS pathogens	2014	30
24952505	3553	Franklin BS	The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation.	Nature immunology	2014	84
24978137	3553	Ye SB	Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma.	Oncotarget	2014	44
25164131	3553	Dong L	Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis.	Journal of cellular and molecular medicine	2014	21
25412102	3553	Escudero-PÃ©rez B	Shed GP of Ebola virus triggers immune activation and increased vascular permeability.	PLoS pathogens	2014	26
25453823	3553	Chittezhath M	Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression.	Immunity	2014	26
25649144	3553	CriÈan TO	Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra.	Annals of the rheumatic diseases	2016	13
25879286	3553	Zhao Y	The NAIP-NLRC4 inflammasome in innate immune detection of bacterial flagellin and type III secretion apparatus.	Immunological reviews	2015	16
26187413	3553	Bernink JH	Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.	Immunity	2015	37
26926996	3553	Shirai T	The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease.	The Journal of experimental medicine	2016	16
27030597	3553	Masters SL	Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation.	Science translational medicine	2016	15
1846244	3558	Fraser JD	Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.	Science	1991	152
2871125	3558	Kehrl JH	Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.	The Journal of experimental medicine	1986	304
2995487	3558	McDougal JS	Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.	Journal of immunology	1985	169
3264384	3558	Rosenberg SA	Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.	The New England journal of medicine	1988	246
6327821	3558	Weiss A	The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level.	Journal of immunology	1984	179
7523571	3558	Carson WE	Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.	The Journal of experimental medicine	1994	200
8028037	3558	Rosenberg SA	Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2.	Journal of the National Cancer Institute	1994	157
8691133	3558	Groux H	Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells.	The Journal of experimental medicine	1996	137
10358752	3558	Waldmann TA	The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens.	Annual review of immunology	1999	139
10371503	3558	Chun TW	Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.	Nature medicine	1999	122
10611346	3558	Davey RT Jr	HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression.	Proceedings of the National Academy of Sciences of the United States of America	1999	198
10887096	3558	Kunzmann V	Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma.	Blood	2000	98
11081504	3558	Parrish-Novak J	Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function.	Nature	2000	237
11357146	3558	Rosenberg SA	Progress in human tumour immunology and immunotherapy.	Nature	2001	236
11565838	3558	Dudley ME	Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.	Journal of immunotherapy	2001	108
11675346	3558	Ng WF	Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells.	Blood	2001	100
12000866	3558	Dudley ME	A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.	Journal of immunotherapy	2002	86
12218168	3558	Wedemeyer H	Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.	Journal of immunology	2002	173
12427970	3558	Yee C	Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.	Proceedings of the National Academy of Sciences of the United States of America	2002	320
12480696	3558	Fehniger TA	CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.	Blood	2003	179
12623838	3558	Wilhelm M	Gammadelta T cells for immune therapy of patients with lymphoid malignancies.	Blood	2003	109
12663797	3558	Wherry EJ	Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment.	Journal of virology	2003	484
12843795	3558	Dudley ME	Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients.	Journal of immunotherapy	2003	157
14961035	3558	Imai C	Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia.	Leukemia	2004	141
15100259	3558	Zheng SG	Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.	Journal of immunology	2004	148
15128946	3558	Sundrud MS	Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion.	Proceedings of the National Academy of Sciences of the United States of America	2004	80
15218108	3558	Sivori S	CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells.	Proceedings of the National Academy of Sciences of the United States of America	2004	87
15632206	3558	Miller JS	Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.	Blood	2005	340
15638853	3558	Hayashi T	Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application.	British journal of haematology	2005	70
15777785	3558	Rasmusson I	Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.	Experimental cell research	2005	91
15780987	3558	Freud AG	A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells.	Immunity	2005	99
15800326	3558	Dudley ME	Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.	Journal of clinical oncology 	2005	443
15972602	3558	Wikby A	An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans.	The journals of gerontology. Series A, Biological sciences and medical sciences	2005	83
15980149	3558	Klebanoff CA	Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells.	Proceedings of the National Academy of Sciences of the United States of America	2005	231
16007258	3558	Valmori D	A peripheral circulating compartment of natural naive CD4 Tregs.	The Journal of clinical investigation	2005	96
16051844	3558	Brooks DG	Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection.	Journal of virology	2005	82
16121185	3558	Watanabe N	Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus.	Nature	2005	162
16224276	3558	Attia P	Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma.	Journal of immunotherapy	2005	70
16308572	3558	Dannull J	Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.	The Journal of clinical investigation	2005	257
16364519	3558	Farag SS	Human natural killer cell development and biology.	Blood reviews	2006	79
16567385	3558	Jabbari A	Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype.	The Journal of experimental medicine	2006	83
16763205	3558	Banerjee DK	Expansion of FOXP3high regulatory T cells by human dendritic cells (DCs) in vitro and after injection of cytokine-matured DCs in myeloma patients.	Blood	2006	94
17075125	3558	Mackensen A	Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.	Journal of clinical oncology 	2006	92
17108138	3558	Kowolik CM	CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.	Cancer research	2006	155
17110377	3558	Stopak KS	Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells.	The Journal of biological chemistry	2007	75
17202333	3558	Peluso I	IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes.	Journal of immunology	2007	71
17289812	3558	Biancotto A	Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.	Blood	2007	87
17671216	3558	Clayton A	Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.	Cancer research	2007	106
18334676	3558	Ferrajoli A	Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia.	Blood	2008	105
18508251	3558	Curiel TJ	Regulatory T cells and treatment of cancer.	Current opinion in immunology	2008	66
18509084	3558	Till BG	Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.	Blood	2008	185
18559587	3558	Bergmann C	T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.	Clinical cancer research 	2008	56
18684212	3558	Chang L	Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome.	Neurogastroenterology and motility 	2009	51
18779745	3558	Tran KQ	Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy.	Journal of immunotherapy	2008	61
18809613	3558	Dudley ME	Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.	Journal of clinical oncology 	2008	389
19265131	3558	Castriconi R	NK cells recognize and kill human glioblastoma cells with stem cell-like properties.	Journal of immunology	2009	54
19383914	3558	Fujisaki H	Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.	Cancer research	2009	103
19404981	3558	Pinna D	Clonal dissection of the human memory B-cell repertoire following infection and vaccination.	European journal of immunology	2009	49
19465693	3558	Chung DJ	Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.	Blood	2009	83
19726501	3558	Migueles SA	Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.	Journal of virology	2009	67
19933795	3558	Hopkins S	SCY-635, a novel nonimmunosuppressive analog of cyclosporine that exhibits potent inhibition of hepatitis C virus RNA replication in vitro.	Antimicrobial agents and chemotherapy	2010	41
19965651	3558	Curtale G	An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes.	Blood	2010	92
20085940	3558	Rubnitz JE	NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.	Journal of clinical oncology 	2010	118
20221423	3558	Makedonas G	Perforin and IL-2 upregulation define qualitative differences among highly functional virus-specific human CD8 T cells.	PLoS pathogens	2010	56
20304086	3558	Jensen MC	Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans.	Biology of blood and marrow transplantation 	2010	119
20382097	3558	Coura JR	Chagas disease: 100 years after its discovery. A systemic review.	Acta tropica	2010	42
20406835	3558	Besser MJ	Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.	Clinical cancer research 	2010	105
20439625	3558	AbÃ¨s R	Long-lasting antitumor protection by anti-CD20 antibody through cellular immune response.	Blood	2010	55
20491785	3558	Meraviglia S	In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients.	Clinical and experimental immunology	2010	57
20558731	3558	Mandapathil M	Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.	The Journal of biological chemistry	2010	47
20651070	3558	GÃ¶rgÃ¼n G	Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.	Blood	2010	47
20668005	3558	Dudley ME	CD8+ enriched "young" tumor infiltrating lymphocytes can mediate regression of metastatic melanoma.	Clinical cancer research 	2010	60
20680271	3558	Bachanova V	Allogeneic natural killer cells for refractory lymphoma.	Cancer immunology, immunotherapy 	2010	46
20736326	3558	Jacobs JF	Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.	Clinical cancer research 	2010	50
20849361	3558	Geller MA	A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.	Cytotherapy	2011	84
20935224	3558	Delgado DC	Genotypes of NK cell KIR receptors, their ligands, and FcÎ³ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.	Cancer research	2010	50
20952687	3558	Brunstein CG	Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.	Blood	2011	272
20978269	3558	Hsu AK	The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy.	Blood	2011	43
21278738	3558	Yang XP	Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5.	Nature immunology	2011	191
21389874	3558	Hernandez-Chacon JA	Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.	Journal of immunotherapy	2011	37
21498393	3558	Rosenberg SA	Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy.	Clinical cancer research 	2011	412
21532597	3558	Wuest SC	A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy.	Nature medicine	2011	76
21771874	3558	Lesterhuis WJ	Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients.	Clinical cancer research 	2011	39
21791425	3558	Curti A	Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.	Blood	2011	69
21889323	3558	Liao W	IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation.	Current opinion in immunology	2011	102
21998698	3558	Olotu A	Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.	PloS one	2011	38
22072753	3558	Lachmann R	Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses.	Journal of virology	2012	33
22129252	3558	Koreth J	Interleukin-2 and regulatory T cells in graft-versus-host disease.	The New England journal of medicine	2011	209
22129253	3558	Saadoun D	Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.	The New England journal of medicine	2011	142
22160384	3558	Kochenderfer JN	B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.	Blood	2012	345
22275504	3558	Liu L	Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma.	Clinical cancer research 	2012	37
22311675	3558	Andersen RS	Dissection of T-cell antigen specificity in human melanoma.	Cancer research	2012	44
22393002	3558	Chapuis AG	Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype.	Proceedings of the National Academy of Sciences of the United States of America	2012	47
22453018	3558	Wu R	Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.	Cancer journal	2012	39
22461703	3558	Garg G	Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.	Journal of immunology	2012	43
22555974	3558	Yao X	Levels of peripheral CD4(+)FoxP3(+) regulatory T cells are negatively associated with clinical response to adoptive immunotherapy of human cancer.	Blood	2012	44
22706088	3558	Moorman JP	Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.	Journal of immunology	2012	32
22710188	3558	Kennedy PTF	Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B.	Gastroenterology	2012	39
23552371	3558	Matsuoka K	Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease.	Science translational medicine	2013	93
23639322	3558	Lippitz BE	Cytokine patterns in patients with cancer: a systematic review.	The Lancet. Oncology	2013	136
23650429	3558	Dudley ME	Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.	Journal of clinical oncology 	2013	44
23741305	3558	Singh H	Manufacture of clinical-grade CD19-specific T cells stably expressing chimeric antigen receptor using Sleeping Beauty system and artificial antigen presenting cells.	PloS one	2013	39
24094496	3558	Tonn T	Treatment of patients with advanced cancer with the natural killer cell line NK-92.	Cytotherapy	2013	40
24573552	3558	Kennedy-Nasser AA	Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.	Clinical cancer research 	2014	32
24622415	3558	Hartemann A	Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.	The lancet. Diabetes and endocrinology	2013	45
24650034	3558	Kimbrel EA	Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties.	Stem cells and development	2014	28
24719405	3558	Bachanova V	Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein.	Blood	2014	59
24782509	3558	Xu Y	Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15.	Blood	2014	59
24907378	3558	Rosenberg SA	IL-2: the first effective immunotherapy for human cancer.	Journal of immunology	2014	84
25171868	3558	Bartemes KR	Enhanced innate type 2 immune response in peripheral blood from patients with asthma.	The Journal of allergy and clinical immunology	2014	40
25415285	3558	Szmania S	Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patients.	Journal of immunotherapy	2015	24
25503054	3558	Schuetz A	Initiation of ART during early acute HIV infection preserves mucosal Th17 function and reverses HIV-related immune activation.	PLoS pathogens	2014	48
25576057	3558	Yu A	Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes.	Diabetes	2015	21
25695689	3558	Zhang L	Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma.	Clinical cancer research 	2015	29
25747273	3558	Lee JH	Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.	Gastroenterology	2015	31
25850950	3558	Katz SC	Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.	Clinical cancer research 	2015	23
25939024	3558	Thiault N	Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors.	Nature immunology	2015	23
25940712	3558	Ninomiya S	Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs.	Blood	2015	25
26324847	3558	von Spee-Mayer C	Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.	Annals of the rheumatic diseases	2016	12
27073224	3558	Koreth J	Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host disease.	Blood	2016	15
27500725	3558	He J	Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.	Nature medicine	2016	11
10606632	3559	Novak EJ	MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.	The Journal of clinical investigation	1999	107
11722623	3559	Shevach EM	Control of T-cell activation by CD4+ CD25+ suppressor T cells.	Immunological reviews	2001	98
12119349	3559	Dieckmann D	Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells corrected.	The Journal of experimental medicine	2002	103
12119350	3559	Jonuleit H	Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells.	The Journal of experimental medicine	2002	126
12594850	3559	Cao D	Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis.	European journal of immunology	2003	95
12840064	3559	Anderson BE	Memory CD4+ T cells do not induce graft-versus-host disease.	The Journal of clinical investigation	2003	99
14599852	3559	Crispin JC	Quantification of regulatory T cells in patients with systemic lupus erythematosus.	Journal of autoimmunity	2003	83
14738769	3559	Wang HY	Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy.	Immunity	2004	122
14963140	3559	Aandahl EM	Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.	Journal of virology	2004	165
14987885	3559	Ling EM	Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease.	Lancet	2004	123
15032588	3559	Sakaguchi S	Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.	Annual review of immunology	2004	720
15096182	3559	Somerset DA	Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset.	Immunology	2004	111
15520849	3559	FehÃ©rvari Z	CD4+ Tregs and immune control.	The Journal of clinical investigation	2004	100
15577848	3559	Karagiannidis C	Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.	The Journal of allergy and clinical immunology	2004	73
15753318	3559	Walker MR	De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.	Proceedings of the National Academy of Sciences of the United States of America	2005	87
15785759	3559	von Boehmer H	Mechanisms of suppression by suppressor T cells.	Nature immunology	2005	230
15902688	3559	Roncador G	Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level.	European journal of immunology	2005	118
15940622	3559	Maul J	Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease.	Gastroenterology	2005	115
15972448	3559	Zorn E	Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.	Blood	2005	101
16034085	3559	Baratelli F	Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.	Journal of immunology	2005	117
16177055	3559	Lim HW	Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells.	Journal of immunology	2005	137
16206232	3559	Haas J	Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.	European journal of immunology	2005	84
16210336	3559	Coenen JJ	Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.	Blood	2006	71
16339919	3559	Guyot-Revol V	Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis.	American journal of respiratory and critical care medicine	2006	124
16410445	3559	Beyer M	In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma.	Blood	2006	67
16432251	3559	Miyara M	The immune paradox of sarcoidosis and regulatory T cells.	The Journal of experimental medicine	2006	72
16537805	3559	Valencia X	TNF downmodulates the function of human CD4+CD25hi T-regulatory cells.	Blood	2006	208
16585503	3559	Bielekova B	Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2006	149
16585553	3559	Baecher-Allan C	MHC class II expression identifies functionally distinct human regulatory T cells.	Journal of immunology	2006	98
16715091	3559	Ochi H	Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+ CD25- LAP+ T cells.	Nature medicine	2006	78
16741253	3559	Amrolia PJ	Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation.	Blood	2006	60
16775224	3559	Hussain SF	The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses.	Neuro-oncology	2006	119
16960692	3559	Ghiringhelli F	Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients.	Cancer immunology, immunotherapy 	2007	250
17082659	3559	Miller AM	CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients.	Journal of immunology	2006	85
17196245	3559	Caudy AA	CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes.	The Journal of allergy and clinical immunology	2007	66
17200409	3559	Nadkarni S	Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta.	The Journal of experimental medicine	2007	90
17241111	3559	MartÃ­nez-Llordella M	Multiparameter immune profiling of operational tolerance in liver transplantation.	American journal of transplantation 	2007	58
17277167	3559	Arruvito L	Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction.	Journal of immunology	2007	59
17277168	3559	Valencia X	Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.	Journal of immunology	2007	143
17328073	3559	Bleesing J	The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.	Arthritis and rheumatism	2007	58
17360656	3559	Kinter A	Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals.	Proceedings of the National Academy of Sciences of the United States of America	2007	70
17389235	3559	NylÃ©n S	Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis.	The Journal of experimental medicine	2007	120
17483450	3559	Joosten SA	Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4.	Proceedings of the National Academy of Sciences of the United States of America	2007	61
17875732	3559	Kryczek I	Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma.	Cancer research	2007	75
17897887	3559	Saruta M	Characterization of FOXP3+CD4+ regulatory T cells in Crohn's disease.	Clinical immunology	2007	60
17972355	3559	Sakaguchi S	Regulatory T cells - a brief history and perspective.	European journal of immunology	2007	56
17975141	3559	Strauss L	The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck.	Clinical cancer research 	2007	93
18242215	3559	Harris PR	Helicobacter pylori gastritis in children is associated with a regulatory T-cell response.	Gastroenterology	2008	67
18281535	3559	Yokokawa J	Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer.	Clinical cancer research 	2008	55
18294918	3559	Cheng X	The Th17/Treg imbalance in patients with acute coronary syndrome.	Clinical immunology	2008	88
18337568	3559	Ebinuma H	Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection.	Journal of virology	2008	56
18485901	3559	Hoechst B	A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.	Gastroenterology	2008	191
18804271	3559	Zhang N	Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease.	The Journal of allergy and clinical immunology	2008	82
19022917	3559	Chaput N	Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.	Gut	2009	60
19210524	3559	English K	Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells.	Clinical and experimental immunology	2009	146
19221744	3559	Banissi C	Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model.	Cancer immunology, immunotherapy 	2009	50
19538496	3559	Robinson DS	Regulatory T cells and asthma.	Clinical and experimental allergy 	2009	45
19692638	3559	Wieckowski EU	Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes.	Journal of immunology	2009	70
19701192	3559	Dendrou CA	Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource.	Nature genetics	2009	100
19769742	3559	Rech AJ	Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells.	Annals of the New York Academy of Sciences	2009	82
19825957	3559	Mandapathil M	Increased ectonucleotidase expression and activity in regulatory T cells of patients with head and neck cancer.	Clinical cancer research 	2009	53
20357241	3559	MartÃ­n-Gayo E	Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development.	Blood	2010	47
20389017	3559	Matsuoka K	Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.	The Journal of clinical investigation	2010	61
20615947	3559	Shultz LD	Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice.	Proceedings of the National Academy of Sciences of the United States of America	2010	96
20937945	3559	Karussis D	Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.	Archives of neurology	2010	171
21099108	3559	Badell IR	LFA-1-specific therapy prolongs allograft survival in rhesus macaques.	The Journal of clinical investigation	2010	50
21287325	3559	Sakaguchi S	Regulatory T cells: history and perspective.	Methods in molecular biology	2011	48
21525866	3559	Gori A	Specific prebiotics modulate gut microbiota and immune activation in HAART-naive HIV-infected adults: results of the "COPA" pilot randomized trial.	Mucosal immunology	2011	45
21750674	3559	Nikolova M	CD39/adenosine pathway is involved in AIDS progression.	PLoS pathogens	2011	42
22045986	3559	Kim YH	In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.	Blood	2012	41
22723342	3559	Marek-Trzonkowska N	Administration of CD4+CD25highCD127- regulatory T cells preserves Î²-cell function in type 1 diabetes in children.	Diabetes care	2012	62
22855463	3559	Perry JS	Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis.	Science translational medicine	2012	43
23242600	3559	ScottÃ  C	Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations.	Haematologica	2013	28
23453135	3559	van de Veen W	IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses.	The Journal of allergy and clinical immunology	2013	49
24244610	3559	Preston CC	The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.	PloS one	2013	34
25214635	3559	Ye CJ	Intersection of population variation and autoimmunity genetics in human T cell activation.	Science	2014	35
25449680	3559	Grant CR	Regulatory T-cells in autoimmune diseases: challenges, controversies and--yet--unanswered questions.	Autoimmunity reviews	2015	17
8266077	3561	Noguchi M	Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.	Science	1993	151
10784449	3561	Cavazzana-Calvo M	Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.	Science	2000	381
11961146	3561	Hacein-Bey-Abina S	Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.	The New England journal of medicine	2002	184
14564000	3561	Hacein-Bey-Abina S	LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.	Science	2003	831
15610804	3561	Gaspar HB	Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.	Lancet	2004	156
17671652	3561	Deichmann A	Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.	The Journal of clinical investigation	2007	92
17671654	3561	Schwarzwaelder K	Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivo.	The Journal of clinical investigation	2007	80
20156973	3561	Xie Y	Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.	The Journal of experimental medicine	2010	130
20660403	3561	Hacein-Bey-Abina S	Efficacy of gene therapy for X-linked severe combined immunodeficiency.	The New England journal of medicine	2010	155
21865537	3561	Gaspar HB	Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.	Science translational medicine	2011	54
25893296	3561	Morton JJ	XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer.	Oncogene	2016	10
7732003	3565	Stemme S	T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.	Proceedings of the National Academy of Sciences of the United States of America	1995	143
8637918	3565	Zhou LJ	CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells.	Proceedings of the National Academy of Sciences of the United States of America	1996	182
8674125	3565	Ho IC	The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4.	Cell	1996	140
9200435	3565	KaliÅski P	IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells.	Journal of immunology	1997	108
9590218	3565	Prescott SL	Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile.	Journal of immunology	1998	100
10323452	3565	Chabaud M	Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium.	Arthritis and rheumatism	1999	230
10441602	3565	Durham SR	Long-term clinical efficacy of grass-pollen immunotherapy.	The New England journal of medicine	1999	138
11035433	3565	Wong CK	Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus.	Lupus	2000	98
12241933	3565	Pombo DJ	Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.	Lancet	2002	113
12813022	3565	Zimmermann N	Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis.	The Journal of clinical investigation	2003	152
12874210	3565	Rodriguez PC	L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes.	Journal of immunology	2003	98
15173208	3565	Akdis M	Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells.	The Journal of experimental medicine	2004	180
15930352	3565	Yamanaka R	Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial.	Clinical cancer research 	2005	77
16083712	3565	Heller F	Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution.	Gastroenterology	2005	227
16192477	3565	Lowsky R	Protective conditioning for acute graft-versus-host disease.	The New England journal of medicine	2005	81
18266465	3565	Miller JL	The mannose receptor mediates dengue virus infection of macrophages.	PLoS pathogens	2008	89
18641314	3565	Avery DT	IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4.	Journal of immunology	2008	59
19191336	3565	Bai L	Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis.	Glia	2009	108
19604299	3565	Soroosh P	Th9 and allergic disease.	Immunology	2009	66
19800266	3565	Kitoh A	Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells.	Immunity	2009	60
20039421	3565	Colin EM	1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis.	Arthritis and rheumatism	2010	50
20357251	3565	Metenou S	At homeostasis filarial infections have expanded adaptive T regulatory but not classical Th2 cells.	Journal of immunology	2010	41
20483789	3565	Herbert DR	Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis.	Journal of immunology	2010	50
20620947	3565	Elo LL	Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming.	Immunity	2010	41
21060320	3565	Lloyd CM	Functions of T cells in asthma: more than just T(H)2 cells.	Nature reviews. Immunology	2010	106
21298112	3565	Purwar R	Resident memory T cells (T(RM)) are abundant in human lung: diversity, function, and antigen specificity.	PloS one	2011	71
21474644	3565	Tan HL	The Th17 pathway in cystic fibrosis lung disease.	American journal of respiratory and critical care medicine	2011	49
21898360	3565	Tanaka A	Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease.	Arthritis and rheumatism	2012	34
21918169	3565	Brunsvig PF	Telomerase peptide vaccination in NSCLC: a phase II trial in stage III patients vaccinated after chemoradiotherapy and an 8-year update on a phase I/II trial.	Clinical cancer research 	2011	38
22261031	3565	Clark RA	Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients.	Science translational medicine	2012	51
22385633	3565	Bossley CJ	Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines.	The Journal of allergy and clinical immunology	2012	43
22396530	3565	Ji Y	Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity.	The Journal of biological chemistry	2012	53
22484696	3565	Rao AJ	Revision joint replacement, wear particles, and macrophage polarization.	Acta biomaterialia	2012	35
22801446	3565	Gerdemann U	Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.	Molecular therapy 	2012	55
22922258	3565	Petrovas C	CD4 T follicular helper cell dynamics during SIV infection.	The Journal of clinical investigation	2012	120
23454746	3565	Karagiannis P	IgG4 subclass antibodies impair antitumor immunity in melanoma.	The Journal of clinical investigation	2013	33
23685836	3565	Rosenblatt J	Vaccination with dendritic cell/tumor fusions following autologous stem cell transplant induces immunologic and clinical responses in multiple myeloma patients.	Clinical cancer research 	2013	30
23757729	3565	Zhang H	Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer.	Blood	2013	31
23777851	3565	SuÃ¡rez-FariÃ±as M	Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.	The Journal of allergy and clinical immunology	2013	32
23803704	3565	Roep BO	Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8âº T cells in type 1 diabetes.	Science translational medicine	2013	28
24698730	3565	Jiang Z	Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis.	Immunology letters	2014	25
25350863	3565	Jackson DJ	IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.	American journal of respiratory and critical care medicine	2014	52
25662302	3565	Fajt ML	Asthma phenotypes and the use of biologic medications in asthma and allergic disease: the next steps toward personalized care.	The Journal of allergy and clinical immunology	2015	36
26383000	3565	Chung KF	Targeting the interleukin pathway in the treatment of asthma.	Lancet	2015	25
26410628	3565	Chen CY	Induction of Interleukin-9-Producing Mucosal Mast Cells Promotes Susceptibility to IgE-Mediated Experimental Food Allergy.	Immunity	2015	17
27618652	3565	Fujimura KE	Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation.	Nature medicine	2016	19
10556116	3567	Jatakanon A	Neutrophilic inflammation in severe persistent asthma.	American journal of respiratory and critical care medicine	1999	136
11191542	3567	Leckie MJ	Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.	Lancet	2000	224
12406833	3567	Flood-Page PT	Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway.	American journal of respiratory and critical care medicine	2003	117
15546393	3567	Wills-Karp M	Interleukin-13 in asthma pathogenesis.	Immunological reviews	2004	155
17872493	3567	Flood-Page P	A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.	American journal of respiratory and critical care medicine	2007	101
18344568	3567	Rothenberg ME	Treatment of patients with the hypereosinophilic syndrome with mepolizumab.	The New England journal of medicine	2008	90
19264686	3567	Haldar P	Mepolizumab and exacerbations of refractory eosinophilic asthma.	The New England journal of medicine	2009	279
19264687	3567	Nair P	Mepolizumab for prednisone-dependent asthma with sputum eosinophilia.	The New England journal of medicine	2009	221
19828470	3567	Straumann A	Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.	Gut	2010	80
21835135	3567	Assa'ad AH	An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis.	Gastroenterology	2011	58
21852542	3567	Castro M	Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study.	American journal of respiratory and critical care medicine	2011	90
22092535	3567	Molfino NA	Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.	Clinical and experimental allergy 	2012	45
22206777	3567	Spergel JM	Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial.	The Journal of allergy and clinical immunology	2012	78
22987325	3567	Sun YQ	Human pluripotent stem cell-derived mesenchymal stem cells prevent allergic airway inflammation in mice.	Stem cells	2012	35
23623266	3567	Otani IM	Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis.	The Journal of allergy and clinical immunology	2013	32
25208464	3567	Brightling CE	Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.	The Lancet. Respiratory medicine	2014	25
25736990	3567	Castro M	Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.	The Lancet. Respiratory medicine	2015	49
2444978	3569	Gauldie J	Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.	Proceedings of the National Academy of Sciences of the United States of America	1987	261
3491322	3569	Hirano T	Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.	Nature	1986	253
8562936	3569	Chauhan D	Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B.	Blood	1996	119
8939871	3569	Moore PS	Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.	Science	1996	242
9041933	3569	Tak PP	Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity.	Arthritis and rheumatism	1997	115
9389420	3569	Pickup JC	NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.	Diabetologia	1997	150
10815894	3569	Almand B	Clinical significance of defective dendritic cell differentiation in cancer.	Clinical cancer research 	2000	144
11831551	3569	Lenzlinger PM	The duality of the inflammatory response to traumatic brain injury.	Molecular neurobiology	2001	91
12220549	3569	Ishihara K	IL-6 in autoimmune disease and chronic inflammatory proliferative disease.	Cytokine and growth factor reviews	2002	126
12393667	3569	Silliman CC	Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.	Blood	2003	94
12857678	3569	Steensberg A	IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans.	American journal of physiology. Endocrinology and metabolism	2003	107
12932356	3569	Jego G	Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.	Immunity	2003	263
14567964	3569	Raper SE	Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.	Molecular genetics and metabolism	2003	272
15033490	3569	Wulster-Radcliffe MC	Adiponectin differentially regulates cytokines in porcine macrophages.	Biochemical and biophysical research communications	2004	95
15124018	3569	Nemeth E	IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.	The Journal of clinical investigation	2004	452
15196211	3569	Schaefer TM	Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells.	Immunology	2004	75
15598976	3569	Chen JJ	Tumor-associated macrophages: the double-edged sword in cancer progression.	Journal of clinical oncology 	2005	72
16012934	3569	Hart AL	Characteristics of intestinal dendritic cells in inflammatory bowel diseases.	Gastroenterology	2005	95
16046295	3569	Di Gregorio GB	Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone.	Diabetes	2005	111
16052591	3569	Roelofs MF	The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.	Arthritis and rheumatism	2005	72
16412224	3569	Baker AR	Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.	Cardiovascular diabetology	2006	121
16613757	3569	Bastard JP	Recent advances in the relationship between obesity, inflammation, and insulin resistance.	European cytokine network	2006	383
16801397	3569	Sumimoto H	The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells.	The Journal of experimental medicine	2006	128
16849509	3569	Levy O	The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn.	Journal of immunology	2006	71
16864705	3569	Angelone DF	Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo.	Pediatric research	2006	61
16927176	3569	KnÃ¼pfer H	Significance of interleukin-6 (IL-6) in breast cancer (review).	Breast cancer research and treatment	2007	108
16946190	3569	Pace TW	Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress.	The American journal of psychiatry	2006	172
16949415	3569	Andrews WW	The Alabama Preterm Birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants.	American journal of obstetrics and gynecology	2006	64
17085599	3569	Sato A	Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells.	Proceedings of the National Academy of Sciences of the United States of America	2006	88
17090751	3569	Creely SJ	Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.	American journal of physiology. Endocrinology and metabolism	2007	160
17569118	3569	Tedelind S	Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease.	World journal of gastroenterology	2007	62
17849470	3569	Hong DS	Interleukin-6 and its receptor in cancer: implications for translational therapeutics.	Cancer	2007	101
17932421	3569	Raffaghello L	Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche.	Stem cells	2008	81
18358926	3569	Smolen JS	Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.	Lancet	2008	229
18482990	3569	Cambi A	Dendritic cell interaction with Candida albicans critically depends on N-linked mannan.	The Journal of biological chemistry	2008	52
18577591	3569	Serada S	IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.	Proceedings of the National Academy of Sciences of the United States of America	2008	88
18728182	3569	Pichiorri F	MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2008	184
18759290	3569	Nile CJ	Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis.	Arthritis and rheumatism	2008	56
18776137	3569	Miao F	Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes.	Diabetes	2008	53
19073750	3569	Miller GE	Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later.	Psychosomatic medicine	2009	53
19111922	3569	O'Donovan A	Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women.	Brain, behavior, and immunity	2009	46
19268915	3569	Lindqvist D	Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.	Biological psychiatry	2009	93
19318968	3569	Tarantino G	Could inflammatory markers help diagnose nonalcoholic steatohepatitis?	European journal of gastroenterology and hepatology	2009	46
19321461	3569	Correale J	Immunomodulatory effects of Vitamin D in multiple sclerosis.	Brain 	2009	108
19348917	3569	Schaub B	Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells.	The Journal of allergy and clinical immunology	2009	63
19604260	3569	Nalbandian A	Interleukin-17 and systemic lupus erythematosus: current concepts.	Clinical and experimental immunology	2009	56
19648274	3569	Goodman WA	IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells.	Journal of immunology	2009	59
19738918	3569	Bilbo SD	Early-life programming of later-life brain and behavior: a critical role for the immune system.	Frontiers in behavioral neuroscience	2009	123
19828697	3569	Funderburg NT	Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation.	Blood	2010	89
19833726	3569	Roca H	CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization.	The Journal of biological chemistry	2009	128
19937696	3569	HÃ¶sel M	Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection.	Hepatology	2009	72
19997642	3569	Yoshimura T	Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases.	PloS one	2009	67
20032961	3569	Murugan R	Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival.	Kidney international	2010	66
20052801	3569	Qin Z	Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes.	Journal of leukocyte biology	2010	62
20112381	3569	Illei GG	Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.	Arthritis and rheumatism	2010	78
20176930	3569	Cole SW	Computational identification of gene-social environment interaction at the human IL6 locus.	Proceedings of the National Academy of Sciences of the United States of America	2010	91
20215499	3569	Germano G	Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.	Cancer research	2010	52
20230889	3569	Boksa P	Effects of prenatal infection on brain development and behavior: a review of findings from animal models.	Brain, behavior, and immunity	2010	114
20446847	3569	Kalayjian RC	Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.	The Journal of infectious diseases	2010	56
20629534	3569	Cassol E	Persistent microbial translocation and immune activation in HIV-1-infected South Africans receiving combination antiretroviral therapy.	The Journal of infectious diseases	2010	73
20734355	3569	Zhang QZ	Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing.	Stem cells	2010	81
20846162	3569	Crop MJ	Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells.	Clinical and experimental immunology	2010	48
21245574	3569	Hassman LM	KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.	The Journal of clinical investigation	2011	36
21321193	3569	Chihara N	Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.	Proceedings of the National Academy of Sciences of the United States of America	2011	47
21346738	3569	Conti HR	New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome.	Mucosal immunology	2011	41
21364186	3569	Schenk U	ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors.	Science signaling	2011	46
21377916	3569	Neurath MF	IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer.	Cytokine and growth factor reviews	2011	102
21505312	3569	Marchetti G	Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count.	AIDS	2011	64
21519361	3569	Begue B	Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease.	The American journal of gastroenterology	2011	40
21576701	3569	Piconi S	Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.	Blood	2011	50
21726511	3569	Sandler NG	Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.	Gastroenterology	2011	90
21784145	3569	Kiecolt-Glaser JK	Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial.	Brain, behavior, and immunity	2011	41
21801431	3569	Chen DY	Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-Î± therapy.	Arthritis research and therapy	2011	36
21801830	3569	Pace TW	Increased peripheral NF-ÎºB pathway activity in women with childhood abuse-related posttraumatic stress disorder.	Brain, behavior, and immunity	2012	42
21809006	3569	Niu Q	Disturbed Th17/Treg balance in patients with rheumatoid arthritis.	Rheumatology international	2012	33
21910626	3569	Tanaka T	Therapeutic targeting of the interleukin-6 receptor.	Annual review of pharmacology and toxicology	2012	56
21964948	3569	Zeng C	The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications.	Journal of molecular medicine	2012	36
22022504	3569	Lee N	Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults.	PloS one	2011	41
22146091	3569	Pervanidou P	Metabolic consequences of stress during childhood and adolescence.	Metabolism	2012	45
22184247	3569	Gibbs JE	The nuclear receptor REV-ERBÎ± mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines.	Proceedings of the National Academy of Sciences of the United States of America	2012	108
22187279	3569	Boomer JS	Immunosuppression in patients who die of sepsis and multiple organ failure.	JAMA	2011	264
22334567	3569	Antoniades CG	Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humans.	Hepatology	2012	46
22876722	3569	Paulsen G	Leucocytes, cytokines and satellite cells: what role do they play in muscle damage and regeneration following eccentric exercise?	Exercise immunology review	2012	51
22883707	3569	Rincon M	Interleukin-6: from an inflammatory marker to a target for inflammatory diseases.	Trends in immunology	2012	40
23065151	3569	Funderburg NT	Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome.	Blood	2012	73
23071313	3569	Rossato M	IL-10-induced microRNA-187 negatively regulates TNF-Î±, IL-6, and IL-12p40 production in TLR4-stimulated monocytes.	Proceedings of the National Academy of Sciences of the United States of America	2012	39
23332012	3569	Longenecker CT	Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.	HIV medicine	2013	52
23349310	3569	Melief SM	Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6.	Haematologica	2013	29
23363979	3569	Schneider A	In active relapsing-remitting multiple sclerosis, effector T cell resistance to adaptive T(regs) involves IL-6-mediated signaling.	Science translational medicine	2013	28
23536012	3569	Khandpur R	NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis.	Science translational medicine	2013	153
23559466	3569	Erlandson KM	Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy.	The Journal of infectious diseases	2013	46
23784932	3569	Reinartz S	Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse.	International journal of cancer	2014	38
24076269	3569	Yao X	Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.	Pharmacology and therapeutics	2014	59
24378753	3569	Noel N	Elevated IP10 levels are associated with immune activation and low CD4âº T-cell counts in HIV controller patients.	AIDS	2014	28
24667956	3569	Maude SL	Managing cytokine release syndrome associated with novel T cell-engaging therapies.	Cancer journal	2014	62
24795473	3569	Tenorio AR	Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.	The Journal of infectious diseases	2014	99
24819450	3569	Trayhurn P	Hypoxia and adipocyte physiology: implications for adipose tissue dysfunction in obesity.	Annual review of nutrition	2014	26
24876563	3569	Lee DW	Current concepts in the diagnosis and management of cytokine release syndrome.	Blood	2014	124
25084831	3569	Darcy CJ	Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients.	Critical care	2014	20
25174587	3569	Wang QS	Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia.	Molecular therapy 	2015	28
25317870	3569	Maude SL	Chimeric antigen receptor T cells for sustained remissions in leukemia.	The New England journal of medicine	2014	447
25341798	3569	McLaughlin T	T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans.	Arteriosclerosis, thrombosis, and vascular biology	2014	31
25387317	3569	Somsouk M	Gut epithelial barrier and systemic inflammation during chronic HIV infection.	AIDS	2015	26
25505246	3569	Park H	MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins.	The Journal of biological chemistry	2015	26
25583168	3569	Hileman CO	Differential Reduction in Monocyte Activation and Vascular Inflammation With Integrase Inhibitor-Based Initial Antiretroviral Therapy Among HIV-Infected Individuals.	The Journal of infectious diseases	2015	16
25802036	3569	de Vrij J	Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.	International journal of cancer	2015	18
25849830	3569	Couturier J	Human adipose tissue as a reservoir for memory CD4+ T cells and HIV.	AIDS	2015	16
25898198	3569	Hunter CA	IL-6 as a keystone cytokine in health and disease.	Nature immunology	2015	100
25992861	3569	Hirahara K	Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity.	Immunity	2015	17
26428501	3569	Kim CJ	Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance.	American journal of obstetrics and gynecology	2015	26
26435067	3569	Wang D	The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.	Cellular and molecular immunology	2017	9
27070405	3569	Coughlin JM	In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using (11)CDPA-713 PET and analysis of CSF and plasma.	Translational psychiatry	2016	14
27207799	3569	Brudno JN	Toxicities of chimeric antigen receptor T cells: recognition and management.	Blood	2016	24
11342421	3574	Fry TJ	A potential role for interleukin-7 in T-cell homeostasis.	Blood	2001	113
15630452	3574	Wang FX	IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.	The Journal of clinical investigation	2005	94
16461915	3574	Malaspina A	Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7.	Proceedings of the National Academy of Sciences of the United States of America	2006	81
16699374	3574	Rosenberg SA	IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells.	Journal of immunotherapy	2006	119
18431516	3574	Monti P	Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells.	The Journal of clinical investigation	2008	50
19060209	3574	Catalfamo M	HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells.	Proceedings of the National Academy of Sciences of the United States of America	2008	54
19167470	3574	Raqib R	Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh.	Toxicology letters	2009	56
19380868	3574	Sereti I	IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.	Blood	2009	115
20062065	3574	Liu X	Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease.	Nature medicine	2010	45
20068111	3574	SportÃ¨s C	Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.	Clinical cancer research 	2010	49
20543139	3574	Irish JM	B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
21422987	3574	Lewin SR	HIV cure and eradication: how will we get from the laboratory to effective clinical trials?	AIDS	2011	40
21508983	3574	Mackall CL	Harnessing the biology of IL-7 for therapeutic application.	Nature reviews. Immunology	2011	107
21795588	3574	Lee LF	IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-Î² in multiple sclerosis.	Science translational medicine	2011	36
21946256	3574	Lee JC	Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis.	The Journal of clinical investigation	2011	43
22550117	3574	LÃ©vy Y	Effects of recombinant human interleukin 7 on T-cell recovery and thymic output in HIV-infected patients receiving antiretroviral therapy: results of a phase I/IIa randomized, placebo-controlled, multicenter study.	Clinical infectious diseases 	2012	65
23053510	3574	Venet F	IL-7 restores lymphocyte functions in septic patients.	Journal of immunology	2012	36
23160470	3574	Cieri N	IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors.	Blood	2013	91
24067565	3574	Boomer JS	The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?	Virulence	2014	32
24585897	3574	Shive CL	Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.	The Journal of infectious diseases	2014	25
24766814	3574	Bendall SC	Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development.	Cell	2014	110
25957683	3574	Cui G	IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity.	Cell	2015	39
26738796	3574	Singh N	Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies.	Science translational medicine	2016	10
1281554	3576	Koch AE	Interleukin-8 as a macrophage-derived mediator of angiogenesis.	Science	1992	310
2648569	3576	Larsen CG	The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.	Science	1989	172
3260265	3576	Matsushima K	Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.	The Journal of experimental medicine	1988	186
3480540	3576	Yoshimura T	Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.	Proceedings of the National Academy of Sciences of the United States of America	1987	175
8036519	3576	Cacalano G	Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog.	Science	1994	159
8564092	3576	Keatings VM	Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.	American journal of respiratory and critical care medicine	1996	230
9143704	3576	Baggiolini M	Human chemokines: an update.	Annual review of immunology	1997	324
11179105	3576	Aaron SD	Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.	American journal of respiratory and critical care medicine	2001	90
11489059	3576	Baggiolini M	Chemokines in pathology and medicine.	Journal of internal medicine	2001	114
11744011	3576	Frangogiannis NG	The inflammatory response in myocardial infarction.	Cardiovascular research	2002	361
12091913	3576	Li Jeon N	Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device.	Nature biotechnology	2002	182
15337792	3576	Cosio BG	Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages.	The Journal of experimental medicine	2004	85
15534087	3576	Benoy IH	Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.	Clinical cancer research 	2004	72
16195477	3576	Henrichot E	Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?	Arteriosclerosis, thrombosis, and vascular biology	2005	77
16892062	3576	Hanna J	Decidual NK cells regulate key developmental processes at the human fetal-maternal interface.	Nature medicine	2006	268
17141434	3576	Pulskamp K	Carbon nanotubes show no sign of acute toxicity but induce intracellular reactive oxygen species in dependence on contaminants.	Toxicology letters	2007	105
19667085	3576	Nasser MW	Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.	Journal of immunology	2009	49
20049649	3576	Bucki R	Cathelicidin LL-37: a multitask antimicrobial peptide.	Archivum immunologiae et therapiae experimentalis	2010	46
20092409	3576	Jain SK	Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?	Antioxidants and redox signaling	2010	51
21060150	3576	Bergin DA	Î±-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8.	The Journal of clinical investigation	2010	46
21190185	3576	Trellakis S	Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease.	International journal of cancer	2011	39
21731723	3576	Zimmermann HW	Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.	PloS one	2011	54
21741942	3576	Bekes EM	Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation.	The American journal of pathology	2011	51
22702508	3576	Nair P	Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial.	Clinical and experimental allergy 	2012	48
22925812	3576	Motomura T	Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment.	Journal of hepatology	2013	59
24291763	3576	Mohamed MM	Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties.	The international journal of biochemistry and cell biology	2014	22
24608042	3576	Fang W	Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.	Carcinogenesis	2014	21
24955983	3576	Green BJ	Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.	PloS one	2014	26
25242415	3576	Gibbons D	Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants.	Nature medicine	2014	28
25377785	3576	Ponce DM	High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.	Blood	2015	23
25619830	3576	Visciano C	Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway.	Oncogene	2015	17
1371884	3586	Rousset F	Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.	Proceedings of the National Academy of Sciences of the United States of America	1992	240
7603570	3586	Chen Y	Peripheral deletion of antigen-reactive T cells in oral tolerance.	Nature	1995	115
10677520	3586	Kotenko SV	Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10).	Proceedings of the National Academy of Sciences of the United States of America	2000	139
11095260	3586	van den Biggelaar AH	Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10.	Lancet	2000	112
11208863	3586	Dhodapkar MV	Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells.	The Journal of experimental medicine	2001	224
11342442	3586	Cooper MA	Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.	Blood	2001	248
11773404	3586	Spencer JV	Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10.	Journal of virology	2002	89
12359728	3586	van der Kleij D	A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization.	The Journal of biological chemistry	2002	113
12438424	3586	Levings MK	Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.	The Journal of experimental medicine	2002	90
12773629	3586	Asadullah K	Interleukin-10 therapy--review of a new approach.	Pharmacological reviews	2003	170
14755342	3586	Arif S	Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.	The Journal of clinical investigation	2004	112
14978133	3586	Nouri-Aria KT	Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.	Journal of immunology	2004	75
15036232	3586	Baecher-Allan C	Human CD4+CD25+ regulatory T cells.	Seminars in immunology	2004	91
15070757	3586	Verreck FA	Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.	Proceedings of the National Academy of Sciences of the United States of America	2004	192
15128934	3586	Granelli-Piperno A	HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation.	Proceedings of the National Academy of Sciences of the United States of America	2004	90
15514012	3586	Beyth S	Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness.	Blood	2005	218
15529255	3586	Kanto T	Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection.	The Journal of infectious diseases	2004	71
15765388	3586	O'Mahony L	Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles.	Gastroenterology	2005	212
15818686	3586	Ikeuchi H	Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine.	Arthritis and rheumatism	2005	84
15879155	3586	Netea MG	Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release.	Journal of immunology	2005	78
15919939	3586	Rushbrook SM	Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection.	Journal of virology	2005	79
15919940	3586	Boettler T	T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.	Journal of virology	2005	115
16341266	3586	Xystrakis E	Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients.	The Journal of clinical investigation	2006	124
17234458	3586	Chen X	CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.	Clinical immunology	2007	79
17336072	3586	Blackburn SD	IL-10, T cell exhaustion and viral persistence.	Trends in microbiology	2007	69
17475834	3586	Duddy M	Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis.	Journal of immunology	2007	136
17785865	3586	Damjanovic AK	Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients.	Journal of immunology	2007	130
17900301	3586	Boniface K	A role for T cell-derived interleukin 22 in psoriatic skin inflammation.	Clinical and experimental immunology	2007	64
18345021	3586	Wells JM	Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria.	Nature reviews. Microbiology	2008	115
18430198	3586	Karanikas V	Foxp3 expression in human cancer cells.	Journal of translational medicine	2008	57
18467372	3586	Robinson K	Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses.	Gut	2008	55
18509436	3586	Mazmanian SK	A microbial symbiosis factor prevents intestinal inflammatory disease.	Nature	2008	507
18613849	3586	Allan SE	CD4+ T-regulatory cells: toward therapy for human diseases.	Immunological reviews	2008	67
18701085	3586	Maroof A	Posttranscriptional regulation of II10 gene expression allows natural killer cells to express immunoregulatory function.	Immunity	2008	62
19124525	3586	Gonzalez-Rey E	Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis.	Annals of the rheumatic diseases	2010	92
19136511	3586	Gonzalez-Rey E	Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis.	Gut	2009	162
19333946	3586	GonzÃ¡lez MA	Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells.	Arthritis and rheumatism	2009	112
19349988	3586	Noguchi E	A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1.	Nature immunology	2009	62
19528258	3586	Campbell JD	Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression.	The Journal of experimental medicine	2009	62
19895848	3586	Heo YJ	IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients.	Immunology letters	2010	43
19902470	3586	Vuk-PavloviÄ S	Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.	The Prostate	2010	75
20047977	3586	Skibola CF	Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.	American journal of epidemiology	2010	59
20213444	3586	Goyette J	Inflammation-associated S100 proteins: new mechanisms that regulate function.	Amino acids	2011	65
20661303	3586	Van Grol J	HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3.	PloS one	2010	42
20809522	3586	Bouaziz JD	IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro.	European journal of immunology	2010	66
20889800	3586	O'Leary S	IL-10 blocks phagosome maturation in mycobacterium tuberculosis-infected human macrophages.	American journal of respiratory cell and molecular biology	2011	60
21254163	3586	Zhang Z	Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients.	Hepatology	2011	44
21262918	3586	Benjamin JL	Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.	Gut	2011	39
21712423	3586	Miyazaki Y	Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis.	International immunology	2011	39
21881130	3586	Gautam S	IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis.	The Journal of infectious diseases	2011	47
22222887	3586	Peterson RA	Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression.	Toxicologic pathology	2012	48
22223212	3586	Frangogiannis NG	Regulation of the inflammatory response in cardiac repair.	Circulation research	2012	163
22225835	3586	Boks MA	IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction--a comparative study of human clinical-applicable DC.	Clinical immunology	2012	44
22236434	3586	Glocker EO	IL-10 and IL-10 receptor defects in humans.	Annals of the New York Academy of Sciences	2011	45
22438968	3586	Li X	IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines.	PloS one	2012	40
22464647	3586	Senti G	Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.	The Journal of allergy and clinical immunology	2012	34
22535664	3586	Banchereau J	The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming.	Blood	2012	36
22547651	3586	Chu CC	Resident CD141 (BDCA3)+ dendritic cells in human skin produce IL-10 and induce regulatory T cells that suppress skin inflammation.	The Journal of experimental medicine	2012	68
22586040	3586	Swaminathan S	Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression.	Journal of immunology	2012	38
22972930	3586	Das A	IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection.	Journal of immunology	2012	57
23246690	3586	Lech M	Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair.	Biochimica et biophysica acta	2013	49
23712682	3586	Melief SM	Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages.	Stem cells	2013	45
23764929	3586	Arihara F	Increase in CD14+HLA-DR -/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis.	Cancer immunology, immunotherapy 	2013	27
23798430	3586	Curtale G	Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b.	Proceedings of the National Academy of Sciences of the United States of America	2013	45
24089515	3586	van Lummel M	Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes.	Diabetes	2014	30
24213679	3586	Whiteside TL	Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?	Cancer immunology, immunotherapy 	2014	40
24415936	3586	Jagannathan P	IFNÎ³/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children.	PLoS pathogens	2014	35
24712468	3586	Finlay CM	Induction of regulatory cells by helminth parasites: exploitation for the treatment of inflammatory diseases.	Immunological reviews	2014	24
24712469	3586	Kleinewietfeld M	Regulatory T cells in autoimmune neuroinflammation.	Immunological reviews	2014	27
24712471	3586	Candando KM	B10 cell regulation of health and disease.	Immunological reviews	2014	38
24773202	3586	West CE	The gut microbiota and its role in the development of allergic disease: a wider perspective.	Clinical and experimental allergy 	2015	18
24939426	3586	Arif S	Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes.	Diabetes	2014	30
25034146	3586	Peng Y	Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.	Leukemia	2015	28
25365074	3586	Akdis CA	Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs.	The Journal of clinical investigation	2014	24
26071023	3586	Mauri C	The expanding family of regulatory B cells.	International immunology	2015	25
26463422	3586	Melenotte C	B-cell non-Hodgkin lymphoma linked to Coxiella burnetii.	Blood	2016	10
26849074	3586	Najar M	The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network.	Journal of immunotherapy	2016	15
11133738	3600	Fehniger TA	Interleukin 15: biology and relevance to human disease.	Blood	2001	175
12949719	3600	Mention JJ	Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease.	Gastroenterology	2003	83
15536127	3600	Ferlazzo G	Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs.	Proceedings of the National Academy of Sciences of the United States of America	2004	117
18981132	3600	Krutzik SR	IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway.	Journal of immunology	2008	64
20428207	3600	Hoyos V	Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety.	Leukemia	2010	100
20703455	3600	Iliopoulou EG	A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.	Cancer immunology, immunotherapy 	2010	47
21123821	3600	Wang X	Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice.	Blood	2011	57
22032984	3600	Steel JC	Interleukin-15 biology and its therapeutic implications in cancer.	Trends in pharmacological sciences	2012	66
24648340	3600	Mlecnik B	Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients.	Science translational medicine	2014	31
25403209	3600	Conlon KC	Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.	Journal of clinical oncology 	2015	62
17371945	3604	Wolfl M	Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities.	Blood	2007	69
18645038	3604	Hippen KL	Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.	Blood	2008	54
19211796	3604	Carpenito C	Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains.	Proceedings of the National Academy of Sciences of the United States of America	2009	211
19384291	3604	Milone MC	Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo.	Molecular therapy 	2009	216
21193697	3604	Kohrt HE	CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.	Blood	2011	69
21546571	3604	Song DG	In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB).	Cancer research	2011	56
21830940	3604	Porter DL	Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.	The New England journal of medicine	2011	746
21832238	3604	Kalos M	T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.	Science translational medicine	2011	536
22326955	3604	Kohrt HE	Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.	The Journal of clinical investigation	2012	61
24045181	3604	Ye Q	CD137 accurately identifies and enriches for naturally occurring tumor-reactive T cells in tumor.	Clinical cancer research 	2014	24
25823737	3604	StevanoviÄ S	Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells.	Journal of clinical oncology 	2015	48
26885860	3604	Kawalekar OU	Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells.	Immunity	2016	37
8676080	3605	Fossiez F	T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.	The Journal of experimental medicine	1996	323
9973514	3605	Laan M	Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways.	Journal of immunology	1999	238
10335518	3605	Matusevicius D	Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis.	Multiple sclerosis	1999	175
11781375	3605	Aggarwal S	IL-17: prototype member of an emerging cytokine family.	Journal of leukocyte biology	2002	127
12354389	3605	Nakae S	Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses.	Immunity	2002	289
12477762	3605	Fujino S	Increased expression of interleukin 17 in inflammatory bowel disease.	Gut	2003	356
15642151	3605	Lubberts E	The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models.	Arthritis research and therapy	2005	91
17083726	3605	Bullens DM	IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx?	Respiratory research	2006	114
17486092	3605	Acosta-Rodriguez EV	Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells.	Nature immunology	2007	484
17635957	3605	Annunziato F	Phenotypic and functional features of human Th17 cells.	The Journal of experimental medicine	2007	481
17965778	3605	Burlingham WJ	IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.	The Journal of clinical investigation	2007	147
18156204	3605	Tzartos JS	Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.	The American journal of pathology	2008	250
18311821	3605	Nistala K	Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers.	Arthritis and rheumatism	2008	72
18373953	3605	Wong CK	Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity.	Clinical immunology	2008	113
18432274	3605	Koga C	Possible pathogenic role of Th17 cells for atopic dermatitis.	The Journal of investigative dermatology	2008	71
18613831	3605	Tesmer LA	Th17 cells in human disease.	Immunological reviews	2008	186
18615114	3605	Eyerich K	Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.	The Journal of investigative dermatology	2008	57
18617638	3605	Koenen HJ	Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells.	Blood	2008	177
18655770	3605	Zhang B	The prevalence of Th17 cells in patients with gastric cancer.	Biochemical and biophysical research communications	2008	71
18663128	3605	Cosmi L	Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor.	The Journal of experimental medicine	2008	192
18669891	3605	Dhodapkar KM	Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.	Blood	2008	53
18684981	3605	Sakai A	Identification of IL-18 and Th17 cells in salivary glands of patients with SjÃ¶gren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18.	Journal of immunology	2008	61
18719207	3605	Gaffen SL	A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17.	Journal of dental research	2008	70
18832156	3605	Miyahara Y	Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer.	Proceedings of the National Academy of Sciences of the United States of America	2008	75
19014637	3605	Zhu X	IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines.	Breast cancer research 	2008	66
19029905	3605	Cupedo T	Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells.	Nature immunology	2009	149
19050297	3605	CrispÃ­n JC	Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.	Journal of immunology	2008	163
19155469	3605	Chauhan SK	Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression.	Journal of immunology	2009	74
19177575	3605	Lemmers A	The interleukin-17 pathway is involved in human alcoholic liver disease.	Hepatology	2009	91
19244159	3605	Hughes T	Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22.	Blood	2009	54
19265168	3605	Shahrara S	IL-17 induces monocyte migration in rheumatoid arthritis.	Journal of immunology	2009	47
19273860	3605	Voo KS	Identification of IL-17-producing FOXP3+ regulatory T cells in humans.	Proceedings of the National Academy of Sciences of the United States of America	2009	198
19322214	3605	Di Cesare A	The IL-23/Th17 axis in the immunopathogenesis of psoriasis.	The Journal of investigative dermatology	2009	155
19325128	3605	Evans HG	In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses.	Proceedings of the National Academy of Sciences of the United States of America	2009	53
19329213	3605	Zhang JP	Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients.	Journal of hepatology	2009	124
19404966	3605	Yang J	Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.	Arthritis and rheumatism	2009	101
19410689	3605	Louten J	Development and function of TH17 cells in health and disease.	The Journal of allergy and clinical immunology	2009	63
19439349	3605	Nograles KE	IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells.	The Journal of allergy and clinical immunology	2009	106
19439651	3605	Ayyoub M	Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t.	Proceedings of the National Academy of Sciences of the United States of America	2009	86
19479869	3605	Shen H	Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis.	Arthritis and rheumatism	2009	96
19487306	3605	Ortega C	IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.	Journal of leukocyte biology	2009	56
19620772	3605	Pitta MG	IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani.	The Journal of clinical investigation	2009	62
19700754	3605	Katsifis GE	Systemic and local interleukin-17 and linked cytokines associated with SjÃ¶gren's syndrome immunopathogenesis.	The American journal of pathology	2009	54
19701202	3605	Wu S	A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses.	Nature medicine	2009	321
19737863	3605	Taleb S	Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis.	The Journal of experimental medicine	2009	95
19748982	3605	Bradshaw EM	Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells.	Journal of immunology	2009	80
19798029	3605	van den Berg WB	IL-17 as a future therapeutic target for rheumatoid arthritis.	Nature reviews. Rheumatology	2009	82
19844129	3605	Zhao Y	Th17 immunity in patients with allergic asthma.	International archives of allergy and immunology	2010	54
19902483	3605	Kuang DM	Activated monocytes in peritumoral stroma of hepatocellular carcinoma promote expansion of memory T helper 17 cells.	Hepatology	2010	60
19936899	3605	Eastaff-Leung N	Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.	Journal of clinical immunology	2010	74
20022135	3605	Chen X	Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients.	Lung cancer	2010	45
20032993	3605	Kagami S	Circulating Th17, Th22, and Th1 cells are increased in psoriasis.	The Journal of investigative dermatology	2010	109
20127485	3605	Lubberts E	Th17 cytokines and arthritis.	Seminars in immunopathology	2010	42
20200272	3605	Hueber AJ	Mast cells express IL-17A in rheumatoid arthritis synovium.	Journal of immunology	2010	94
20485275	3605	O'Connor W Jr	The dual nature of T(H)17 cells: shifting the focus to function.	Nature immunology	2010	50
20592279	3605	Honkanen J	IL-17 immunity in human type 1 diabetes.	Journal of immunology	2010	66
20664052	3605	Noonan K	A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.	Blood	2010	43
20810982	3605	Marwaha AK	Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes.	Journal of immunology	2010	48
21145847	3605	Kuang DM	Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma.	Journal of hepatology	2011	77
21147109	3605	Hovhannisyan Z	Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.	Gastroenterology	2011	73
21306467	3605	Toldi G	Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia.	American journal of reproductive immunology	2011	39
21357259	3605	Kryczek I	IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer.	Journal of immunology	2011	74
21419481	3605	Guttman-Yassky E	Contrasting pathogenesis of atopic dermatitis and psoriasis--part II: immune cell subsets and therapeutic concepts.	The Journal of allergy and clinical immunology	2011	49
21505189	3605	Caccamo N	Differentiation, phenotype, and function of interleukin-17-producing human VÎ³9VÎ´2 T cells.	Blood	2011	57
21606249	3605	Lin AM	Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis.	Journal of immunology	2011	121
21654831	3605	Bovenschen HJ	Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.	The Journal of investigative dermatology	2011	47
21762495	3605	Liu B	Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration.	Journal of translational medicine	2011	46
21828034	3605	Zijlstra GJ	Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells.	The European respiratory journal	2012	34
21968742	3605	Noordenbos T	Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis.	Arthritis and rheumatism	2012	40
22362575	3605	Raychaudhuri SP	Role of IL-17 in psoriasis and psoriatic arthritis.	Clinical reviews in allergy and immunology	2013	31
22643849	3605	Klatt NR	Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection.	Mucosal immunology	2012	66
22677045	3605	Krueger JG	IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis.	The Journal of allergy and clinical immunology	2012	43
22951056	3605	Gittler JK	Progressive activation of T(H)2/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis.	The Journal of allergy and clinical immunology	2012	55
23054412	3605	Amedei A	Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma.	Internal and emergency medicine	2014	28
23255555	3605	Cosgrove C	Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.	Blood	2013	59
23596310	3605	Zizzo G	IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids.	Journal of immunology	2013	28
23683514	3605	Nanzer AM	Enhanced production of IL-17A in patients with severe asthma is inhibited by 1Î±,25-dihydroxyvitamin D3 in a glucocorticoid-independent fashion.	The Journal of allergy and clinical immunology	2013	33
23774107	3605	Geremia A	Innate and adaptive immunity in inflammatory bowel disease.	Autoimmunity reviews	2014	84
24060272	3605	Brandt EB	Diesel exhaust particle induction of IL-17A contributes to severe asthma.	The Journal of allergy and clinical immunology	2013	42
24097227	3605	Ueno A	Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.	Inflammatory bowel diseases	2013	38
24310226	3605	Benedetti G	Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis.	European journal of immunology	2014	22
24509084	3605	Sanchez Rodriguez R	Memory regulatory T cells reside in human skin.	The Journal of clinical investigation	2014	38
24585899	3605	Byakwaga H	The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy.	The Journal of infectious diseases	2014	28
24655820	3605	Lynde CW	Interleukin 17A: toward a new understanding of psoriasis pathogenesis.	Journal of the American Academy of Dermatology	2014	25
24679469	3605	Sofen H	Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis.	The Journal of allergy and clinical immunology	2014	24
24858580	3605	Martin JC	Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus.	Clinical immunology	2014	27
25162311	3605	ChesnÃ© J	IL-17 in severe asthma. Where do we stand?	American journal of respiratory and critical care medicine	2014	27
25234818	3605	Taleb S	IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles.	Arteriosclerosis, thrombosis, and vascular biology	2015	21
25660949	3605	Rei M	The emerging Protumor role of Î³Î´ T lymphocytes: implications for cancer immunotherapy.	Cancer research	2015	18
25697599	3605	Siebert S	Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases.	Pharmacological reviews	2015	26
25751065	3605	Magalhaes I	Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.	The Journal of clinical investigation	2015	31
25961452	3605	Burkett PR	Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.	The Journal of clinical investigation	2015	24
26829644	3605	Ryan ES	Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques.	PLoS pathogens	2016	13
12186837	3620	Terness P	Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.	The Journal of experimental medicine	2002	186
12228717	3620	Munn DH	Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.	Science	2002	191
15001472	3620	Meisel R	Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.	Blood	2004	349
15459668	3620	Mellor AL	IDO expression by dendritic cells: tolerance and tryptophan catabolism.	Nature reviews. Immunology	2004	495
16237046	3620	Mellor AL	Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling.	Journal of immunology	2005	96
16489067	3620	Brandacher G	Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.	Clinical cancer research 	2006	100
17158233	3620	Boasso A	HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.	Blood	2007	116
18832696	3620	Chen W	The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.	Journal of immunology	2008	118
20484731	3620	Favre D	Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease.	Science translational medicine	2010	176
21873989	3620	Balachandran VP	Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido.	Nature medicine	2011	125
22068654	3620	Godin-Ethier J	Indoleamine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives.	Clinical cancer research 	2011	49
22182446	3620	Li T	Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO.	Cancer letters	2012	33
22201909	3620	Munn DH	Blocking IDO activity to enhance anti-tumor immunity.	Frontiers in bioscience	2012	39
22932670	3620	Wainwright DA	IDO expression in brain tumors increases the recruitment of regulatory T cells and negatively impacts survival.	Clinical cancer research 	2012	57
23440412	3620	Yu J	Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.	Journal of immunology	2013	78
24147117	3620	Jenabian MA	Distinct tryptophan catabolism and Th17/Treg balance in HIV progressors and elite controllers.	PloS one	2013	26
24218513	3620	Iversen TZ	Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenase.	Clinical cancer research 	2014	22
24976919	3620	Mangge H	Antioxidants, inflammation and cardiovascular disease.	World journal of cardiology	2014	35
26214521	3620	Melief CJ	Therapeutic cancer vaccines.	The Journal of clinical investigation	2015	36
26411680	3620	Holmgaard RB	Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner.	Cell reports	2015	27
3018187	3684	Giulian D	Characterization of ameboid microglia isolated from developing mammalian brain.	The Journal of neuroscience 	1986	182
12208882	3684	Santoso S	The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1.	The Journal of experimental medicine	2002	90
14593498	3684	Serafini P	Derangement of immune responses by myeloid suppressor cells.	Cancer immunology, immunotherapy 	2004	82
15488763	3684	Yang L	Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.	Cancer cell	2004	324
16424180	3684	Hayakawa Y	CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity.	Journal of immunology	2006	188
18509085	3684	Pluskota E	Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticles.	Blood	2008	51
22110167	3684	Griffin DO	A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus.	The Journal of experimental medicine	2011	46
22156198	3684	Pillay J	A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1.	The Journal of clinical investigation	2012	113
22222080	3684	Lee WW	PET/MRI of inflammation in myocardial infarction.	Journal of the American College of Cardiology	2012	56
22315352	3684	John LB	Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer.	Cancer research	2012	30
22959433	3684	Ugel S	Immune tolerance to tumor antigens occurs in a specialized environment of the spleen.	Cell reports	2012	54
23271806	3684	Predina J	Changes in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgery.	Proceedings of the National Academy of Sciences of the United States of America	2013	28
23321256	3684	GÃ¶rgÃ¼n GT	Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans.	Blood	2013	53
23460744	3684	Ramachandran IR	Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow.	Journal of immunology	2013	36
23754403	3684	DuMont AL	Staphylococcus aureus LukAB cytotoxin kills human neutrophils by targeting the CD11b subunit of the integrin Mac-1.	Proceedings of the National Academy of Sciences of the United States of America	2013	50
23794437	3684	Fullerton JN	Pathways mediating resolution of inflammation: when enough is too much.	The Journal of pathology	2013	28
23828240	3684	Lu-Emerson C	Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma.	Neuro-oncology	2013	32
24741628	3684	Khaled YS	Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients.	Journal of immunology research	2014	27
27030272	3684	Avalos CR	Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques.	Journal of virology	2016	11
9430220	3805	Valiante NM	Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors.	Immunity	1997	138
9430221	3805	Uhrberg M	Human diversity in killer cell inhibitory receptor genes.	Immunity	1997	200
10381530	3805	Ruggeri L	Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.	Blood	1999	126
12689936	3805	Giebel S	Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.	Blood	2003	97
15477349	3805	Hiby SE	Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success.	The Journal of experimental medicine	2004	198
15719024	3805	Parham P	MHC class I molecules and KIRs in human history, health and survival.	Nature reviews. Immunology	2005	298
16533882	3805	Yawata M	Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.	The Journal of experimental medicine	2006	134
16824023	3805	Bashirova AA	The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense.	Annual review of genomics and human genetics	2006	85
16901727	3805	Anfossi N	Human NK cell education by inhibitory receptors for MHC class I.	Immunity	2006	299
17100885	3805	Khakoo SI	KIR and disease: a model system or system of models?	Immunological reviews	2006	70
17317850	3805	Miller JS	Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.	Blood	2007	80
18583565	3805	Yawata M	MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.	Blood	2008	103
18635379	3805	Kulkarni S	The Yin and Yang of HLA and KIR in human disease.	Seminars in immunology	2008	99
18650461	3805	Caligiuri MA	Human natural killer cells.	Blood	2008	359
20028428	3805	Middleton D	The extensive polymorphism of KIR genes.	Immunology	2010	53
20972337	3805	Hiby SE	Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.	The Journal of clinical investigation	2010	105
21219175	3805	Bashirova AA	HLA/KIR restraint of HIV: surviving the fittest.	Annual review of immunology	2011	45
21708957	3805	Platonova S	Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma.	Cancer research	2011	70
22863621	3805	Tarek N	Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.	The Journal of clinical investigation	2012	61
23002117	3805	Vey N	A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission.	Blood	2012	64
23033266	3805	Benson DM Jr	A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.	Blood	2012	61
25999435	3805	Benson DM Jr	A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma.	Clinical cancer research 	2015	20
2161532	4353	Falk RJ	Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.	Proceedings of the National Academy of Sciences of the United States of America	1990	218
2453802	4353	Falk RJ	Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.	The New England journal of medicine	1988	204
8018341	4353	Stolk J	Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol.	American journal of respiratory cell and molecular biology	1994	152
8040285	4353	Daugherty A	Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.	The Journal of clinical investigation	1994	175
11694155	4353	Zhang R	Association between myeloperoxidase levels and risk of coronary artery disease.	JAMA	2001	139
12952835	4353	Baldus S	Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.	Circulation	2003	145
17850484	4353	Nauseef WM	How human neutrophils kill and degrade microbes: an integrated view.	Immunological reviews	2007	186
20364135	4353	Kagan VE	Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation.	Nature nanotechnology	2010	94
20399194	4353	Arnhold J	Human myeloperoxidase in innate and acquired immunity.	Archives of biochemistry and biophysics	2010	44
20974672	4353	Metzler KD	Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity.	Blood	2011	102
22267330	4353	Charles-Schoeman C	Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.	Annals of the rheumatic diseases	2012	34
22389696	4353	Saffarzadeh M	Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones.	PloS one	2012	153
22802447	4353	Parker H	Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus.	Journal of leukocyte biology	2012	74
22932797	4353	Sangaletti S	Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity.	Blood	2012	62
23818485	4353	Borissoff JI	Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state.	Arteriosclerosis, thrombosis, and vascular biology	2013	36
25831236	4353	Lakritz JR	Gut bacteria require neutrophils to promote mammary tumorigenesis.	Oncotarget	2015	16
26468056	4353	Cortjens B	Neutrophil extracellular traps cause airway obstruction during respiratory syncytial virus disease.	The Journal of pathology	2016	13
27036091	4353	Thieblemont N	Human neutrophils in auto-immunity.	Seminars in immunology	2016	12
15814742	4684	Hotchkiss RS	Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways.	Journal of immunology	2005	95
18323793	4684	White CL	Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial.	Gene therapy	2008	58
19552894	4684	Gannon PO	Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients.	Journal of immunological methods	2009	48
19596474	4684	Bonorino P	Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C.	Journal of hepatology	2009	48
20659089	4684	Hidalgo LG	NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection.	American journal of transplantation 	2010	59
22872572	4684	Crane CA	Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone protein.	Clinical cancer research 	2013	38
23592754	4684	Rusakiewicz S	Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors.	Cancer research	2013	54
23891972	4684	Ene-Obong A	Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.	Gastroenterology	2013	43
24646734	4684	Carrega P	CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph.	Journal of immunology	2014	23
25205117	4684	Azzi T	Role for early-differentiated natural killer cells in infectious mononucleosis.	Blood	2014	24
26358406	4684	Doherty DG	Immunity, tolerance and autoimmunity in the liver: A comprehensive review.	Journal of autoimmunity	2016	12
1508666	4790	Matthews JR	Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62.	Nucleic acids research	1992	138
1829648	4790	Haskill S	Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity.	Cell	1991	207
2654643	4790	Griffin GE	Activation of HIV gene expression during monocyte differentiation by induction of NF-kappa B.	Nature	1989	173
8460169	4790	Brown K	Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha.	Proceedings of the National Academy of Sciences of the United States of America	1993	174
9616307	4790	Schreiber S	Activation of nuclear factor kappa B inflammatory bowel disease.	Gut	1998	132
9679041	4790	Rogler G	Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa.	Gastroenterology	1998	123
10940278	4790	Segain JP	Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.	Gut	2000	157
12451177	4790	Guzman ML	Preferential induction of apoptosis for primary human leukemic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2002	95
12697733	4790	Tiede I	CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes.	The Journal of clinical investigation	2003	117
12813024	4790	Adams AB	Heterologous immunity provides a potent barrier to transplantation tolerance.	The Journal of clinical investigation	2003	184
12820969	4790	Saccani S	Modulation of NF-kappaB activity by exchange of dimers.	Molecular cell	2003	88
12857922	4790	Brown HJ	NF-kappaB inhibits gammaherpesvirus lytic replication.	Journal of virology	2003	104
15190178	4790	Matta H	Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP).	Proceedings of the National Academy of Sciences of the United States of America	2004	72
15578112	4790	Lehrke M	An inflammatory cascade leading to hyperresistinemia in humans.	PLoS medicine	2004	87
16105840	4790	Sasaki CY	Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway.	The Journal of biological chemistry	2005	97
16517740	4790	Gersuk GM	Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states.	Journal of immunology	2006	103
16857737	4790	Liu HH	Essential role of TAK1 in thymocyte development and activation.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
18440494	4790	Miller GE	A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling.	Biological psychiatry	2008	141
18561896	4790	Irwin MR	Sleep loss activates cellular inflammatory signaling.	Biological psychiatry	2008	84
18566250	4790	Kravchenko VV	Modulation of gene expression via disruption of NF-kappaB signaling by a bacterial small molecule.	Science	2008	65
19190178	4790	van Baarlen P	Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance.	Proceedings of the National Academy of Sciences of the United States of America	2009	94
20041225	4790	Gao X	Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.	PLoS pathogens	2009	59
20231449	4790	Polyak SJ	Identification of hepatoprotective flavonolignans from silymarin.	Proceedings of the National Academy of Sciences of the United States of America	2010	50
20525923	4790	Milhollen MA	MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma.	Blood	2010	100
24846769	4790	Ghosh S	Elevated muscle TLR4 expression and metabolic endotoxemia in human aging.	The journals of gerontology. Series A, Biological sciences and medical sciences	2015	21
2307933	5788	Mackay CR	Naive and memory T cells show distinct pathways of lymphocyte recirculation.	The Journal of experimental medicine	1990	160
7800006	5788	Mackall CL	Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.	The New England journal of medicine	1995	154
15263023	5788	KÃ¶gler G	A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential.	The Journal of experimental medicine	2004	183
16332974	5788	Seddiki N	Persistence of naive CD45RA+ regulatory T cells in adult life.	Blood	2006	76
19171766	5788	Haniffa M	Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation.	The Journal of experimental medicine	2009	57
19858404	5788	PagÃ¨s F	In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.	Journal of clinical oncology 	2009	172
20231690	5788	Booth NJ	Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO.	Journal of immunology	2010	48
20600576	5788	Kimura M	Synchrony of telomere length among hematopoietic cells.	Experimental hematology	2010	43
21398287	5788	Mullins RF	Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration.	Investigative ophthalmology and visual science	2011	55
22134787	5788	Dohil R	Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.	Digestive diseases and sciences	2012	31
22266112	5788	Erdag G	Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.	Cancer research	2012	93
22952446	5788	de Vries RD	Measles immune suppression: lessons from the macaque model.	PLoS pathogens	2012	30
24832787	5788	Rack B	Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.	Journal of the National Cancer Institute	2014	66
10384090	7097	Yoshimura A	Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2.	Journal of immunology	1999	258
11477091	7097	Re F	Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells.	The Journal of biological chemistry	2001	136
11836257	7097	Asea A	Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.	The Journal of biological chemistry	2002	307
11842086	7097	Vabulas RM	HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway.	The Journal of biological chemistry	2002	197
12430718	7097	Bsibsi M	Broad expression of Toll-like receptors in the human central nervous system.	Journal of neuropathology and experimental neurology	2002	216
12663765	7097	Compton T	Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2.	Journal of virology	2003	181
12946842	7097	Becker I	Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2.	Molecular and biochemical parasitology	2003	90
14607814	7097	Adamo R	Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5.	American journal of respiratory cell and molecular biology	2004	77
14981245	7097	Komai-Koma M	TLR2 is expressed on activated T cells as a costimulatory receptor.	Proceedings of the National Academy of Sciences of the United States of America	2004	119
15294983	7097	Gehring AJ	Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.	Journal of immunology	2004	75
15521019	7097	Dolganiuc A	Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.	Gastroenterology	2004	98
16709849	7097	Cole LE	Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.	Journal of immunology	2006	70
18029454	7097	Devaraj S	Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state.	The Journal of clinical endocrinology and metabolism	2008	93
18458151	7097	Nilsen NJ	Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36.	Journal of leukocyte biology	2008	50
19342676	7097	Huang QQ	Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling.	Journal of immunology	2009	54
19509287	7097	Benakanakere MR	Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes.	The Journal of biological chemistry	2009	48
19661481	7097	Erridge C	Saturated fatty acids do not directly stimulate Toll-like receptor signaling.	Arteriosclerosis, thrombosis, and vascular biology	2009	62
19735274	7097	SjÃ¶gren YM	Influence of early gut microbiota on the maturation of childhood mucosal and systemic immune responses.	Clinical and experimental allergy 	2009	63
19897561	7097	Taylor AE	Defective macrophage phagocytosis of bacteria in COPD.	The European respiratory journal	2010	56
20067962	7097	Dasu MR	Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.	Diabetes care	2010	107
20551157	7097	Harry RA	Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis.	Annals of the rheumatic diseases	2010	44
21055975	7097	Crellin NK	Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2.	Immunity	2010	53
21248167	7097	Jiang D	Hyaluronan as an immune regulator in human diseases.	Physiological reviews	2011	162
21512004	7097	Round JL	The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.	Science	2011	322
21775683	7097	Nyirenda MH	TLR2 stimulation drives human naive and effector regulatory T cells into a Th17-like phenotype with reduced suppressive function.	Journal of immunology	2011	52
22922410	7097	Yipp BG	Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo.	Nature medicine	2012	149
25628407	7097	Zhong J	Cardiac autonomic dysfunction: particulate air pollution effects are modulated by epigenetic immunoregulation of Toll-like receptor 2 and dietary flavonoid intake.	Journal of the American Heart Association	2015	15
8015728	7124	Mogi M	Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients.	Neuroscience letters	1994	133
8119492	7124	Rietschel ET	Bacterial endotoxin: molecular relationships of structure to activity and function.	FASEB journal 	1994	266
9725266	7124	Balcewicz-Sablinska MK	Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha.	Journal of immunology	1998	106
10604883	7124	Ouchi N	Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.	Circulation	1999	304
11092892	7124	Kelso GF	Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties.	The Journal of biological chemistry	2001	175
11792859	7124	Angelini G	Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation.	Proceedings of the National Academy of Sciences of the United States of America	2002	83
11828008	7124	Piccioli D	Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.	The Journal of experimental medicine	2002	146
11907116	7124	Belge KU	The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF.	Journal of immunology	2002	167
12493553	7124	Panossian LA	Telomere shortening in T cells correlates with Alzheimer's disease status.	Neurobiology of aging	2003	94
12682019	7124	Jordan A	HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.	The EMBO journal	2003	271
15044327	7124	Hagemann T	Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.	Carcinogenesis	2004	92
15122768	7124	Naveau S	A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.	Hepatology	2004	72
15383597	7124	Levy O	Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848.	Journal of immunology	2004	99
15613320	7124	Yonezawa A	Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha.	Journal of virology	2005	70
16481637	7124	Berry MA	Evidence of a role of tumor necrosis factor alpha in refractory asthma.	The New England journal of medicine	2006	150
17066036	7124	Kawane K	Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages.	Nature	2006	100
17660390	7124	Rajesh M	CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.	American journal of physiology. Heart and circulatory physiology	2007	70
18560012	7124	Miller DS	Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.	Pharmacological reviews	2008	76
18566296	7124	Apovian CM	Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects.	Arteriosclerosis, thrombosis, and vascular biology	2008	90
19652016	7124	Smith AM	Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease.	The Journal of experimental medicine	2009	107
21128258	7124	Mease P	Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.	Arthritis and rheumatism	2011	39
21133840	7124	Parameswaran N	Tumor necrosis factor-Î± signaling in macrophages.	Critical reviews in eukaryotic gene expression	2010	89
21252670	7124	Danesh-Meyer HV	Neuroprotection in glaucoma: recent and future directions.	Current opinion in ophthalmology	2011	37
21569482	7124	Danchuk S	Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-Î±-induced protein 6.	Stem cell research and therapy	2011	54
21969554	7124	Rajaram MV	Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and microRNA miR-125b.	Proceedings of the National Academy of Sciences of the United States of America	2011	69
22505457	7124	Harre U	Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin.	The Journal of clinical investigation	2012	97
22684480	7124	Swan C	Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFÎ±.	Gut	2013	35
22887987	7124	Teo GS	Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-Î±-activated endothelial cells via both leukocyte-like and novel mechanisms.	Stem cells	2012	33
23178294	7124	Vincent FB	Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective.	Annals of the rheumatic diseases	2013	33
23192911	7124	Listing J	The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.	Rheumatology	2013	32
23267561	7124	Christy AL	Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.	Journal of autoimmunity	2013	28
25125469	7124	Shoemark DK	The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease.	Journal of Alzheimer's disease 	2015	17
25422582	7124	Tuttolomondo A	Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.	Drug design, development and therapy	2014	23
25535390	7124	He X	Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
25562322	7124	Reissfelder C	Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.	The Journal of clinical investigation	2015	23
26117714	7124	Probert L	TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects.	Neuroscience	2015	32
8181668	10242	Albelda SM	Adhesion molecules and inflammatory injury.	FASEB journal 	1994	131
8986723	10242	Coxon A	A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.	Immunity	1996	164
15016372	10242	Herwald H	M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage.	Cell	2004	77
17928596	10242	Bisgaard H	Childhood asthma after bacterial colonization of the airway in neonates.	The New England journal of medicine	2007	151
19647494	10242	Light AR	Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects.	The journal of pain 	2009	47
9463416	10563	Legler DF	B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5.	The Journal of experimental medicine	1998	131
11104798	10563	Schaerli P	CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.	The Journal of experimental medicine	2000	261
11441118	10563	Takemura S	Lymphoid neogenesis in rheumatoid synovitis.	Journal of immunology	2001	138
15193029	10563	Serafini B	Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.	Brain pathology	2004	176
15210760	10563	Chtanova T	T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells.	Journal of immunology	2004	190
16141348	10563	Corcione A	Human mesenchymal stem cells modulate B-cell functions.	Blood	2006	328
16280350	10563	Krumbholz M	Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.	Brain 	2006	97
16317096	10563	Piqueras B	Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors.	Blood	2006	67
16791882	10563	Rasheed AU	Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression.	European journal of immunology	2006	98
19930447	10563	Mygland A	EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.	European journal of neurology	2010	49
19996075	10563	Sellebjerg F	Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.	Neurology	2009	48
20558389	10563	Piccio L	Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis.	Archives of neurology	2010	42
21084753	10563	Moreth K	The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis.	The Journal of clinical investigation	2010	49
21192231	10563	Regidor DL	Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation.	AIDS	2011	42
21900403	10563	de Chaisemartin L	Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer.	Cancer research	2011	48
22393154	10563	Kapetanovic R	Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide.	Journal of immunology	2012	38
22591862	10563	Kowarik MC	CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation.	Journal of neuroinflammation	2012	39
22692510	10563	Pallikkuth S	Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1/09 vaccine.	Blood	2012	66
23778140	10563	Gu-Trantien C	CD4âº follicular helper T cell infiltration predicts breast cancer survival.	The Journal of clinical investigation	2013	90
23940282	10563	Chang BY	Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients.	Blood	2013	38
24138885	10563	Bindea G	Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.	Immunity	2013	157
25217476	10563	DePianto DJ	Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis.	Thorax	2015	27
25534375	10563	Denkert C	Tumor-infiltrating lymphocytes and response to neoadjuvant chemotherapy with or without carboplatin in human epidermal growth factor receptor 2-positive and triple-negative primary breast cancers.	Journal of clinical oncology 	2015	98
25879435	10563	Klimatcheva E	CXCL13 antibody for the treatment of autoimmune disorders.	BMC immunology	2015	16
25924065	10563	Shalapour S	Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.	Nature	2015	39
26908875	10563	Havenar-Daughton C	CXCL13 is a plasma biomarker of germinal center activity.	Proceedings of the National Academy of Sciences of the United States of America	2016	22
12913096	10666	Bottino C	Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.	The Journal of experimental medicine	2003	147
15536144	10666	Pende D	Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112).	Blood	2005	73
16150947	10666	Bryceson YT	Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.	Blood	2006	173
17875681	10666	El-Sherbiny YM	The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.	Cancer research	2007	66
19098271	10666	Soriani A	ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype.	Blood	2009	92
19349689	10666	Lakshmikanth T	NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.	The Journal of clinical investigation	2009	75
20542985	10666	Cho D	Cytotoxicity of activated natural killer cells against pediatric solid tumors.	Clinical cancer research 	2010	59
21118979	10666	Bellora F	The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes.	Proceedings of the National Academy of Sciences of the United States of America	2010	43
21821703	10666	Pievani A	Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.	Blood	2011	48
21841316	10666	Mamessier E	Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.	The Journal of clinical investigation	2011	98
22427644	10666	Lozano E	The TIGIT/CD226 axis regulates human T cell function.	Journal of immunology	2012	38
23029029	10666	Beyer M	High-resolution transcriptome of human macrophages.	PloS one	2012	45
25866972	10666	Chauvin JM	TIGIT and PD-1 impair tumor antigen-specific CD8âº T cells in melanoma patients.	The Journal of clinical investigation	2015	38
10359578	10673	Schneider P	BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.	The Journal of experimental medicine	1999	252
10398604	10673	Moore PA	BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.	Science	1999	235
11123269	10673	Zhang J	Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus.	Journal of immunology	2001	140
12427767	10673	Mackay F	BAFF AND APRIL: a tutorial on B cell survival.	Annual review of immunology	2003	198
12566413	10673	Scapini P	G-CSF-stimulated neutrophils are a prominent source of functional BLyS.	The Journal of experimental medicine	2003	81
12865416	10673	Avery DT	BAFF selectively enhances the survival of plasmablasts generated from human memory B cells.	The Journal of clinical investigation	2003	99
14673998	10673	Stohl W	B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.	Arthritis and rheumatism	2003	86
15070697	10673	Moreaux J	BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone.	Blood	2004	106
15353552	10673	Moir S	Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily.	The Journal of experimental medicine	2004	75
15634903	10673	Gong Q	Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy.	Journal of immunology	2005	107
15642740	10673	Krumbholz M	BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma.	The Journal of experimental medicine	2005	67
15701725	10673	Sims GP	Identification and characterization of circulating human transitional B cells.	Blood	2005	133
16477017	10673	Gottenberg JE	Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary SjÃ¶gren's syndrome.	Proceedings of the National Academy of Sciences of the United States of America	2006	113
16914324	10673	Bossen C	BAFF, APRIL and their receptors: structure, function and signaling.	Seminars in immunology	2006	82
16973390	10673	Enzler T	Alternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like disease.	Immunity	2006	66
17433868	10673	Mackay F	B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling.	Current opinion in immunology	2007	61
17928212	10673	Kato A	Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity.	Current opinion in immunology	2007	101
17942753	10673	Woodland RT	Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival.	Blood	2008	52
17942754	10673	Bossen C	TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.	Blood	2008	81
19168788	10673	Sarantopoulos S	Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.	Blood	2009	86
19483719	10673	Doreau A	Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.	Nature immunology	2009	171
19521398	10673	Mackay F	Cracking the BAFF code.	Nature reviews. Immunology	2009	202
19561614	10673	Chen K	Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils.	Nature immunology	2009	76
20039404	10673	Jacobi AM	Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study.	Arthritis and rheumatism	2010	45
20360558	10673	Obata T	Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid tissues and share a mucosal antibody-mediated symbiosis.	Proceedings of the National Academy of Sciences of the United States of America	2010	49
20531452	10673	Pallier A	Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.	Kidney international	2010	54
20534450	10673	Cella M	Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity.	Proceedings of the National Academy of Sciences of the United States of America	2010	64
20683439	10673	Voulgarelis M	Pathogenetic mechanisms in the initiation and perpetuation of SjÃ¶gren's syndrome.	Nature reviews. Rheumatology	2010	43
20727041	10673	Townsend MJ	B-cell targeted therapies in human autoimmune diseases: an updated perspective.	Immunological reviews	2010	63
21097674	10673	Sarantopoulos S	Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.	Blood	2011	36
21482945	10673	Pellkofer HL	Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab.	Neurology	2011	39
21555857	10673	Rotger M	Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.	The Journal of clinical investigation	2011	73
21875503	10673	Jacobson CA	Immune reconstitution after double umbilical cord blood stem cell transplantation: comparison with unrelated peripheral blood stem cell transplantation.	Biology of blood and marrow transplantation 	2012	33
22124120	10673	Kreuzaler M	Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors.	Journal of immunology	2012	43
22197976	10673	Puga I	B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen.	Nature immunology	2011	138
22275291	10673	Stohl W	Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.	Arthritis and rheumatism	2012	43
22736090	10673	Brkic Z	Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.	Annals of the rheumatic diseases	2013	28
23299618	10673	Yates NL	HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life.	Mucosal immunology	2013	33
24018164	10673	Burger JA	The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies.	Seminars in cancer biology	2014	39
24504026	10673	Jourdan M	IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors.	Leukemia	2014	22
27354687	10673	Lood C	Neutrophil extracellular traps as a potential source of autoantigen in cocaine-associated autoimmunity.	Rheumatology	2017	5
9382880	10859	Colonna M	A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.	The Journal of experimental medicine	1997	142
9560253	10859	Lee N	HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.	Proceedings of the National Academy of Sciences of the United States of America	1998	145
17947671	10859	Yu J	Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.	Journal of immunology	2007	67
18755890	10859	Foekens JA	Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2008	124
20477761	10859	Le Garff-Tavernier M	Human NK cells display major phenotypic and functional changes over the life span.	Aging cell	2010	71
24204327	10859	Norman PJ	Co-evolution of human leukocyte antigen (HLA) class I ligands with killer-cell immunoglobulin-like receptors (KIR) in a genetically diverse population of sub-Saharan Africans.	PLoS genetics	2013	27
1967191	10959	Fahey JL	The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.	The New England journal of medicine	1990	152
6189183	10959	BarrÃ©-Sinoussi F	Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).	Science	1983	1031
7509000	10959	Richman DD	Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy.	Journal of virology	1994	131
8096374	10959	Koot M	Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS.	Annals of internal medicine	1993	226
11157057	10959	Kelleher AD	Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.	The Journal of experimental medicine	2001	198
15271794	10959	Weiss L	Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients.	Blood	2004	142
16501126	10959	ZuÃ±iga R	Relative dominance of Gag p24-specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control.	Journal of virology	2006	123
16537629	10959	Martinez-Picado J	Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.	Journal of virology	2006	235
16954502	10959	Watanabe S	Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.	Blood	2007	74
19958227	10959	Nowacek AS	NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery.	Nanomedicine	2009	53
21992606	10959	Saleh S	Expression and reactivation of HIV in a chemokine induced model of HIV latency in primary resting CD4+ T cells.	Retrovirology	2011	41
11208866	11251	Hirai H	Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2.	The Journal of experimental medicine	2001	149
16782037	11251	Wang YH	Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells.	Immunity	2006	81
21909091	11251	MjÃ¶sberg JM	Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.	Nature immunology	2011	228
23379537	11251	Straumann A	Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitis.	Allergy	2013	30
23506843	11251	Fajt ML	Prostaglandin Dâ pathway upregulation: relation to asthma severity, control, and TH2 inflammation.	The Journal of allergy and clinical immunology	2013	30
24388011	11251	Xue L	Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.	The Journal of allergy and clinical immunology	2014	54
25429730	11251	Ho J	Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia.	Clinical and experimental allergy 	2015	18
11567106	22914	Girardi M	Regulation of cutaneous malignancy by gammadelta T cells.	Science	2001	201
14685277	22914	Moretta L	Unravelling natural killer cell function: triggering and inhibitory human NK receptors.	The EMBO journal	2004	114
15070686	22914	Verneris MR	Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.	Blood	2004	90
15328155	22914	Carbone E	HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells.	Blood	2005	71
17312110	22914	Draghi M	NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.	Journal of immunology	2007	65
17392508	22914	Cooley S	A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.	Blood	2007	79
17405908	22914	Cerboni C	Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.	Blood	2007	63
18266471	22914	Fang M	A role for NKG2D in NK cell-mediated resistance to poxvirus disease.	PLoS pathogens	2008	65
18490724	22914	Clayton A	Human tumor-derived exosomes down-modulate NKG2D expression.	Journal of immunology	2008	115
19201769	22914	Fisicaro P	Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.	Gut	2009	55
19319200	22914	Viaud S	Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha.	PloS one	2009	60
19454726	22914	Todaro M	Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes.	Journal of immunology	2009	68
19470388	22914	Oliviero B	Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.	Gastroenterology	2009	115
19542445	22914	Hedlund M	Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function.	Journal of immunology	2009	53
20080094	22914	Amadei B	Activation of natural killer cells during acute infection with hepatitis C virus.	Gastroenterology	2010	51
20103663	22914	Di Tomaso T	Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.	Clinical cancer research 	2010	57
20150362	22914	Crane CA	TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.	Neuro-oncology	2010	51
20169160	22914	Spanholtz J	High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy.	PloS one	2010	47
20519625	22914	Maniar A	Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.	Blood	2010	41
20536569	22914	Champsaur M	Effect of NKG2D ligand expression on host immune responses.	Immunological reviews	2010	155
21364924	22914	Hedlund M	Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells.	PloS one	2011	43
21844012	22914	Parkhurst MR	Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression.	Clinical cancer research 	2011	66
22102694	22914	Heinemann A	Tumor suppressive microRNAs miR-34a/c control cancer cell expression of ULBP2, a stress-induced ligand of the natural killer cell receptor NKG2D.	Cancer research	2012	41
22258454	22914	Pietra G	Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.	Cancer research	2012	62
22384114	22914	Nielsen N	Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.	PloS one	2012	31
22396543	22914	Lv LH	Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro.	The Journal of biological chemistry	2012	59
22660791	22914	Abadie V	Intraepithelial lymphocytes in celiac disease immunopathology.	Seminars in immunopathology	2012	33
22730533	22914	Hilpert J	Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses.	Journal of immunology	2012	39
23601842	22914	Crome SQ	Natural killer cells regulate diverse T cell responses.	Trends in immunology	2013	30
23846901	22914	Chaigne-Delalande B	Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D.	Science	2013	37
21613998	25939	Laguette N	SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx.	Nature	2011	457
22056990	25939	Goldstone DC	HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.	Nature	2011	248
22327569	25939	Lahouassa H	SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates.	Nature immunology	2012	250
22589553	25939	Kim B	Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages.	The Journal of biological chemistry	2012	84
22972397	25939	Baldauf HM	SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.	Nature medicine	2012	192
23035819	25939	Koppensteiner H	Macrophages and their relevance in Human Immunodeficiency Virus Type I infection.	Retrovirology	2012	63
23092122	25939	Descours B	SAMHD1 restricts HIV-1 reverse transcription in quiescent CD4(+) T-cells.	Retrovirology	2012	120
23158101	25939	White TE	Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.	Virology	2013	49
23858451	25939	Franzolin E	The deoxynucleotide triphosphohydrolase SAMHD1 is a major regulator of DNA precursor pools in mammalian cells.	Proceedings of the National Academy of Sciences of the United States of America	2013	53
24445253	25939	Kretschmer S	SAMHD1 prevents autoimmunity by maintaining genome stability.	Annals of the rheumatic diseases	2015	29
25847232	25939	Yan J	CyclinA2-Cyclin-dependent Kinase Regulates SAMHD1 Protein Phosphohydrolase Domain.	The Journal of biological chemistry	2015	18
6790607	27087	Abo T	A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1).	Journal of immunology	1981	196
11772532	27087	Wikby A	Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study.	Experimental gerontology	2002	101
19880576	27087	Focosi D	CD57+ T lymphocytes and functional immune deficiency.	Journal of leukocyte biology	2010	60
20696944	27087	BjÃ¶rkstrÃ¶m NK	Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education.	Blood	2010	136
20733159	27087	Lopez-VergÃ¨s S	CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.	Blood	2010	129
20971955	27087	Hinrichs CS	Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.	Blood	2011	81
21492857	27087	Kaplan RC	T cell activation predicts carotid artery stiffness among HIV-infected women.	Atherosclerosis	2011	42
22560929	27087	Solana R	Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans.	Seminars in immunology	2012	75
24585893	27087	Lee SA	Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infection.	The Journal of infectious diseases	2014	22
24586783	27087	Lee SA	Impact of HIV on CD8+ T cell CD57 expression is distinct from that of CMV and aging.	PloS one	2014	28
26416461	27087	Cichocki F	CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT.	Leukemia	2016	17
27372564	27087	Pesce S	Identification of a subset of human natural killer cells expressing high levels of programmed death 1: AÂ phenotypic and functional characterization.	The Journal of allergy and clinical immunology	2017	15
12091876	29126	Dong H	Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.	Nature medicine	2002	813
12538684	29126	Brown JA	Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.	Journal of immunology	2003	194
12704383	29126	Curiel TJ	Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.	Nature medicine	2003	270
14612546	29126	Wintterle S	Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis.	Cancer research	2003	78
15297412	29126	Konishi J	B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.	Clinical cancer research 	2004	166
15569934	29126	Thompson RH	Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.	Proceedings of the National Academy of Sciences of the United States of America	2004	181
16482562	29126	Blank C	Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.	International journal of cancer	2006	75
16699366	29126	Gajewski TF	Immune suppression in the tumor microenvironment.	Journal of immunotherapy	2006	62
16876901	29126	MÃ¼hlbauer M	PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis.	Journal of hepatology	2006	91
17071860	29126	Chang CJ	Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma.	Stem cells	2006	63
17186290	29126	Nakanishi J	Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers.	Cancer immunology, immunotherapy 	2007	65
17195077	29126	Blank C	Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion.	Cancer immunology, immunotherapy 	2007	85
17287266	29126	Boni C	Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.	Journal of virology	2007	198
17340590	29126	Inman BA	PD-L1 (B7-H1) expression by urothelial carcinoma of the bladder and BCG-induced granulomata: associations with localized stage progression.	Cancer	2007	63
17360651	29126	Hamanishi J	Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	289
17363736	29126	Liu J	Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-{gamma} and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway.	Blood	2007	100
17875753	29126	Gajewski TF	Failure at the effector phase: immune barriers at the level of the melanoma tumor microenvironment.	Clinical cancer research 	2007	82
18223165	29126	Azuma T	B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells.	Blood	2008	91
18268286	29126	Rawstron AC	Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.	Haematologica	2008	72
19155478	29126	Gong AY	MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytes.	Journal of immunology	2009	50
19229109	29126	Franceschini D	PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.	The Journal of clinical investigation	2009	87
19451266	29126	Kuang DM	Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.	The Journal of experimental medicine	2009	128
19825956	29126	Karim R	Tumor-expressed B7-H1 and B7-DC in relation to PD-1+ T-cell infiltration and survival of patients with cervical carcinoma.	Clinical cancer research 	2009	62
19826049	29126	Wu K	Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions.	Cancer research	2009	54
20068105	29126	Wei J	Glioma-associated cancer-initiating cells induce immunosuppression.	Clinical cancer research 	2010	68
20143437	29126	Hino R	Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma.	Cancer	2010	128
20308313	29126	Rodrigues JC	Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties.	Neuro-oncology	2010	57
20373055	29126	Mu CY	High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation.	Medical oncology	2011	105
20460501	29126	Benson DM Jr	The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.	Blood	2010	114
20473887	29126	Shi F	PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients.	International journal of cancer	2011	71
21523733	29126	Gadiot J	Overall survival and PD-L1 expression in metastasized malignant melanoma.	Cancer	2011	40
22133721	29126	Amarnath S	The PDL1-PD1 axis converts human TH1 cells into regulatory T cells.	Science translational medicine	2011	74
22461641	29126	Taube JM	Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape.	Science translational medicine	2012	408
22547582	29126	Ramsay AG	Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer.	Blood	2012	58
22658128	29126	Brahmer JR	Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.	The New England journal of medicine	2012	1346
22828443	29126	Tamura H	Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma.	Leukemia	2013	28
23087408	29126	Chen DS	Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.	Clinical cancer research 	2012	66
23288508	29126	Lyford-Pike S	Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma.	Cancer research	2013	114
23340297	29126	Abiko K	PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction.	Clinical cancer research 	2013	28
23370250	29126	Yao S	Advances in targeting cell surface signalling molecules for immune modulation.	Nature reviews. Drug discovery	2013	51
23389362	29126	Chen YB	Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: a 5-year-follow-up study.	Tumori	2012	51
23613317	29126	Bloch O	Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages.	Clinical cancer research 	2013	71
23792703	29126	Gianchecchi E	Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity.	Autoimmunity reviews	2013	39
24153012	29126	Atanackovic D	Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma.	Leukemia	2014	21
24217091	29126	Velcheti V	Programmed death ligand-1 expression in non-small cell lung cancer.	Laboratory investigation; a journal of technical methods and pathology	2014	145
24270737	29126	Yang H	Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.	Leukemia	2014	47
24297569	29126	Maine CJ	Programmed death ligand-1 over-expression correlates with malignancy and contributes to immune regulation in ovarian cancer.	Cancer immunology, immunotherapy 	2014	22
24315741	29126	Sideras K	Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies.	Cancer treatment reviews	2014	25
24349382	29126	Kim JR	Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas.	PloS one	2013	48
24387680	29126	Chang K	Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis.	Critical care	2014	47
24403533	29126	Chinnadurai R	IDO-independent suppression of T cell effector function by IFN-Î³-licensed human mesenchymal stromal cells.	Journal of immunology	2014	40
24416729	29126	Lipson EJ	PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survival.	Cancer immunology research	2013	53
24626392	29126	Bowers NL	Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway.	PLoS pathogens	2014	37
24657498	29126	Hou J	Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer.	Experimental and molecular pathology	2014	27
24691993	29126	Lines JL	VISTA is an immune checkpoint molecule for human T cells.	Cancer research	2014	26
24714771	29126	Taube JM	Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy.	Clinical cancer research 	2014	326
24804867	29126	Geng Y	Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.	International journal of clinical oncology	2015	21
24866169	29126	Shen JK	Programmed cell death ligand 1 expression in osteosarcoma.	Cancer immunology research	2014	28
25314639	29126	Berghoff AS	Tumour-infiltrating lymphocytes and expression of programmed death ligand 1 (PD-L1) in melanoma brain metastases.	Histopathology	2015	21
25348003	29126	Chen L	Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression.	Nature communications	2014	75
25355681	29126	Berghoff AS	Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma.	Neuro-oncology	2015	59
25381385	29126	Clarke EV	Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation.	Journal of leukocyte biology	2015	20
25428503	29126	Powles T	MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.	Nature	2014	345
25428505	29126	Tumeh PC	PD-1 blockade induces responses by inhibiting adaptive immune resistance.	Nature	2014	512
25440090	29126	Ohaegbulam KC	Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway.	Trends in molecular medicine	2015	47
25477049	29126	Madore J	PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials.	Pigment cell and melanoma research	2015	25
25527356	29126	Wimberly H	PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer.	Cancer immunology research	2015	41
25538263	29126	Choueiri TK	Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial.	Clinical cancer research 	2015	27
25540867	29126	D'Angelo SP	Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment.	Human pathology	2015	23
25582496	29126	Schultheis AM	PD-L1 expression in small cell neuroendocrine carcinomas.	European journal of cancer	2015	24
25600565	29126	Bellmunt J	Association of PD-L1 expression on tumor-infiltrating mononuclear cells and overall survival in patients with urothelial carcinoma.	Annals of oncology 	2015	29
25609202	29126	Mao Y	B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.	Oncotarget	2015	18
25609381	29126	Khan AR	PD-L1hi B cells are critical regulators of humoral immunity.	Nature communications	2015	22
25622193	29126	Woo SR	Innate immune recognition of cancer.	Annual review of immunology	2015	43
25695955	29126	Patel SP	PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.	Molecular cancer therapeutics	2015	104
25751499	29126	Lussier DM	Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactions.	Journal of immunotherapy	2015	22
25897014	29126	Ali HR	PD-L1 protein expression in breast cancer is rare, enriched in basal-like tumours and associated with infiltrating lymphocytes.	Annals of oncology 	2015	29
26014098	29126	Boyerinas B	Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells.	Cancer immunology research	2015	28
26181000	29126	Howitt BE	Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1.	JAMA oncology	2015	35
26408403	29126	Vassilakopoulou M	Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma.	Clinical cancer research 	2016	18
26527522	29126	Cimino-Mathews A	PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas.	Human pathology	2016	19
26541606	29126	Sivan A	Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.	Science	2015	114
26681673	29126	Chen J	Regulation of PD-L1: a novel role of pro-survival signalling in cancer.	Annals of oncology 	2016	29
26761210	29126	Chen MF	The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression.	Oncotarget	2016	13
26801886	29126	Thompson ED	Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.	Gut	2017	21
26977880	29126	Tang H	Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.	Cancer cell	2016	19
27030389	29126	Georgiou K	Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas.	Blood	2016	11
27196573	29126	Masugi Y	Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.	Gut	2017	8
27269947	29126	Lesokhin AM	Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study.	Journal of clinical oncology 	2016	35
27569912	29126	Daley D	Î³Î´ T Cells Support Pancreatic Oncogenesis by Restraining Î±Î² T Cell Activation.	Cell	2016	15
27924752	29126	Gibney GT	Predictive biomarkers for checkpoint inhibitor-based immunotherapy.	The Lancet. Oncology	2016	17
28278348	29126	Rimm DL	A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer.	JAMA oncology	2017	8
28291584	29126	Alley EW	Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial.	The Lancet. Oncology	2017	7
10617205	29851	Yoshinaga SK	T-cell co-stimulation through B7RP-1 and ICOS.	Nature	1999	125
11224528	29851	Chapoval AI	B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.	Nature immunology	2001	162
12577056	29851	Grimbacher B	Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.	Nature immunology	2003	120
18513999	29851	Ito T	Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.	Immunity	2008	118
19721453	29851	Ma CS	Early commitment of naÃ¯ve human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12.	Immunology and cell biology	2009	104
20980695	29851	Paulos CM	The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.	Science translational medicine	2010	72
21314428	29851	Crotty S	Follicular helper CD4 T cells (TFH).	Annual review of immunology	2011	682
21808017	29851	Bentebibel SE	Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers.	Proceedings of the National Academy of Sciences of the United States of America	2011	35
22233865	29851	Zhao Y	Reversal of type 1 diabetes via islet Î² cell regeneration following immune modulation by cord blood-derived multipotent stem cells.	BMC medicine	2012	35
22403255	29851	Ma CS	Functional STAT3 deficiency compromises the generation of human T follicular helper cells.	Blood	2012	69
23159227	29851	Lee SK	Interferon-Î³ excess leads to pathogenic accumulation of follicular helper T cells and germinal centers.	Immunity	2012	59
23591982	29851	Di Giacomo AM	Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10Â mg/kg within an expanded access programme.	Cancer immunology, immunotherapy 	2013	30
24089408	29851	Herazo-Maya JD	Peripheral blood mononuclear cell gene expression profiles predict poor outcome in idiopathic pulmonary fibrosis.	Science translational medicine	2013	58
24292706	29851	Sim GC	IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.	The Journal of clinical investigation	2014	39
11799181	30835	Jameson B	Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques.	Journal of virology	2002	83
12515819	30835	Tailleux L	DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells.	The Journal of experimental medicine	2003	138
12783086	30835	Navarro-Sanchez E	Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses.	EMBO reports	2003	126
16177066	30835	Granelli-Piperno A	Dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin/CD209 is abundant on macrophages in the normal human lymph node and is not required for dendritic cell stimulation of the mixed leukocyte reaction.	Journal of immunology	2005	70
16469696	30835	Pokidysheva E	Cryo-EM reconstruction of dengue virus in complex with the carbohydrate recognition domain of DC-SIGN.	Cell	2006	77
16951327	30835	Shreffler WG	The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro.	Journal of immunology	2006	63
18337571	30835	Rappocciolo G	Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN.	Journal of virology	2008	61
19386588	30835	Martinez-Nunez RT	MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN).	The Journal of biological chemistry	2009	60
19837374	30835	Montoya D	Divergence of macrophage phagocytic and antimicrobial programs in leprosy.	Cell host and microbe	2009	50
20035511	30835	Henderson AP	Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.	Annals of neurology	2009	60
20484028	30835	Poschke I	Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign.	Cancer research	2010	118
11120765	50943	Chatila TA	JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.	The Journal of clinical investigation	2000	185
11483607	50943	Schubert LA	Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation.	The Journal of biological chemistry	2001	111
14597769	50943	Walker MR	Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.	The Journal of clinical investigation	2003	257
15172973	50943	Miura Y	Association of Foxp3 regulatory gene expression with graft-versus-host disease.	Blood	2004	82
15252446	50943	Oswald-Richter K	HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.	PLoS biology	2004	113
15374887	50943	Godfrey WR	Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.	Blood	2005	80
15454488	50943	Balandina A	Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.	Blood	2005	66
15466453	50943	Yagi H	Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells.	International immunology	2004	169
15620457	50943	Morgan ME	Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.	Human immunology	2005	108
15781662	50943	Ormandy LA	Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.	Cancer research	2005	118
15791617	50943	Stoop JN	Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.	Hepatology	2005	117
15952173	50943	Huan J	Decreased FOXP3 levels in multiple sclerosis patients.	Journal of neuroscience research	2005	91
16169501	50943	Walther M	Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection.	Immunity	2005	118
16211090	50943	Allan SE	The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs.	The Journal of clinical investigation	2005	113
16278306	50943	Rieger K	Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.	Blood	2006	66
16322292	50943	Wolf D	The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.	Clinical cancer research 	2005	103
16339542	50943	Crellin NK	Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells.	Journal of immunology	2005	91
16428488	50943	Badoual C	Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.	Clinical cancer research 	2006	108
16517728	50943	Mantel PY	Molecular mechanisms underlying FOXP3 induction in human T cells.	Journal of immunology	2006	103
16551248	50943	Ziegler SF	FOXP3: of mice and men.	Annual review of immunology	2006	292
16627754	50943	Rezvani K	High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.	Blood	2006	76
16645171	50943	Zorn E	IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.	Blood	2006	179
16728694	50943	Epple HJ	Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.	Blood	2006	86
16741580	50943	Bacchetta R	Defective regulatory and effector T cell functions in patients with FOXP3 mutations.	The Journal of clinical investigation	2006	93
16825494	50943	Carreras J	High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.	Blood	2006	84
16902147	50943	Nilsson J	HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.	Blood	2006	130
16955142	50943	Vukmanovic-Stejic M	Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo.	The Journal of clinical investigation	2006	137
17099880	50943	Petersen RP	Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.	Cancer	2006	76
17154262	50943	Wang J	Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells.	European journal of immunology	2007	259
17237765	50943	Marson A	Foxp3 occupancy and regulation of key target genes during T-cell stimulation.	Nature	2007	214
17289884	50943	Kobayashi N	FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.	Clinical cancer research 	2007	89
17329235	50943	Allan SE	Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.	International immunology	2007	228
17412402	50943	Hartl D	Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma.	The Journal of allergy and clinical immunology	2007	86
17440451	50943	Zheng Y	Foxp3 in control of the regulatory T cell lineage.	Nature immunology	2007	225
17577038	50943	Gao Q	Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.	Journal of clinical oncology 	2007	209
17694575	50943	Baron U	DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.	European journal of immunology	2007	171
17972346	50943	Steinman RM	Dendritic cells: understanding immunogenicity.	European journal of immunology	2007	101
17984976	50943	Allan SE	Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3.	Molecular therapy 	2008	51
18056169	50943	Kiniwa Y	CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.	Clinical cancer research 	2007	78
18270368	50943	Passerini L	STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.	International immunology	2008	51
18279718	50943	Di Ianni M	Mesenchymal cells recruit and regulate T regulatory cells.	Experimental hematology	2008	77
18286169	50943	Janson PC	FOXP3 promoter demethylation reveals the committed Treg population in humans.	PloS one	2008	58
18413770	50943	Ebert LM	The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.	Cancer research	2008	53
18698034	50943	Heimberger AB	Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.	Clinical cancer research 	2008	79
18791714	50943	Leffers N	Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.	Cancer immunology, immunotherapy 	2009	91
18981158	50943	Schneider A	The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.	Journal of immunology	2008	92
19064967	50943	Salama P	Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.	Journal of clinical oncology 	2009	207
19109157	50943	Lal G	Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation.	Journal of immunology	2009	139
19128359	50943	Willcox A	Analysis of islet inflammation in human type 1 diabetes.	Clinical and experimental immunology	2009	138
19147574	50943	Wieczorek G	Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue.	Cancer research	2009	96
19237575	50943	De Jager PL	The role of the CD58 locus in multiple sclerosis.	Proceedings of the National Academy of Sciences of the United States of America	2009	57
19283780	50943	Hoffmann P	Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.	European journal of immunology	2009	79
19343213	50943	Walther M	Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria.	PLoS pathogens	2009	74
19383912	50943	Kryczek I	FOXP3 defines regulatory T cells in human tumor and autoimmune disease.	Cancer research	2009	53
19390618	50943	Minigo G	Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.	PLoS pathogens	2009	54
19464196	50943	Miyara M	Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.	Immunity	2009	401
19569243	50943	Zhou J	Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.	International journal of cancer	2009	51
19577568	50943	Sinicrope FA	Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.	Gastroenterology	2009	77
19641607	50943	Milne K	Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors.	PloS one	2009	85
19648226	50943	Chen W	TGF-beta and 'adaptive' Foxp3(+) regulatory T cells.	Journal of molecular cell biology	2010	45
19856313	50943	Frey DM	High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.	International journal of cancer	2010	80
19875613	50943	Long SA	Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.	Diabetes	2010	73
19908042	50943	Suzuki H	Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer.	Cancer immunology, immunotherapy 	2010	44
20234320	50943	Shimizu K	Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.	Journal of thoracic oncology 	2010	46
20547850	50943	Welters MJ	Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses.	Proceedings of the National Academy of Sciences of the United States of America	2010	69
20559327	50943	Sakaguchi S	FOXP3+ regulatory T cells in the human immune system.	Nature reviews. Immunology	2010	463
20661468	50943	Szajnik M	Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).	PloS one	2010	83
20883548	50943	Gurkan S	Immune reconstitution following rabbit antithymocyte globulin.	American journal of transplantation 	2010	52
20920773	50943	Nadeau K	Ambient air pollution impairs regulatory T-cell function in asthma.	The Journal of allergy and clinical immunology	2010	77
21030558	50943	Rapoport AP	Combination immunotherapy using adoptive T-cell transfer and tumor antigen vaccination on the basis of hTERT and survivin after ASCT for myeloma.	Blood	2011	41
21221592	50943	Wang W	The Th17/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis.	Rheumatology international	2012	33
21253593	50943	Golovina TN	Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells.	PloS one	2011	42
21257987	50943	Ciccocioppo R	Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.	Gut	2011	91
21301480	50943	Miyara M	Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns.	Immunology and cell biology	2011	45
21488902	50943	Rudensky AY	Regulatory T cells and Foxp3.	Immunological reviews	2011	142
21493801	50943	Hoechst B	Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells.	Blood	2011	58
21644034	50943	Ladoire S	Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer.	Cancer immunology, immunotherapy 	2011	76
21719142	50943	Tao H	Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.	Lung cancer	2012	41
21856944	50943	Long SA	CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.	Journal of immunology	2011	66
21896932	50943	Ferraro A	Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes.	Diabetes	2011	45
22190180	50943	Fuchs S	Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency.	Journal of immunology	2012	39
22267598	50943	Weitkamp JH	Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios.	Gut	2013	27
22438251	50943	Duhen T	Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells.	Blood	2012	81
22465232	50943	Whiteside TL	What are regulatory T cells (Treg) regulating in cancer and why?	Seminars in cancer biology	2012	50
22510350	50943	deLeeuw RJ	The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature.	Clinical cancer research 	2012	91
22770213	50943	Samstein RM	Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict.	Cell	2012	117
23010736	50943	Katz SC	Regulatory T cell infiltration predicts outcome following resection of colorectal cancer liver metastases.	Annals of surgical oncology	2013	26
23097687	50943	Messina JL	12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?	Scientific reports	2012	61
23253182	50943	Weisse K	Maternal and newborn vitamin D status and its impact on food allergy development in the German LINA cohort study.	Allergy	2013	33
23274471	50943	von Boehmer H	Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer.	Nature reviews. Drug discovery	2013	48
23676463	50943	Kinnunen T	Specific peripheral B cell tolerance defects in patients with multiple sclerosis.	The Journal of clinical investigation	2013	29
23681097	50943	Sakaguchi S	The plasticity and stability of regulatory T cells.	Nature reviews. Immunology	2013	97
23993223	50943	Lluis A	Increased regulatory T-cell numbers are associated with farm milk exposure and lower atopic sensitization and asthma in childhood.	The Journal of allergy and clinical immunology	2014	25
24129245	50943	Balermpas P	Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer.	British journal of cancer	2014	38
24177180	50943	Curti BD	OX40 is a potent immune-stimulating target in late-stage cancer patients.	Cancer research	2013	62
24211039	50943	Kleinewietfeld M	The plasticity of human Treg and Th17 cells and its role in autoimmunity.	Seminars in immunology	2013	55
24636474	50943	Syed A	Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).	The Journal of allergy and clinical immunology	2014	51
24704576	50943	Marek-Trzonkowska N	Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up.	Clinical immunology	2014	28
24712466	50943	Sawant DV	Once a Treg, always a Treg?	Immunological reviews	2014	45
25043484	50943	Wang Y	An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling.	Nature communications	2014	30
25255802	50943	Fong L	Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer.	Journal of the National Cancer Institute	2014	22
26272906	50943	Sefik E	MUCOSAL IMMUNOLOGY. Individual intestinal symbionts induce a distinct population of RORÎ³âº regulatory T cells.	Science	2015	49
26524592	50943	Hernandez AL	Sodium chloride inhibits the suppressive function of FOXP3+ regulatory T cells.	The Journal of clinical investigation	2015	29
26606968	50943	Bluestone JA	Type 1 diabetes immunotherapy using polyclonal regulatory T cells.	Science translational medicine	2015	56
12045249	51284	Ito T	Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets.	The Journal of experimental medicine	2002	99
15778362	51284	Bekeredjian-Ding IB	Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN.	Journal of immunology	2005	87
15827165	51284	Schlender J	Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus.	Journal of virology	2005	92
16111635	51284	KarikÃ³ K	Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.	Immunity	2005	176
16224540	51284	Beignon AS	Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions.	The Journal of clinical investigation	2005	249
16230478	51284	Barrat FJ	Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus.	The Journal of experimental medicine	2005	213
16330816	51284	Vollmer J	Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8.	The Journal of experimental medicine	2005	114
16365416	51284	Chaperot L	Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells.	Journal of immunology	2006	72
17190786	51284	Kawai T	Antiviral signaling through pattern recognition receptors.	Journal of biochemistry	2007	145
20014959	51284	Avalos AM	Regulation of autoreactive B cell responses to endogenous TLR ligands.	Autoimmunity	2010	43
20100933	51284	Panda A	Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response.	Journal of immunology	2010	115
20146710	51284	Lande R	Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses.	Annals of the New York Academy of Sciences	2010	41
20424013	51284	Koyama S	Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes.	Science translational medicine	2010	41
20559388	51284	Guiducci C	TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus.	Nature	2010	94
20832340	51284	Cros J	Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors.	Immunity	2010	237
21102570	51284	Brint EK	Differential expression of toll-like receptors in patients with irritable bowel syndrome.	The American journal of gastroenterology	2011	51
26553869	51284	Sampey GC	Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA.	The Journal of biological chemistry	2016	20
1378631	51497	Noelle RJ	A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.	Proceedings of the National Academy of Sciences of the United States of America	1992	159
8011282	51497	Romagnani S	Lymphokine production by human T cells in disease states.	Annual review of immunology	1994	169
9701160	51497	Shankar AH	Zinc and immune function: the biological basis of altered resistance to infection.	The American journal of clinical nutrition	1998	147
10202341	51497	BjÃ¶rkstÃ©n B	The intestinal microflora in allergic Estonian and Swedish 2-year-old children.	Clinical and experimental allergy 	1999	98
10490767	51497	Chirmule N	Immune responses to adenovirus and adeno-associated virus in humans.	Gene therapy	1999	153
14707090	51497	Davidson DJ	The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization.	Journal of immunology	2004	72
15032590	51497	North RJ	Immunity to tuberculosis.	Annual review of immunology	2004	235
15479434	51497	Petrovsky N	Vaccine adjuvants: current state and future trends.	Immunology and cell biology	2004	142
15479435	51497	Lindblad EB	Aluminium compounds for use in vaccines.	Immunology and cell biology	2004	98
16573591	51497	Crews FT	Cytokines and alcohol.	Alcoholism, clinical and experimental research	2006	96
16946019	51497	Budhu A	The role of cytokines in hepatocellular carcinoma.	Journal of leukocyte biology	2006	65
17150027	51497	Bendelac A	The biology of NKT cells.	Annual review of immunology	2007	685
17726308	51497	Wintergerst ES	Contribution of selected vitamins and trace elements to immune function.	Annals of nutrition and metabolism	2007	68
18317671	51497	Weiner HL	A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis.	Journal of neurology	2008	56
18666314	51497	Sanchez-Munoz F	Role of cytokines in inflammatory bowel disease.	World journal of gastroenterology	2008	97
18952487	51497	Wang KX	Osteopontin: role in immune regulation and stress responses.	Cytokine and growth factor reviews	2008	159
19079189	51497	Cecchinato V	Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques.	Mucosal immunology	2008	92
19188532	51497	Dube SR	Cumulative childhood stress and autoimmune diseases in adults.	Psychosomatic medicine	2009	77
19208455	51497	Sun HX	Advances in saponin-based adjuvants.	Vaccine	2009	49
19406170	51497	Hewitson JP	Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity.	Molecular and biochemical parasitology	2009	160
19672903	51497	Sallusto F	Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity.	European journal of immunology	2009	72
19912252	51497	Crome SQ	Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease.	Clinical and experimental immunology	2010	62
20133091	51497	Biasucci G	Mode of delivery affects the bacterial community in the newborn gut.	Early human development	2010	75
20192806	51497	Zhu J	Differentiation of effector CD4 T cell populations (*).	Annual review of immunology	2010	668
21198665	51497	Liu MA	DNA vaccines: an historical perspective and view to the future.	Immunological reviews	2011	97
21246542	51497	de Lalla C	High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells.	European journal of immunology	2011	40
21861858	51497	Duffy MM	Mesenchymal stem cell effects on T-cell effector pathways.	Stem cell research and therapy	2011	73
22323527	51497	Pesonen S	Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: assessment of safety and immunologic responses in patients.	Cancer research	2012	37
22430490	51497	Segura E	Characterization of resident and migratory dendritic cells in human lymph nodes.	The Journal of experimental medicine	2012	86
22679012	51497	Selman M	Hypersensitivity pneumonitis: insights in diagnosis and pathobiology.	American journal of respiratory and critical care medicine	2012	37
22719180	51497	Sykes L	The Th1:th2 dichotomy of pregnancy and preterm labour.	Mediators of inflammation	2012	32
23220043	51497	Klaver EJ	Trichuris suis-induced modulation of human dendritic cell function is glycan-mediated.	International journal for parasitology	2013	28
23359064	51497	Yang CY	The implication of vitamin D and autoimmunity: a comprehensive review.	Clinical reviews in allergy and immunology	2013	25
23791644	51497	Hawkins RD	Global chromatin state analysis reveals lineage-specific enhancers during the initiation of human T helper 1 and T helper 2 cell polarization.	Immunity	2013	30
23889510	51497	Eyerich K	Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.	Allergy	2013	30
24286760	51497	Bergink V	Autoimmunity, inflammation, and psychosis: a search for peripheral markers.	Biological psychiatry	2014	32
24975812	51497	Scheiermann J	Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer.	Vaccine	2014	25
25454872	51497	van Dissel JT	A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.	Vaccine	2014	21
25818339	51497	Vinay DS	Immune evasion in cancer: Mechanistic basis and therapeutic strategies.	Seminars in cancer biology	2015	46
25879814	51497	Schmitt N	Regulation of human helper T cell subset differentiation by cytokines.	Current opinion in immunology	2015	20
26095509	51497	Luabeya AK	First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults.	Vaccine	2015	17
26576827	51497	Ip B	Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFÎ± production.	Obesity	2016	12
26702627	51497	Tappe D	Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase.	Medical microbiology and immunology	2016	14
26772756	51497	Mills CD	A Breakthrough: Macrophage-Directed Cancer Immunotherapy.	Cancer research	2016	15
27640624	51497	Liew FY	Interleukin-33 in health and disease.	Nature reviews. Immunology	2016	19
11130078	54106	Hemmi H	A Toll-like receptor recognizes bacterial DNA.	Nature	2000	1194
11561001	54106	Kadowaki N	Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens.	The Journal of experimental medicine	2001	398
12560217	54106	Bernasconi NL	A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells.	Blood	2003	159
12689944	54106	Bourke E	The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells.	Blood	2003	99
15240708	54106	Leifer CA	TLR9 is localized in the endoplasmic reticulum prior to stimulation.	Journal of immunology	2004	81
16864658	54106	Guiducci C	Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.	The Journal of experimental medicine	2006	99
18178818	54106	Capolunghi F	CpG drives human transitional B cells to terminal differentiation and production of natural antibodies.	Journal of immunology	2008	67
20442853	54106	Nguyen M	Acquisition of adult-like TLR4 and TLR9 responses during the first year of life.	PloS one	2010	45
20697067	54106	Brody JD	In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study.	Journal of clinical oncology 	2010	105
21129170	54106	GonzÃ¡lez-Reyes S	Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis.	BMC cancer	2010	48
21389263	54106	Lande R	Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus.	Science translational medicine	2011	241
22207622	54106	Miles K	A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells.	Proceedings of the National Academy of Sciences of the United States of America	2012	33
22351936	54106	Tillack K	T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses.	Journal of immunology	2012	34
25638528	54106	Coit P	Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils.	Journal of autoimmunity	2015	18
26168081	54106	Meller S	T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26.	Nature immunology	2015	19
26808498	54106	Garcia-Martinez I	Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9.	The Journal of clinical investigation	2016	15
7506951	54474	Reff ME	Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.	Blood	1994	246
9310469	54474	Maloney DG	IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma.	Blood	1997	187
11067960	54474	Odendahl M	Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus.	Journal of immunology	2000	114
12853585	54474	Sarwal M	Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling.	The New England journal of medicine	2003	138
14530402	54474	Whitfield ML	Systemic and cell type-specific gene expression patterns in scleroderma skin.	Proceedings of the National Academy of Sciences of the United States of America	2003	96
15087226	54474	Crotty S	Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system.	Journal of immunological methods	2004	159
15529346	54474	Anolik JH	Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.	Arthritis and rheumatism	2004	79
15689582	54474	Kaminski MS	131I-tositumomab therapy as initial treatment for follicular lymphoma.	The New England journal of medicine	2005	103
16926291	54474	Vera J	T lymphocytes redirected against the kappa light chain of human immunoglobulin efficiently kill mature B lymphocyte-derived malignant cells.	Blood	2006	92
17709552	54474	Ahuja A	Depletion of B cells in murine lupus: efficacy and resistance.	Journal of immunology	2007	79
18272891	54474	Hauser SL	B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.	The New England journal of medicine	2008	360
18339801	54474	Ahuja A	Maintenance of the plasma cell pool is independent of memory B cells.	Proceedings of the National Academy of Sciences of the United States of America	2008	52
18453625	54474	James SE	Antigen sensitivity of CD22-specific chimeric TCR is modulated by target epitope distance from the cell membrane.	Journal of immunology	2008	53
18578012	54474	Funke S	Targeted cell entry of lentiviral vectors.	Molecular therapy 	2008	57
18698040	54474	Al-Shibli KI	Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.	Clinical cancer research 	2008	89
19535640	54474	Pawluczkowycz AW	Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.	Journal of immunology	2009	48
19940299	54474	Pescovitz MD	Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.	The New England journal of medicine	2009	229
20194898	54474	MÃ¶ssner E	Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity.	Blood	2010	125
20501946	54474	Newell KA	Identification of a B cell signature associated with renal transplant tolerance in humans.	The Journal of clinical investigation	2010	160
20813259	54474	Chao MP	Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.	Cell	2010	133
20962266	54474	Nelson BH	CD20+ B cells: the other tumor-infiltrating lymphocytes.	Journal of immunology	2010	68
20980506	54474	Ma SD	A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas.	Journal of virology	2011	60
21220451	54474	Griffin DO	Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-.	The Journal of experimental medicine	2011	178
21289059	54474	Caliskan M	The effects of EBV transformation on gene expression levels and methylation profiles.	Human molecular genetics	2011	49
22039471	54474	Fluge Ã	Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.	PloS one	2011	39
22047971	54474	Kappos L	Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.	Lancet	2011	105
22308288	54474	Till BG	CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.	Blood	2012	97
23319647	54474	Marzi A	Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates.	Proceedings of the National Academy of Sciences of the United States of America	2013	45
23613519	54474	Covens K	Characterization of proposed human B-1 cells reveals pre-plasmablast phenotype.	Blood	2013	25
23720127	54474	Hallek M	Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.	American journal of hematology	2013	37
24475900	54474	Woo JR	Tumor infiltrating B-cells are increased in prostate cancer tissue.	Journal of translational medicine	2014	24
24815737	54474	Mattoo H	De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.	The Journal of allergy and clinical immunology	2014	24
24817416	54474	Wallace ZS	Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.	Annals of the rheumatic diseases	2015	31
25344523	54474	Da Roit F	Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.	Haematologica	2015	25
25636338	54474	Castillo JJ	The biology and treatment of plasmablastic lymphoma.	Blood	2015	22
25653369	54474	Doyle KP	B-lymphocyte-mediated delayed cognitive impairment following stroke.	The Journal of neuroscience 	2015	21
25908509	54474	Hallek M	Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment.	American journal of hematology	2015	38
26581594	54474	Campbell-Thompson M	Insulitis and Î²-Cell Mass in the Natural History of Type 1 Diabetes.	Diabetes	2016	25
27059623	54474	Zah E	T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells.	Cancer immunology research	2016	19
28002688	54474	Montalban X	Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.	The New England journal of medicine	2017	19
15084263	59067	King C	Homeostatic expansion of T cells during immune insufficiency generates autoimmunity.	Cell	2004	194
15100251	59067	PÃ¨ne J	Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells.	Journal of immunology	2004	73
16081794	59067	Li Y	IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response.	Journal of immunology	2005	80
16339522	59067	Ettinger R	IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells.	Journal of immunology	2005	165
17947662	59067	Kuchen S	Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration.	Journal of immunology	2007	83
18056361	59067	Bryant VL	Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells.	Journal of immunology	2007	132
18469800	59067	Yang L	IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.	Nature	2008	297
19546505	59067	Jones JL	IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).	The Journal of clinical investigation	2009	50
19592276	59067	Schmitt N	Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12.	Immunity	2009	105
19949086	59067	Iannello A	Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study.	Journal of immunology	2010	58
20048285	59067	Avery DT	B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans.	The Journal of experimental medicine	2010	95
21215658	59067	Morita R	Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion.	Immunity	2011	251
22188745	59067	Zhu C	Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease.	The Journal of clinical endocrinology and metabolism	2012	42
22649468	59067	Ma J	Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis.	Clinical and developmental immunology	2012	61
23447018	59067	Chapuis AG	Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients.	Science translational medicine	2013	75
23515118	59067	Knorr DA	Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy.	Stem cells translational medicine	2013	35
23853592	59067	Pallikkuth S	Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21.	PLoS pathogens	2013	35
24695686	59067	Liarski VM	Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue.	Science translational medicine	2014	27
24746753	59067	Salzer E	Early-onset inflammatory bowel disease and common variable immunodeficiency-like disease caused by IL-21 deficiency.	The Journal of allergy and clinical immunology	2014	22
26286233	59067	Ortiz AM	IL-21 and probiotic therapy improve Th17 frequencies, microbial translocation, and microbiome in ARV-treated, SIV-infected macaques.	Mucosal immunology	2016	19
11574464	112744	Hymowitz SG	IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding.	The EMBO journal	2001	95
12651226	112744	Moseley TA	Interleukin-17 family and IL-17 receptors.	Cytokine and growth factor reviews	2003	199
16670771	112744	Chen Y	Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.	The Journal of clinical investigation	2006	165
17355969	112744	Wright JF	Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells.	The Journal of biological chemistry	2007	66
17676044	112744	Wilson NJ	Development, cytokine profile and function of human interleukin 17-producing helper T cells.	Nature immunology	2007	495
18039580	112744	Lubberts E	IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?	Cytokine	2008	65
18088064	112744	Seiderer J	Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.	Inflammatory bowel diseases	2008	81
19161418	112744	Fouser LA	Th17 cytokines and their emerging roles in inflammation and autoimmunity.	Immunological reviews	2008	61
19161423	112744	Dubin PJ	Th17 cytokines and mucosal immunity.	Immunological reviews	2008	60
19273625	112744	Boniface K	Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling.	The Journal of experimental medicine	2009	112
19592695	112744	Brand S	Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.	Gut	2009	161
19604272	112744	Di Stefano A	T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients.	Clinical and experimental immunology	2009	68
19890092	112744	Pelletier M	Evidence for a cross-talk between human neutrophils and Th17 cells.	Blood	2010	130
20123959	112744	Kisand K	Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.	The Journal of experimental medicine	2010	148
20348925	112744	Axtell RC	T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis.	Nature medicine	2010	172
20674321	112744	Puel A	Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?	Current opinion in immunology	2010	48
21350122	112744	Puel A	Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity.	Science	2011	216
21381156	112744	Hundorfean G	Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease.	Inflammatory bowel diseases	2012	34
23563688	112744	Bermejo DA	Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORÎ³t and Ahr that leads to IL-17 production by activated B cells.	Nature immunology	2013	46
23956763	112744	Qu N	Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.	Clinical and developmental immunology	2013	29
24035139	112744	Newcomb DC	Th17-mediated inflammation in asthma.	Current opinion in immunology	2013	34
24986688	112744	Guedan S	ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.	Blood	2014	38
25174402	112744	De Simone V	Th17-type cytokines, IL-6 and TNF-Î± synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.	Oncogene	2015	37
25254011	112744	Shabgah AG	Interleukin-17 in human inflammatory diseases.	Postepy dermatologii i alergologii	2014	32
25844618	112744	Roos AB	IL-17A Is Elevated in End-Stage Chronic Obstructive Pulmonary Disease and Contributes to Cigarette Smoke-induced Lymphoid Neogenesis.	American journal of respiratory and critical care medicine	2015	20
26160376	112744	Okada S	IMMUNODEFICIENCIES. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations.	Science	2015	42
12032915	114548	Feldmann J	Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes.	American journal of human genetics	2002	138
15030775	114548	Agostini L	NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.	Immunity	2004	381
15530394	114548	Martinon F	Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome.	Current biology 	2004	151
18005730	114548	Willingham SB	Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC.	Cell host and microbe	2007	105
19105226	114548	Caicedo MS	Soluble and particulate Co-Cr-Mo alloy implant metals activate the inflammasome danger signaling pathway in human macrophages: a novel mechanism for implant debris reactivity.	Journal of orthopaedic research 	2009	47
19246182	114548	Lambrecht BN	Mechanism of action of clinically approved adjuvants.	Current opinion in immunology	2009	76
19454352	114548	Hise AG	An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans.	Cell host and microbe	2009	163
19805629	114548	Lamkanfi M	Glyburide inhibits the Cryopyrin/Nalp3 inflammasome.	The Journal of cell biology	2009	151
19826485	114548	Craven RR	Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.	PloS one	2009	115
20008285	114548	Meixenberger K	Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3.	Journal of immunology	2010	65
20038581	114548	Okamoto M	Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta.	The Journal of biological chemistry	2010	66
20368800	114548	SaÃ¯d-Sadier N	Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase.	PloS one	2010	90
20383149	114548	Ichinohe T	Influenza virus activates inflammasomes via its intracellular M2 ion channel.	Nature immunology	2010	166
20407038	114548	van Bruggen R	Human NLRP3 inflammasome activation is Nox1-4 independent.	Blood	2010	53
20421639	114548	Kankkunen P	(1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages.	Journal of immunology	2010	65
20668705	114548	RajamÃ¤ki K	Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation.	PloS one	2010	147
20835230	114548	Masters SL	Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1Î² in type 2 diabetes.	Nature immunology	2010	281
20980503	114548	Barlan AU	Adenovirus membrane penetration activates the NLRP3 inflammasome.	Journal of virology	2011	51
21300955	114548	Dehghan A	Meta-analysis of genome-wide association studies in &amp;gt;80 000 subjects identifies multiple loci for C-reactive protein levels.	Circulation	2011	140
21349431	114548	Guarda G	Type I interferon inhibits interleukin-1 production and inflammasome activation.	Immunity	2011	203
21474346	114548	Kool M	An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma.	Immunity	2011	76
21508263	114548	Niemi K	Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.	Journal of immunology	2011	63
21740493	114548	Wong KW	Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis.	Cellular microbiology	2011	46
21800904	114548	PalomÃ¤ki J	Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism.	ACS nano	2011	72
22461501	114548	Shenoy AR	GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals.	Science	2012	88
22523386	114548	Benoit ME	Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells.	Journal of immunology	2012	49
22541070	114548	Tarallo V	DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88.	Cell	2012	149
22948162	114548	Juliana C	Non-transcriptional priming and deubiquitination regulate NLRP3 inflammasome activation.	The Journal of biological chemistry	2012	98
23530046	114548	RajamÃ¤ki K	Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome.	The Journal of biological chemistry	2013	40
23633957	114548	Negash AA	IL-1Î² production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease.	PLoS pathogens	2013	88
23809162	114548	Yan Y	Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.	Immunity	2013	71
23871209	114548	Mitoma H	The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome.	Immunity	2013	33
23955712	114548	Jourdan T	Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.	Nature medicine	2013	63
24043885	114548	Snodgrass RG	Inflammasome-mediated secretion of IL-1Î² in human monocytes through TLR2 activation; modulation by dietary fatty acids.	Journal of immunology	2013	31
24398679	114548	Bakele M	Localization and functionality of the inflammasome in neutrophils.	The Journal of biological chemistry	2014	20
24417322	114548	Li R	Surface interactions with compartmentalized cellular phosphates explain rare earth oxide nanoparticle hazard and provide opportunities for safer design.	ACS nano	2014	21
24453977	114548	Ataide MA	Malaria-induced NLRP12/NLRP3-dependent caspase-1 activation mediates inflammation and hypersensitivity to bacterial superinfection.	PLoS pathogens	2014	30
24513871	114548	Alcocer-GÃ³mez E	NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder.	Brain, behavior, and immunity	2014	24
24623131	114548	Ghonime MG	Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function.	Journal of immunology	2014	28
24939850	114548	Guo H	HIV-1 infection induces interleukin-1Î² production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes.	The Journal of biological chemistry	2014	22
24952504	114548	Baroja-Mazo A	The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response.	Nature immunology	2014	100
25217959	114548	Canna SW	An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.	Nature genetics	2014	53
25686106	114548	Youm YH	The ketone metabolite Î²-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.	Nature medicine	2015	70
25730877	114548	Carta S	Cell stress increases ATP release in NLRP3 inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
25917098	114548	Sokolowska M	Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.	Journal of immunology	2015	21
25993444	114548	Schaale K	Strain- and host species-specific inflammasome activation, IL-1Î² release, and cell death in macrophages infected with uropathogenic Escherichia coli.	Mucosal immunology	2016	11
26341399	114548	Bronner DN	Endoplasmic Reticulum Stress Activates the Inflammasome via NLRP3- and Caspase-2-Driven Mitochondrial Damage.	Immunity	2015	27
26611636	114548	He WT	Gasdermin D is an executor of pyroptosis and required for interleukin-1Î² secretion.	Cell research	2015	55
26814970	114548	He Y	NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.	Nature	2016	24
26877061	114548	Karmakar M	Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1Î² secretion in response to ATP.	Nature communications	2016	23
26972847	114548	Iannitti RG	IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis.	Nature communications	2016	11
27037191	114548	Gaidt MM	Human Monocytes Engage an Alternative Inflammasome Pathway.	Immunity	2016	25
27313051	114548	Arbore G	T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4âº T cells.	Science	2016	26
27650785	114548	Montesinos J	Impact of the Innate Immune Response in the Actions of Ethanol on the Central Nervous System.	Alcoholism, clinical and experimental research	2016	12
27669650	114548	He Y	Mechanism and Regulation of NLRP3 Inflammasome Activation.	Trends in biochemical sciences	2016	22
10024247	116255	Rissoan MC	Reciprocal control of T helper cell and dendritic cell differentiation.	Science	1999	249
11726975	116255	Zou W	Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells.	Nature medicine	2001	135
11823500	116255	de Jong EC	Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals.	Journal of immunology	2002	84
11901196	116255	Gilliet M	Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells.	The Journal of experimental medicine	2002	124
12960343	116255	Matsumoto M	Subcellular localization of Toll-like receptor 3 in human dendritic cells.	Journal of immunology	2003	160
15494428	116255	Aggarwal S	Human mesenchymal stem cells modulate allogeneic immune cell responses.	Blood	2005	855
11086035	170482	Dzionek A	BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood.	Journal of immunology	2000	259
11748283	170482	Dzionek A	BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction.	The Journal of experimental medicine	2001	149
17786242	170482	Zaba LC	Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages.	The Journal of clinical investigation	2007	89
22891284	170482	Yin Z	Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells.	Journal of immunology	2012	36
23633414	170482	Laresgoiti-Servitje E	A leading role for the immune system in the pathophysiology of preeclampsia.	Journal of leukocyte biology	2013	35
9547346	246100	Stockert E	A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.	The Journal of experimental medicine	1998	150
15252201	246100	Davis ID	Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans.	Proceedings of the National Academy of Sciences of the United States of America	2004	82
16344461	246100	Sato E	Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.	Proceedings of the National Academy of Sciences of the United States of America	2005	479
16860654	246100	Gnjatic S	NY-ESO-1: review of an immunogenic tumor antigen.	Advances in cancer research	2006	80
17517626	246100	Valmori D	Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.	Proceedings of the National Academy of Sciences of the United States of America	2007	83
17652518	246100	Odunsi K	Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer.	Proceedings of the National Academy of Sciences of the United States of America	2007	64
17947658	246100	Zhao Y	High-affinity TCRs generated by phage display provide CD4+ T cells with the ability to recognize and kill tumor cell lines.	Journal of immunology	2007	71
18093940	246100	Vence L	Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma.	Proceedings of the National Academy of Sciences of the United States of America	2007	58
18424733	246100	Robbins PF	Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions.	Journal of immunology	2008	81
18565862	246100	Hunder NN	Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.	The New England journal of medicine	2008	265
20351194	246100	Schmid DA	Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.	Journal of immunology	2010	44
21149605	246100	Tsuji T	Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity.	Journal of immunology	2011	39
21282551	246100	Robbins PF	Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.	Journal of clinical oncology 	2011	350
22454499	246100	Odunsi K	Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.	Proceedings of the National Academy of Sciences of the United States of America	2012	46
22549784	246100	Irving M	Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness.	The Journal of biological chemistry	2012	32
22553348	246100	Nielsen JS	CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.	Clinical cancer research 	2012	61
23032745	246100	Sabbatini P	Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients.	Clinical cancer research 	2012	48
24323899	246100	Weide B	Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells.	Clinical cancer research 	2014	38
24329789	246100	Hinrichs CS	Exploiting the curative potential of adoptive T-cell therapy for cancer.	Immunological reviews	2014	79
24739759	246100	Dhodapkar MV	Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205.	Science translational medicine	2014	53
25538264	246100	Robbins PF	A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response.	Clinical cancer research 	2015	59
26193344	246100	Rapoport AP	NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma.	Nature medicine	2015	51
14764690	246778	Pflanz S	WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27.	Journal of immunology	2004	164
17496900	246778	Amadi-Obi A	TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1.	Nature medicine	2007	248
19625647	246778	Murugaiyan G	IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells.	Journal of immunology	2009	83
21357266	246778	Ansari NA	IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis.	Journal of immunology	2011	54
21420486	246778	Sweeney CM	IL-27 mediates the response to IFN-Î² therapy in multiple sclerosis patients by inhibiting Th17 cells.	Brain, behavior, and immunity	2011	36
22021194	246778	Nimmo ER	Genome-wide methylation profiling in Crohn's disease identifies altered epigenetic regulation of key host defense mechanisms including the Th17 pathway.	Inflammatory bowel diseases	2012	34
22177689	246778	Wojno ED	New directions in the basic and translational biology of interleukin-27.	Trends in immunology	2012	34
22608254	246778	Hall AO	The immunobiology of IL-27.	Advances in immunology	2012	38
22990890	246778	Banchereau J	From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines.	Nature immunology	2012	71
25861977	246778	Yoshida H	The immunobiology of interleukin-27.	Annual review of immunology	2015	30
26013006	246778	Do JS	An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy.	Mucosal immunology	2016	12
26304966	246778	Kreins AY	Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.	The Journal of experimental medicine	2015	17
26595887	246778	Duerr CU	Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells.	Nature immunology	2016	24
16447239	100133941	Leandro MJ	Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis.	Arthritis and rheumatism	2006	84
17020963	100133941	Balic M	Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.	Clinical cancer research 	2006	161
19188015	100133941	Keller S	Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.	Cancer letters	2009	64
19264983	100133941	Chen GY	CD24 and Siglec-10 selectively repress tissue damage-induced immune responses.	Science	2009	186
19414749	100133941	Palanichamy A	Novel human transitional B cell populations revealed by B cell depletion therapy.	Journal of immunology	2009	80
20079667	100133941	Blair PA	CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.	Immunity	2010	263
20962324	100133941	Iwata Y	Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells.	Blood	2011	221
21067584	100133941	Louie E	Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation.	Breast cancer research 	2010	47
23427243	100133941	Flores-Borja F	CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.	Science translational medicine	2013	88
23436798	100133941	Akalay I	Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis.	Cancer research	2013	43
24129232	100133941	Seo AN	Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer.	British journal of cancer	2013	38
24354874	100133941	Chesneau M	Unique B cell differentiation profile in tolerant kidney transplant patients.	American journal of transplantation 	2014	22
25051962	100133941	Khoder A	Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.	Blood	2014	41
25376628	100133941	Franquesa M	Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells.	Stem cells	2015	18
25605369	100133941	de Masson A	CD24(hi)CD27âº and plasmablast-like regulatory B cells in human chronic graft-versus-host disease.	Blood	2015	24
26968426	100133941	Menon M	A Regulatory Feedback between Plasmacytoid Dendritic Cells and Regulatory B Cells Is Aberrant in Systemic Lupus Erythematosus.	Immunity	2016	18
9497295	100507436	Groh V	Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells.	Science	1998	214
10359807	100507436	Groh V	Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB.	Proceedings of the National Academy of Sciences of the United States of America	1999	186
11491531	100507436	Steinle A	Interactions of human NKG2D with its ligands MICA, MICB, and homologs of the mouse RAE-1 protein family.	Immunogenetics	2001	91
12384702	100507436	Groh V	Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation.	Nature	2002	320
12414645	100507436	Pende D	Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.	Cancer research	2002	106
12714493	100507436	Salih HR	Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia.	Blood	2003	100
12878725	100507436	Groh V	Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis.	Proceedings of the National Academy of Sciences of the United States of America	2003	115
15357948	100507436	HÃ¼e S	A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.	Immunity	2004	145
16024634	100507436	Armeanu S	Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.	Cancer research	2005	79
17218381	100507436	Nedvetzki S	Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.	Blood	2007	62
18176566	100507436	Strid J	Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis.	Nature immunology	2008	79
18202175	100507436	Jinushi M	MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma.	Proceedings of the National Academy of Sciences of the United States of America	2008	64
18519766	100507436	Han LY	HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.	Clinical cancer research 	2008	55
20068167	100507436	Ashiru O	Natural killer cell cytotoxicity is suppressed by exposure to the human NKG2D ligand MICA*008 that is shed by tumor cells in exosomes.	Cancer research	2010	64
20212116	100507436	Chauveau A	Membrane nanotubes facilitate long-distance interactions between natural killer cells and target cells.	Proceedings of the National Academy of Sciences of the United States of America	2010	44
21262824	100507436	Xu B	Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA.	Proceedings of the National Academy of Sciences of the United States of America	2011	37
21339714	100507436	Somanchi SS	Expansion, purification, and functional assessment of human peripheral blood NK cells.	Journal of visualized experiments 	2011	37
21606166	100507436	Szczepanski MJ	Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1.	Haematologica	2011	56
23444227	100507436	Srivastava RM	Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.	Clinical cancer research 	2013	66
23679194	100507436	Chitadze G	Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.	Scandinavian journal of immunology	2013	29
25164008	100507436	Wang B	Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells.	Cancer research	2014	24
26041808	100507436	Lanier LL	NKG2D Receptor and Its Ligands in Host Defense.	Cancer immunology research	2015	40
26215033	100507436	Harden JL	The immunogenetics of Psoriasis: A comprehensive review.	Journal of autoimmunity	2015	20
